0001213900-17-005234.txt : 20170515 0001213900-17-005234.hdr.sgml : 20170515 20170515162614 ACCESSION NUMBER: 0001213900-17-005234 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 44 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170515 DATE AS OF CHANGE: 20170515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORIGINCLEAR, INC. CENTRAL INDEX KEY: 0001419793 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-147980 FILM NUMBER: 17844632 BUSINESS ADDRESS: STREET 1: 525 S. HEWITT ST. CITY: Los Angeles STATE: CA ZIP: 90013 BUSINESS PHONE: 323.939.6645 MAIL ADDRESS: STREET 1: 525 S. HEWITT ST. CITY: Los Angeles STATE: CA ZIP: 90013 FORMER COMPANY: FORMER CONFORMED NAME: ORIGINOIL INC DATE OF NAME CHANGE: 20071129 10-Q 1 f10q0317_originclearinc.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: March 31, 2017

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: ________________

ORIGINCLEAR, INC.

(Exact name of registrant as specified in its charter)

Nevada		26-0287664
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

525 S. Hewitt St.

Los Angeles, CA 90013

(Address of principal executive offices, Zip Code)

(323) 939-6645

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of May 15, 2017, there were 38,318,007 shares of common stock, par value $0.0001, issued and outstanding.

TABLE OF CONTENTS

		Page
PART I

Item 1.	Financial Statements.	2
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	16
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	21
Item 4.	Controls and Procedures.	21

PART II

Item 1.	Legal Proceedings.	23
Item 1A.	Risk Factors.	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	23
Item 3.	Defaults Upon Senior Securities.	23
Item 4.	Mine Safety Disclosures.	23
Item 5.	Other Information.	23
Item 6.	Exhibits.	23

SIGNATURES		24

PART I - FINANCIAL INFORMATION

This Quarterly Report includes forward-looking statements within the meaning of the Securities Exchange Act of 1934 (the “Exchange Act”). These statements are based on management’s beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading “Management’s Discussion and Analysis of Financial Condition or Plan of Operation.” Forward-looking statements also include statements in which words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “consider” or similar expressions are used.

Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.

Item 1. Financial Statements

ORIGINCLEAR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2017			December 31, 2016
		(Unaudited)
ASSETS

CURRENT ASSETS
Cash	$	442,928		$	351,321
Contracts receivable, less allowance for doubtful accounts of $50,000 and $50,000 respectively		130,269			382,895
Inventory		13,613			-
Cost in excess of billing		144,192			47,612
Work in progress		86,085			86,085
Prepaid expenses		33,912			42,128

TOTAL CURRENT ASSETS		850,999			910,041

NET PROPERTY AND EQUIPMENT		181,230			161,912

OTHER ASSETS
Other asset		19,538			19,538
Goodwill		682,145			682,145
Trademark		4,467			4,467
Security deposit		3,500			3,500

TOTAL OTHER ASSETS		709,650			709,650

TOTAL ASSETS	$	1,741,879		$	1,781,603

LIABILITIES AND SHAREHOLDERS' DEFICIT

Current Liabilities
Accounts payable and other payable	$	585,597		$	480,064
Accrued expenses		735,379			715,281
Billing in excess of cost		16,327			-
Customer deposit		113,950			113,950
Warrant reserve		20,000			20,000
Deferred income		10,300			-
Loan payable, current portion		5,978			-
Derivative liabilities		7,629,986			8,702,083
Convertible promissory notes, net of discount of $492,237 and $591,835, respectively		289,831			1,935,233

Total Current Liabilities		9,407,348			11,966,611

Long Term Liabilities
Loan payable, long term portion		25,258			-
Convertible promissory notes, net of discount of $931 and $11,429, respectively		3,084,069			1,613,571

Total Long Term Liabilities		3,109,327			1,613,571

Total Liabilities		12,516,675			13,580,182

SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value, 25,000,000 shares authorized 6,666 shares of Series B issued and outstanding, respectively		1			1
1,000 shares of Series C issued and outstanding, respectively		-			-
Common stock, $0.0001 par value, 5,000,000,000 shares authorized 30,506,732 and 21,428,455 shares issued and outstanding, respectively		3,051			2,143
Preferred treasury stock, 1,000 and 1,000 shares outstanding, respectively		-			-
Additional paid in capital		52,684,407			51,428,976
Accumulated other comprehensive loss		(95	)		(92	)
Accumulated deficit		(63,462,160	)		(63,229,607	)

TOTAL SHAREHOLDERS' DEFICIT		(10,774,796	)		(11,798,579	)

TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$	1,741,879		$	1,781,603

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 2017 AND 2016

(Unaudited)

	Three Months Ended
	March 31, 2017			March 31, 2016

Sales	$	672,129		$	1,467,750

Cost of Goods Sold		582,456			1,068,427

Gross Profit		89,673			399,323

Operating Expenses
Selling and marketing expenses		512,801			493,510
General and administrative expenses		624,530			686,846
Research and development		53,653			210,150
Depreciation and amortization expense		13,600			11,239

Total Operating Expenses		1,204,584			1,401,745

Loss from Operations		(1,114,911	)		(1,002,422	)

OTHER INCOME (EXPENSE)
Fair value of debt financing cost		-			(52,759	)
Gain on net change in derivative liability		1,072,096			2,599,198
Interest expense		(189,738	)		(202,016	)

TOTAL OTHER INCOME (EXPENSE)		882,358			2,344,423


NET (LOSS) INCOME	$	(232,553	)	$	1,342,001

BASIC AND DILUTED (LOSS) EARNING PER SHARE ATTRIBUTABLE TO SHAREHOLDERS'	$	(0.01	)	$	0.18

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED		25,082,031			7,348,638

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31, 2017

									Additional		Accumulated Other
	Preferred stock				Common stock				Paid-in		Comprehensive			Accumulated
	Shares		Amount		Shares		Amount		Capital		loss			Deficit			Total
Balance at December 31, 2016		7,666	$	1		21,428,454	$	2,143	$	51,428,976	$	(92	)	$	(63,229,607	)	$	(11,798,579	)

Common stock issuance for cash		-		-		2,420,000		242		423,258		-			-			423,500

Common stock issuance for conversion of debt		-		-		3,207,139		321		243,891		-			-			244,212

Common stock issuance for settlement of accounts payable		-		-		886,700		89		89,911		-			-			90,000

Common stock issued at fair value for services		-		-		2,564,439		256		463,771		-			-			464,027

Stock compensation cost		-		-		-		-		34,600		-			-			34,600

Other comprehensive loss		-		-		-		-		-		(3	)		-			(3	)

Net loss for the three months ended March 31, 2017		-		-		-		-		-		-			(232,553	)		(232,553	)

Balance at March 31, 2017 (unaudited)		7,666	$	1		30,506,732	$	3,051	$	52,684,407	$	(95	)	$	(63,462,160	)	$	(10,774,796	)

The accompany notes are an integral part of these unaudited condensed consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended
	March 31, 2017			March 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(232,553	)	$	1,342,001
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization		13,600			11,239
Common stock and warrants issued for services		464,027			293,980
Stock option and warrant compensation expense		34,600			52,296
Gain on net change in valuation of derivative liability		(1,072,097	)		(2,546,439	)
Debt discount and original issue discount recognized as interest expense		110,097			120,816
Change in Assets (Increase) Decrease in:
Contracts receivable		252,626			(110,769	)
Cost in excess of billing		(96,580	)		(157,357	)
Inventory asset		(13,613	)		-
Prepaid expenses		8,216			428
Other asset		-			42
Change in Liabilities Increase (Decrease) in:
Accounts payable		105,533			299,036
Accrued expenses		69,309			105,537
Billing in excess of cost		16,327			49,100
Deferred income		10,300			-

NET CASH USED IN OPERATING ACTIVITIES		(330,208	)		(540,090	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets		(32,918	)		(5,699	)

CASH (USED IN) INVESTING ACTIVITIES		(32,918	)		(5,699	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Loan payable		31,236			-
Proceeds from convertible promissory notes		-			100,000
Proceeds for issuance of common stock for cash		423,500			-

NET CASH PROVIDED BY FINANCING ACTIVITIES		454,736			100,000

Foreign currency effect on cash flow		(3	)		-

NET INCREASE (DECREASE) IN CASH		91,607			(445,789	)

CASH BEGINNING OF PERIOD		351,321			695,295

CASH END OF PERIOD	$	442,928		$	249,506

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	1,258		$	366
Taxes paid	$	-		$	-

SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Conversion of accounts payable into a convertible note	$	-		$	430,896
Beneficial conversion feature on convertible note	$	-		$	16,771
Common stock issued for supplemental shares	$	44,440		$	-
Common stock issued for conversion of debt and accrued interest	$	244,212		$	426,114
Common stock issued for settlement of accounts payable	$	90,000		$	-
Change in derivative liability on Series B preferred stock	$	-		$	123,110

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

The accompanying unaudited condensed financial statements of OriginClear, Inc. (the “Company”) (formerly OriginOil, Inc.) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended December 31, 2016.

Going Concern

The accompanying condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying condensed financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company’s revenue is not yet sufficient to cover its operating expenditures and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. Management believes the existing shareholders, the prospective new investors, current and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing.

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear (HK) Company, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.

Loss per Share Calculations

Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

The Company has excluded 3,697,495 of stock options, 506,026 warrants, and the shares issuable from convertible debt of $3,867,068 and shares issuable from convertible preferred stock for the three months ended March 31, 2017, because their impact on the loss per share is anti-dilutive.

The Company has excluded 3,411,561 stock options, 653,851 warrants, and the shares issuable from convertible debt of $4,582,068 and shares issuable from convertible preferred stock for the for the three months ended March 31, 2016, because their impact on the earnings per share is anti-dilutive.

Work-in-Process

The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)

Revenue Recognition

Equipment sales

We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Title to the equipment is transferred to the customer once the last payment is received. We record revenue as goods are shipped, and the equipment has been fully accepted by the customer. Generally, we extend credit to our customers and do not require collateral. We do not ship a product until we have a purchase agreement signed by the customer with a payment arrangement.

Percentage of completion

Revenues and related costs on construction contracts are recognized using the “percentage of completion method” of accounting in accordance with ASC 605-35 – “Accounting for Performance of Construction-Type and Certain Production Type Contracts”. Under this method, contract revenues and related expenses are recognized over the performance period of the contract in direct proportion to the costs incurred as a percentage of total estimated costs for the entirety of the contract. Costs include direct material, direct labor, subcontract labor and any allocable indirect costs. All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined.

The asset “Costs in excess of billings” represents revenues recognized in excess of amounts billed on contracts in progress. The liability “Billings in excess of costs” represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The cost in excess of billings for the three months ending March 31, 2017 and 2016, were $144,192 and $174,105, respectively. The billing in excess of cost was for the three months ending March 31, 2017 and 2016, was $16,327 and $552,818, respectively.

Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined.

Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.

Contract Receivable

The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $50,000 as of March 31, 2017 and December 31, 2016, respectively. The net contract receivable balance was $130,269 and $382,895 at March 31, 2017 and December 31, 2016, respectively.

Fair Value of Financial Instruments

Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2017, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2017.

	Total		(Level 2)		(Level 2)		(Level 3)

Derivative Liability	$	7,629,986	$	-	$	-	$	7,629,986

Total liabilities measured at fair value	$	7,629,986	$	-	$	-	$	7,629,986

The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value:

Balance as of January 1, 2017	$	8,702,083
Fair Value of derivative liabilities issued		-
Gain on conversion of debt and change in derivative liability		(1,072,097	)
Balance as of March 31, 2017		7,629,986

For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows:

				03/31/2017
	Risk free interest rate			.01% - 1.02%
	Stock volatility factor			4.72% - 189.09%
	Weighted average expected option life			6 months - 5 years
	Expected dividend yield			None

Segment Reporting

The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.

Recently Issued Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-2, which creates ASC Topic 842, “Leases.” This update increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This guidance is effective for interim and annual reporting periods beginning after December 15, 2018. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures.

In August 2016, the FASB issued ASU No. 2016-15 which amends ASC Topic 230, “Classification of Certain Cash Receipts and Cash Payments.” The amendments in this Update address eight specific cash flow issues with the objective of reducing the existing diversity in practice. The update outlines the classification of specific transactions as either cash inflows or outflows from financing activities, operating activities, investing activities or non-cash activities. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures.

Management reviewed currently issued pronouncements during the period ended March 31, 2017, and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

3.	CAPITAL STOCK

Preferred Stock

Series A

On March 30, 2017, the Board of Directors of the Company authorized the withdrawal of the Series A preferred stock. As of March 31, 2017, no shares of Series A preferred stock were outstanding.

Series B

On October 1, 2015, the Company filed a Certificate of Designation for Series B preferred stock with the Secretary of State of Nevada and the shares of Series B preferred stock were issued to the shareholders of Progressive Water Treatment, Inc. in connection with the share exchange agreement. One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B Preferred Stock was issued (the “Original Issue Date); one third (1/3) may be converted beginning two (2) years after the Original Issue Date; and the remaining one third (1/3) may be converted beginning three years after the Original Issue Date. The number of shares of common stock issuable for each share of converted Series B preferred stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice. On August 12, 2016, the agreement was amended to include make-good-shares. The conversion price set forth in Section 1.2 of the agreement shall be adjusted to reflect the lower of $1.05 or the price of the Company’s common stock calculated using the average closing prices of the Company’s common

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

3.	CAPITAL STOCK (Continued)

Preferred Stock (Continued)

Series B (Continued)

stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $0.35 per share, the adjusted conversion price shall be $0.35 per share. See Note 3. The conversion price is subject to adjustment in the case of reverse splits, stock dividends, reclassifications and the like. In addition, the conversion price is subject to certain full ratchet anti-dilution protection. Accordingly, the preferred stock is valued under the provision of ASC Topic 815, Derivatives and Hedging, because the conversion feature of the preferred stock was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The Series B preferred stock shall have the rights, preferences and privileges as set forth in the exchange agreement. As of March 31, 2017, there are 6,666 shares of Series B preferred stock outstanding.

Series C

On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares.

Common Stock

On April 7, 2017, the Company filed a certificate of amendment to its articles of incorporation with the State of Nevada effectuating a reverse split of the Company’s common stock at a ratio of 1 for 35 (the “Reverse Split”). The Reverse Split became effective in the State of Nevada on April 12, 2017. Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices, and conversion rates set forth in this Quarterly Report and the accompanying unaudited condensed consolidated financial statement have, where applicable been adjusted retroactively to reflect this reverse stock split.

Three months ended March 31, 2017

The Company issued 2,420,000 shares of common stock through a private placement at a price of $0.175 per share for cash in the amount of $423,500.

The Company issued 3,207,139 shares of common stock for the settlement of convertible promissory notes in an aggregate principal in the amount of $195,000, plus interest in the amount of $49,212, based upon conversion prices of $0.0613 to $0.084.

The Company issued 886,700 shares of common stock for the settlement of accounts payable with a fair value of $90,000.

The Company issued 2,564,439 shares of common stock for services at fair value of $464,027.

4.	CONVERTIBLE PROMISSORY NOTES

On various dates the Company entered into unsecured convertible notes (the “Convertible Promissory Notes” or “Notes”), that matured during the period and were extended sixty (60) days from the effective date of each Note. The Notes bear interest at 10% per annum. The Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $2.10 to $4.90 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes. In addition, for as long as the Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Notes or such other convertible notes or a term was not similarly provided to the purchaser of the Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Notes and such other convertible notes. The conversion feature of the Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the three months ended March 31, 2017, the Company issued 3,207,141 shares of common stock, upon conversion of $195,000 in principal, plus accrued interest of $49,212. As of March 31, 2017, the Notes had an aggregate remaining balance of $1,760,000.

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

4.	CONVERTIBLE PROMISSORY NOTES (Continued)

As of March 31, 2017, unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining principal balance of $170,790, plus accrued interest of $13,334 were amended. The OID Notes included an original issue discount and one time interest, which has been fully amortized. The OID Notes were extended through December 31, 2017. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $15.31. After the amendment, the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes.

The Company entered into various, unsecured convertible notes (the “Notes”), on various dates ending on May 19, 2016. The Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The Notes bear interest at 10% per annum. The Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $0.70 to $2.80 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes. The conversion feature of the Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. The balance of the note as of March 31, 2017, was $1,325,000.

The Company issued a convertible note in exchange for an accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the note and recognized as interest expense in the financial statements. On January 1, 2016, the note meet the criteria of a derivative and was accounted for under ASC 815. The note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of December 31, 2016, the remaining balance was $257,048. During the three months ended March 31, 2017, the Company issued 886,700 shares of common stock upon conversion of principal in the amount of $90,000, leaving a balance of $167,048. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $53,266 during the three months ended March 31, 2017.

The Company issued a convertible note in exchange for an accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. On September 15, 2016, the note met the criteria of a derivative and was accounted for under ASC 815. The note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The note did not meet the criteria of a derivative at the time it was entered into and was accounted for as a beneficial conversion feature, which was amortized over the life of the note and recognized as interest expense in the financial statements. The conversion feature of the Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $46,333 during the three months ended March 31, 2017.

We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations.

The derivative liability recognized in the financial statements as of March 31, 2017 was $7,629,986.

5.	OPTIONS AND WARRANTS

Options

On May 25, 2012, the Board of Directors adopted a new OriginOil, Inc. 2012 Incentive Stock Option Plan (the “2012 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 28,571 shares of common stock. Options granted under these plans may be either incentive options or nonqualified options and shall be administered by the Company's Board of Directors. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the 2012 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the effective date of grant.

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

5.	OPTIONS AND WARRANTS (Continued)

Options (Continued)

On June 14, 2013, the Board of Directors adopted a new OriginOil, Inc. 2013 Incentive Stock Option Plan (the “2013 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 114,286 shares of common stock. Options granted under the Plan may be either incentive options or nonqualified options and shall be administered by the Company's Board of Directors. Each option shall state the number of shares to which it pertains. The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant. Notwithstanding any other provision of the 2013 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the date of grant. If the status of an employee terminates for any reason other than disability or death, then the optionee or their representative shall have the right to exercise the portion of any options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination.

On September 29, 2015, the Board of Directors adopted a new OriginClear, Inc. 2015 Equity Incentive Stock Option Plan (the “2015 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 3,315,714 shares of common stock. On October 2, 2015, the Board of Directors amended the number of shares to reserve for issuance to 4,571,429 shares. Options granted under these plans may be either incentive options or nonqualified options and shall be administered by the Company's Board of Directors. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the 2015 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the fifth (5th) anniversary from the effective date of grant.

During the year ended December 31, 2016, the Company granted 31,429 shares of incentive stock options to employees, and 428,571 shares of non-statutory options to consultants. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. The stock options mature on March 29, 2021 and October 17, 2021, at prices of $0.29 and $1.31.

With respect to Non-Statutory Options granted to employees, directors or consultants, the Board of Directors or Committee of the Board of Directors may specify such period for exercise that the option shall automatically terminate following the termination of employment or services as to shares covered by the option as the Board of Directors or Committee of the Board of Directors deems reasonable and appropriate.

A summary of the Company’s stock option activity and related information follows:

	March 31, 2017
			Weighted
	Number of		average exercise
	Options		price
Outstanding, beginning of period		3,697,495	$	1.505
Granted		-		-
Exercised		-		-
Forfeited/Expired		-		-
Outstanding, end of period		3,697,495	$	1.505
Exercisable at the end of the period		2,641,304	$	1.190
Weighted average fair value of options granted during the period			$	-

The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of March 31, 2017 was as follows:

						Weighted Average
		Stock		Stock		Remaining
Exercisable		Options		Options		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	6.65 - 147.00		52,276		49,954		5.34 - 7.52
$	10.15 - 15.40		32,362		32,362		6.46
$	1.31		3,612,857		2,558,988		3.52 - 4.55
			3,697,495		2,641,304

Stock-based compensation expense recognized during the year is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the three months ended March 31, 2017 and 2016 were $34,600 and $52,296, respectively.

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

5.	OPTIONS AND WARRANTS (Continued)

Restricted Stock to CEO

On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGA are performance based shares and none have yet vested nor have any been issued. The RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the Employees provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 857,143 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “August RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the August RSGA are performance based shares and none have yet vested nor have any been issued. The August RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 857,143 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

Restricted Stock to Employees and Consultants

On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “First Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the First Employee RSGA are performance based shares and none have yet vested nor have any been issued. The First Employee RSGA provides for the issuance of up to 857,143 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 428,571 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Second Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Second Employee RSGA are performance based shares and none have yet vested nor have any been issued. The Second Employee RSGA provides for the issuance of up to 571,429 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 285,714 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Consultants RSGA”) with two of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Consultants RSGA provides to each of the consultants the issuance of up to 285,714 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 142,857 shares to each of

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

5.	OPTIONS AND WARRANTS (Continued)

Restricted Stock to Employees and Consultants

the consultants, its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance.

Warrants

During the three months ended March 31, 2017, no warrants were issued by the Company. A summary of the Company’s warrant activity and related information follows for the three months ended March 31, 2017:

	March 31, 2017
			Weighted
	Number		average
	of		exercise
	Warrants		price
Outstanding -beginning of the period		506,026	$	5.25
Granted		-		-
Exercised		-		-
Forfeited		-		-
Outstanding - end of the period		506,026	$	5.25

At March 31, 2017, the weighted average remaining contractual life of warrants outstanding:

						Weighted
						Average
						Remaining
Exercisable		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	5.25 - 22.75		479,121		479,121		0.24 - 1.20
$	8.75 - 61.25		2,857		2,857		5.63
$	31.50		24,048		24,048		0.07 - 1.47
			506,026		506,026

At March 31, 2017, the aggregate intrinsic value of the warrants outstanding was $506,026.

6.	FOREIGN SUBSIDIARY

On December 31, 2014, the Company formed a wholly owned subsidiary, OriginClear (HK) Company, Ltd (OCHK), in Hong Kong, China. The Company has granted OCHK a master license for the People’s Republic of China, and a non-exclusive license for the rest of Asia. In turn, OCHK is expected to license regional joint ventures for the commercial development of EWS:AOx Technology. A research and manufacturing center are also planned.

7.	COMMITMENTS AND CONTINGENCIES

Operating Lease – Related Party

The Company entered into a month-to-month lease agreement with a shareholder of the Company for office space in McKinney, Texas at a base rent of $4,750 per month.

Warranty Reserve

Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 as of March 31, 2017.

ORIGINCLEAR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2017

8.	SUBSEQUENT EVENTS

Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events:

Between April 12, 2017 and May 11, 2017, the Company sold, in a private placement, an aggregate of 1,562,862 shares of its common stock to accredited investors for an aggregate consideration of $273,500 (the “Offering”). The shares issued in this Offering are subject to price protection for a period of one year from the issuance of the shares providing that under certain circumstances, the Company will issue additional shares of common stock of the Company for no additional consideration to the subscribers thereunder. The subscribers agreed to a lock-up provision, under which subject to certain terms and conditions therein, the subscribers shall not sell any of their shares of common stock of the Company obtained in this Offering for a period of twelve months.

On April 19, 2017, holders of convertible promissory notes converted an aggregate principal and interest amount of $57,021 into an aggregate of 1,267,123 shares of the Company’s common stock.

In connection with certain one-time make good agreements, on April 28, 2017, the Company issued an aggregate of 51,582 shares of its common stock to certain holders of its common stock.

Due to the reverse split effective on April 12, 2017, the Company included 5,117 shares of common stock as a rounding adjustment.

Between April 28, 2017 and May 15, 2017, the Company issued to consultants for services, including investor relations services, an aggregate of 4,924,591 shares of the Company’s common stock in lieu of cash consideration.

On May 12, 2017, the Company’s Board of Directors approved the issuance of an aggregate of 300,000 shares of the Company’s common stock for services.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Form 10-Q contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our control, which may include statements about our:

	●	business strategy;

	●	financial strategy;

	●	intellectual property;

	●	production;

	●	future operating results; and

	●	plans, objectives, expectations and intentions contained in this report that are not historical.

All statements, other than statements of historical fact included in this report, regarding our strategy, intellectual property, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. All forward-looking statements speak only as of the date of this report. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this report are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved. These statements may be found under “Management's Discussion and Analysis of Financial Condition and Results of Operations,” as well as in this report generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur

Organizational History

OriginClear, Inc. (“we”, “us”, “our”, the “Company” or “OriginClear”) was incorporated on June 1, 2007 under the laws of the State of Nevada. We have been engaged in business operations since June 2007. We recently moved into the commercialization phase of our business plan having been primarily involved in research, development and licensing activities. Our principal offices are located at 525 S. Hewitt St., Los Angeles, California 90013. Our main telephone number is (323) 939-6645. Our website address is www.OriginClear.com. In addition to announcing material financial information through our investor relations website, press releases, SEC filings and webcasts, we also intend to use the following social media channels as a means of disclosing information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters and for complying with our disclosure obligations under Regulation FD:

	●	OriginClear’s Twitter Account (https://twitter.com/OriginClear)

	●	OriginClear’s Facebook Page (https://www.facebook.com/OriginClear)

The information we post through these social media channels may be deemed material. Accordingly, investors should monitor these accounts, in addition to following the company’s press releases, SEC filings, public conference calls and webcasts. This list may be updated from time to time.

We have not incorporated by reference into this report the information in, or that can be accessed through, our website or social media channels, and you should not consider it to be a part of this report.

Overview of Business

OriginClear is a leading provider of water treatment solutions and the developer of a breakthrough water cleanup technology. Through its wholly owned subsidiaries, OriginClear provides systems and services to treat water in a wide range of industries, such as municipal, pharmaceutical, semiconductors, industrial, and oil & gas. To rapidly grow this segment of the business, we strategically acquire profitable and well-managed water treatment companies, which allow us to expand our global market presence and technical expertise. To enable a new era of clean and socially responsible water treatment solutions, we invented Electro Water Separation™, a breakthrough high-speed water cleanup technology using multi-stage electrochemistry, that we license worldwide to water treatment equipment manufacturers. Water is our most valuable resource, and the mission of The OriginClear Group™ (the “Group”) is to improve the quality of water and help return it to its original and clear condition.

The Group

Outsourcing is a fast-growing reality in water treatment. Tougher regulations, water scarcities and general outsourcing trends are driving industrial and agricultural water treatment users to delegate their water problem to service providers. As Global Water Intelligence pointed out in their report on October 30, 2015, “Water is often perceived as a secondary importance, with end-users increasingly wanting to focus solely on their own core business. This is driving a move away from internal water personnel towards external service experts to take control of water aspects.” External service experts are typically small–privately owned and locally operated. Consolidating these companies could lead to enormous economies of scale through sharing of best practices, technologies, and customers. Decentralization is an even greater trend in water, similar to what has been seen in energy decentralization through solar and wind off-grid generation. Water is becoming increasingly scarcer. McKinsey’s Transforming Water Economies forecasts that “without action, global water demand could outstrip supply by up to 40 percent by 2030.” Furthermore, existing water infrastructure in the United States is aging and water loss is increasing. According to Lux Research, updating our national water infrastructure will require an investment of $270 billion, money that will be hard to pull together for projects that could take decades to complete. In the meantime, centralized water systems are forcing water users to treat their own water with small, modular water treatment systems. OriginClear is acquiring companies to help industrial water users treat their water themselves, and often reuse it. We believe those companies are going to grow tremendously because of this “local water” growth trend. We believe that assembling a group of water treatment companies is an opportunity for significant growth and increased Company value for the stockholders.

Progressive Water Treatment

On October 1, 2015, Dallas-based Progressive Water Treatment, Inc. (“PWT”) became the first company in the Group. PWT is profitable and is a fast-growing designer, builder and service provider for a wide range of industrial water treatment applications. PWT reported revenue of $4,794,637 for the period ending December 31, 2016. For the first three months of 2017, PWT reported revenue of $662,129 which is included in the consolidated financial statements ending March 31, 2017.

PWT’s Business

Since 1995, PWT has been designing and manufacturing a complete line of water treatment systems for municipal, industrial and pure water applications. Known as an OEM (Original Equipment Manufacturer), PWT utilizes a wide range of technologies, including chemical injection, media filters, membrane, ion exchange and SCADA technology, in turnkey systems that it designs and builds. PWT also offers a broad range of services including maintenance contracts, retrofits and replacement assistance. In addition, PWT rents equipment through contracts of varying duration. Customers are primarily served in the United States and Canada, with PWT’s reach extending worldwide from Japan to Argentina to the Middle East.

OriginClear is currently in discussions for additional, accretive acquisitions of companies specializing in complementary markets and applications.

Technology Licensing

For its first eight years of operations, OriginClear focused uniquely on development and commercialization of its breakthrough Electro Water Separation™ technology. In 2015, the technology went into commercial phase, and the Company launched it as OriginClear Technologies, operating in parallel to the Group. The mission of OriginClear Technologies is to develop Electro Water Separation™ and achieve its full recognition as an international industry standard in treating our increasingly complex wastewater treatment challenges. For this purpose, OriginClear Technologies relies on an ongoing strong R&D and engineering activity for the development of its technology, while actively building its network of partners, licensees and joint venture partners for commercial development. A key element of this strategy is OriginClear (HK), OriginClear’s wholly-owned subsidiary in Hong Kong that manages Asia-Pacific market development, with a special focus on China sales and manufacturing. While OriginClear Technologies focuses on developing and monetizing the Company’s internally-developed Intellectual Property, best practices and trade secrets, it is expected to do the same for technologies which may result in future from the Group’s acquisition of profitable water treatment companies.

The Technology

OriginClear is the proprietary developer of Electro Water Separation™ (EWS), the high-speed, primarily chemical-free technology to clean up large quantities of water. It removes oils, suspended solids, certain dissolved solids, and pathogens, in a continuous and energy-efficient process. The Company originally developed this technology to solve the challenge of removing microalgae from a highly dilute state. The EWS technology remains the most efficient non-chemical, continuous mechanism for the concentration of live algae cells from water. The electro-chemical process was then extended, first to cleaning up oil and gas waste water and most recently, to industrial, agricultural and urban effluents. These water treatment applications are entirely electrochemical in nature and do not rely on algae for its cleaning capabilities, which is a separate application of the technology. EWS is designed to be an early step in removal of oils, solids and pathogens; reducing the work that more expensive, downstream processes such as Ultra Filtration or Reverse Osmosis must do, therefore enabling more cost-efficient and high-volume water cleanup overall.

In March of 2016, OriginClear announced that it had successfully developed and proved Advanced Oxidation for its breakthrough water cleanup system, Electro Water Separation™, or EWS. University laboratory tests have shown that EWS with Advanced Oxidation (EWS:AOx™) can now extract dissolved contaminants, which are otherwise difficult to remove without chemicals such as chlorine. Overall, the system has shown a dramatic reduction in Total Organic Compounds which includes all forms of organic contamination, solids, miscible or dissolved, to meet new stringent global discharge requirements. Even prior to this innovation, EWS, combined with an iSep ultrafiltration membrane, demonstrated up to a 99.9% removal of dispersed oil, 99.5% removal of suspended solids as well as successful treatment of chemical oxygen demand (COD), including specific contaminants such as ammonia, phosphorus and hydrogen sulfide. These results were presented at the International Water Conference in 2015. In 2016, OriginClear filed for a patent to protect the new AOx process and system configuration.

Today, we are capable of pairing the two technologies as EWS:AOx™, or separately, as the application requires. OriginClear believes that its technology is valuable to the industry because it has the potential to greatly extend the life of membranes and filters by effectively treating very dirty, oily water, while reducing chemical use significantly. OriginClear also believes that its Advanced Oxidation technology will help neutralize harmful micro-contaminants, such as industrial solvents, which is difficult or impossible to achieve with other technologies. Overall, the system has shown a dramatic reduction in Total Organic Compounds which includes all forms of organic contamination, solids, miscible or dissolved, to meet new stringent global discharge requirements.

Recently, with our initial commercial contract for a landfill upgrade in Malaysia, we have shown that our systems can be retrofitted into existing installations, avoiding the time and expense of ground-up construction and enabling rapid compliance with new, stringent discharge regulations for treatment companies.

Critical Accounting Policies

The Securities and Exchange Commission ("SEC") defines "critical accounting policies" as those that require application of management's most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of the accounting policies require management to make difficult, subjective or complex judgments or estimates. However, the following policies could be deemed to be critical within the SEC definition.

Revenue Recognition

Equipment sales

Percentage of completion

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options, warrants, convertible notes and common stock for services. Actual results could differ from those estimates.

Fair Value of Financial Instruments

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2017, the amounts reported for cash, prepaid expenses, accounts payable and accrued expenses approximate the fair value because of their short maturities.

Recently Issued Accounting Pronouncements

Management reviewed accounting pronouncements issued during the three months ended March 31, 2017, and no pronouncements were believed by management to have a material impact on our present or future financial statements.

Results of Operation

Results of Operations for the three months ended March 31, 2017 compared to the three months ended March 31, 2016.

Revenue and Cost of Sales

For the three months ended March 31, 2017, we had revenue of $672,129 compared to $1,467,750 for the three months ended March 31, 2016. Cost of sales for the three months ended March 31, 2017, was $582,456 compared to $1,068,427 for the three months ended March 31, 2016. Revenue and cost of sales decreased primarily due to PWT’s focus on marketing during the three months of operations.

Our gross profit was $89,673 and $399,323 for the three months ended March 31, 2017 and 2016, respectively.

Selling and Marketing Expenses

For the three months ended March 31, 2017, we had selling and marketing expenses of $512,801, compared to $493,510 for the three months ended March 31, 2016. The increase in selling and marketing expenses was due to an increase in non-cash investor relations expenses.

General and Administrative Expenses

General and administrative expenses decreased to $624,530 for the three months ended March 31, 2017, compared to $686,846 for the three months ended March 31, 2016. General and administrative expenses decreased primarily due to a decrease in professional fees.

Research and Development Cost

Research and development cost for the three months ended March 31, 2017 and 2016, were $53,653 and $210,150, respectively. The decrease in research and development costs was primarily due to the decrease in consultants and contractors expense and outside services of $136,966, and an overall decrease in salaries, durable items and other expenses of $19,531.

Other Income and (Expenses)

Other income for the three months ended March 31, 2017 and 2016, was $882,358 and $2,344,423, respectively. The decrease in other income was primarily a result of a change in gain of non-cash accounts associated with the fair value of the derivatives in the amount of $1,533,074, with an offset of interest expense of $12,278, which includes non-cash amortization of debt discount of $10,719.

Net Income/(Loss)

Our net income/(loss) decreased to $(232,553) for the three months ended March 31, 2017, compared to a net income of $1,342,001, for the three months ended March 31, 2016. The majority of the decrease in net income was due primarily to a decrease in revenue, operating expenses, other income and (expenses), which consisted of a decrease in gain in non-cash accounts associated with derivatives, and a decrease in gross profit.

Liquidity and Capital Resources

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

The condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying condensed consolidated financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company has not generated significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. We obtained funds from our shareholders during the three months ending March 31, 2017. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, cause substantial dilution for our stockholders, in case of equity financing.

At March 31, 2017 and December 31, 2016, we had cash of $442,928 and $351,321, respectively and working capital deficit of $8,556,349 and $11,056,570, respectively. The decrease in working capital deficit was due to a decrease in contracts receivable, prepaid expense, non-cash derivative liabilities, and convertible notes, with an increase in cash, inventory asset, cost in excess of billing, accounts payable, accrued expenses, billing in excess of cost, deferred income, and loan payable.

Net cash used in operating activities was $330,208 for the three months ended March 31, 2017, compared to $540,090 for the prior period ended March 31, 2016. The decrease in cash used in operating activities was due to the overall decrease in professional fees and research and development.

Net cash flows used in investing activities was $32,918 for the three months ended March 31, 2017, as compared to $5,699 for the prior period ended March 31, 2016. The net increase in cash used in investing activities was due to an increase in equipment purchases in the current period.

Net cash flows provided by financing activities was $454,736 for the three months ended March 31, 2017, as compared to $100,000 for the prior period ended March 31, 2016. The increase in cash provided by financing activities was due to an increase in equity financing. To date we have principally financed our operations through the sale of our common stock and the issuance of debt.

We do not have any material commitments for capital expenditures during the next twelve months. Although proceeds from the issuance of equity together with revenue from operations are currently sufficient to fund our operating expenses, we will need to raise additional funds in the future so that we can expand our operations. Therefore, our future operations are dependent on our ability to secure additional financing. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, the trading price of our common stock and a downturn in the U.S. equity and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. The inability to obtain additional capital may restrict our ability to grow and may reduce our ability to continue to conduct business operations. If we are unable to obtain additional financing or generate sufficient revenue, we may have to curtail our marketing and development plans and possibly cease our operations.

We have estimated our current average burn, and believe that we have assets to ensure that we can function without liquidation over the next twelve months, due to our cash on hand, growing revenue, and our ability to raise money from our investor base. Based on the aforesaid, we believe we have the ability to continue our operations for the foreseeable future and will be able to realize assets and discharge liabilities in the normal course of operations.

Additional Information

In connection with certain one-time make good agreements, on April 28, 2017, the Company issued an aggregate of 51,582 shares of its common stock to certain holders of its common stock.

On May 12, 2017, the Company’s Board of Directors approved the issuance of an aggregate of 300,000 shares of the Company’s common stock to a consultant for services.

The securities above were offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) since, among other things, the transactions did not involve a public offering and the securities were acquired for investment purposes only and not with a view to or for sale in connection with any distribution thereof.

Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Pursuant to Rules 13a-15(b) and 15-d-15(b) under the Securities Exchange Act of 1934, as amended ("Exchange Act"), the Company carried out an evaluation, with the participation of the Company's management, including the Company's Chief Executive Officer and Chief Financial Officer ("CEO/CFO") of the effectiveness of the Company's disclosure controls and procedures as of the end of the period covered by this report. The term "disclosure controls and procedures", as defined under Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

As disclosed in our annual report filing for the year ended December 31, 2016, there was a significant deficiency in the Company's internal control over financial reporting due to a lack of segregation of duties partly due to small Company staff size. Based upon the evaluation of the disclosure controls and procedures at the end of the period covered by this report, the Company's CEO/CFO concluded that the Company's disclosure controls and procedures were ineffective due to the significant deficiency in the Company's internal control over financial reporting.

To address the significant deficiency, we performed additional analysis and other post-closing procedures in an effort to ensure our condensed consolidated financial statements included in this review report have been prepared in accordance with generally accepted accounting principles. Accordingly, management believes that the financial statements included in this quarterly report on Form 10-Q fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15f of the Exchange Act) that occurred during the first three months of 2017 that has materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Limitations on Internal Controls

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

PART II

Item 1. Legal Proceedings.

None

Item 1A. Risk Factors.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information.

None

Item 6. Exhibits.

Exhibit Number		Description of Exhibit

31		Certification by Chief Executive Officer and Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.
32		Certification by Chief Executive Officer and Chief Financial Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code.
101.INS		XBRL Instance Document.*
101.SCH		XBRL Taxonomy Extension Schema.*
101.CAL		XBRL Taxonomy Extension Calculation Linkbase.*
101.DEF		XBRL Taxonomy Extension Definition Linkbase.*
101.LAB		XBRL Taxonomy Extension Label Linkbase.*
101.PRE		XBRL Extension Presentation Linkbase.*

Attached as Exhibit 101 to this report are the following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 formatted in XBRL (eXtensible Business Reporting Language): (i) the Balance Sheets, (ii) the Statement of Operations, (iii) the Statement of Shareholders’ Equity, (iv) the Statement of Cash Flow, and (v) Notes to Financial Statements.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ORIGINCLEAR, INC.

	By:	/s/ T Riggs Eckelberry
		T Riggs Eckelberry
		Chief Executive Officer (Principal Executive Officer) and
		Acting Chief Financial Officer (Principal Accounting and Financial Officer)
		May 15, 2017

EX-31 2 f10q0317ex31_originclearinc.htm CERTIFICATIONS

EXHIBIT 31

CERTIFICATION

I, T Riggs Eckelberry, certify that:

1. I have reviewed this quarterly report on Form 10-Q of OriginClear, Inc., for the quarter ended March 31, 2017;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 15, 2017

		/s/ T Riggs Eckelberry
		T Riggs Eckelberry
		Chief Executive Officer (Principal Executive Officer)
		and Acting Chief Financial Officer (Principal Accounting and Financial Officer)

EX-32 3 f10q0317ex32_originclearinc.htm CERTIFICATIONS

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of OriginClear, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, T Riggs Eckelberry, Chief Executive Officer and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

May 15, 2017		/s/ T Riggs Eckelberry
		T Riggs Eckelberry
		Chief Executive Officer (Principal Executive Officer)
		and Acting Chief Financial Officer (Principal Accounting and Financial Officer)

EX-101.INS 4 ooil-20170331.xml XBRL INSTANCE FILE 0001419793 ooil:IncentiveStockOptionPlanOneMember 2012-05-25 0001419793 ooil:IncentiveStockOptionPlanTwoMember 2013-06-14 0001419793 ooil:IncentiveStockOptionPlanTwoMember 2013-06-02 2013-06-14 0001419793 ooil:IncentiveStockOptionPlanThreeMember 2015-09-29 0001419793 us-gaap:SeriesBPreferredStockMember 2015-10-01 0001419793 us-gaap:SeriesBPreferredStockMember 2015-09-25 2015-10-01 0001419793 ooil:IncentiveStockOptionPlanThreeMember 2015-10-02 0001419793 2015-12-31 0001419793 2016-01-01 2016-03-31 0001419793 us-gaap:ConvertibleDebtMember 2016-01-01 2016-03-31 0001419793 us-gaap:WarrantMember 2016-01-01 2016-03-31 0001419793 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-03-31 0001419793 2016-03-31 0001419793 ooil:RestrictedStockGrantAgreementMember us-gaap:ChiefExecutiveOfficerMember 2016-05-01 2016-05-12 0001419793 ooil:RestrictedStockGrantAgreementMember ooil:EmployeesMember 2016-05-01 2016-05-12 0001419793 ooil:RestrictedStockGrantAgreementMember ooil:EmployeesOneMember 2016-05-01 2016-05-12 0001419793 ooil:RestrictedStockGrantAgreementMember us-gaap:ChiefExecutiveOfficerMember 2016-08-01 2016-08-10 0001419793 ooil:RestrictedStockGrantAgreementMember ooil:EmployeesMember 2016-08-01 2016-08-10 0001419793 ooil:ConsultantsMember 2016-01-01 2016-12-31 0001419793 ooil:EmployeesMember 2016-01-01 2016-12-31 0001419793 2016-12-31 0001419793 us-gaap:SeriesBPreferredStockMember 2016-12-31 0001419793 us-gaap:FairValueInputsLevel3Member 2016-12-31 0001419793 us-gaap:CommonStockMember 2016-12-31 0001419793 us-gaap:ConvertibleDebtMember 2016-12-31 0001419793 ooil:ConsultantsMember 2016-12-31 0001419793 ooil:EmployeesMember 2016-12-31 0001419793 us-gaap:EmployeeStockOptionMember 2016-12-31 0001419793 us-gaap:WarrantMember 2016-12-31 0001419793 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001419793 us-gaap:RetainedEarningsMember 2016-12-31 0001419793 us-gaap:PreferredStockMember 2016-12-31 0001419793 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001419793 us-gaap:SeriesCPreferredStockMember 2016-12-31 0001419793 us-gaap:SeriesCPreferredStockMember 2017-03-14 0001419793 us-gaap:SeriesCPreferredStockMember 2017-03-01 2017-03-14 0001419793 2017-01-01 2017-03-31 0001419793 us-gaap:MaximumMember 2017-01-01 2017-03-31 0001419793 us-gaap:MinimumMember 2017-01-01 2017-03-31 0001419793 us-gaap:FairValueInputsLevel3Member 2017-01-01 2017-03-31 0001419793 us-gaap:CommonStockMember 2017-01-01 2017-03-31 0001419793 us-gaap:ConvertibleDebtMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeOneMember 2017-01-01 2017-03-31 0001419793 ooil:RangeOneMember us-gaap:MinimumMember us-gaap:WarrantMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeOneMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeTwoMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeThreeMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeThreeMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeThreeMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0001419793 us-gaap:WarrantMember 2017-01-01 2017-03-31 0001419793 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-03-31 0001419793 us-gaap:RetainedEarningsMember 2017-01-01 2017-03-31 0001419793 us-gaap:PreferredStockMember 2017-01-01 2017-03-31 0001419793 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-03-31 0001419793 ooil:OriginalIssueDiscountNotesMember 2017-01-01 2017-03-31 0001419793 ooil:ConvertiblePromissoryNotesMember 2017-01-01 2017-03-31 0001419793 ooil:UnsecuredConvertibleNotesTwoMember 2017-01-01 2017-03-31 0001419793 ooil:MckinneyMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeOneMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeTwoMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeThreeMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeOneMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeOneMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeThreeMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeThreeMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001419793 us-gaap:PrivatePlacementMember 2017-01-01 2017-03-31 0001419793 2017-03-31 0001419793 us-gaap:SeriesBPreferredStockMember 2017-03-31 0001419793 us-gaap:FairValueInputsLevel3Member 2017-03-31 0001419793 us-gaap:CommonStockMember 2017-03-31 0001419793 us-gaap:ConvertibleDebtMember 2017-03-31 0001419793 us-gaap:MaximumMember us-gaap:CommonStockMember 2017-03-31 0001419793 us-gaap:MinimumMember us-gaap:CommonStockMember 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeOneMember 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeTwoMember 2017-03-31 0001419793 us-gaap:WarrantMember ooil:RangeThreeMember 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember 2017-03-31 0001419793 us-gaap:WarrantMember 2017-03-31 0001419793 us-gaap:AdditionalPaidInCapitalMember 2017-03-31 0001419793 us-gaap:RetainedEarningsMember 2017-03-31 0001419793 us-gaap:PreferredStockMember 2017-03-31 0001419793 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-03-31 0001419793 us-gaap:FairValueInputsLevel1Member 2017-03-31 0001419793 us-gaap:FairValueInputsLevel2Member 2017-03-31 0001419793 us-gaap:SeriesCPreferredStockMember 2017-03-31 0001419793 ooil:OriginalIssueDiscountNotesMember 2017-03-31 0001419793 ooil:ConvertiblePromissoryNotesMember 2017-03-31 0001419793 ooil:UnsecuredConvertibleNotesTwoMember 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeOneMember 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeTwoMember 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember ooil:RangeThreeMember 2017-03-31 0001419793 ooil:UnsecuredConvertibleNotesTwoMember us-gaap:MaximumMember 2017-03-31 0001419793 ooil:UnsecuredConvertibleNotesTwoMember us-gaap:MinimumMember 2017-03-31 0001419793 ooil:ConvertiblePromissoryNotesMember us-gaap:MinimumMember 2017-03-31 0001419793 ooil:ConvertiblePromissoryNotesMember us-gaap:MaximumMember 2017-03-31 0001419793 us-gaap:EmployeeStockOptionMember ooil:TwoThousandNinePlanTwoThousandTwelveAndTwoThousandThirteenPlanMember 2017-03-31 0001419793 us-gaap:SubsequentEventMember 2017-04-04 2017-04-07 0001419793 us-gaap:SubsequentEventMember 2017-04-10 2017-04-12 0001419793 us-gaap:SubsequentEventMember us-gaap:ConvertibleNotesPayableMember 2017-04-02 2017-04-19 0001419793 us-gaap:SubsequentEventMember 2017-04-15 2017-04-28 0001419793 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2017-04-21 2017-05-11 0001419793 us-gaap:SubsequentEventMember us-gaap:BoardOfDirectorsChairmanMember 2017-05-01 2017-05-12 0001419793 2017-05-15 0001419793 us-gaap:SubsequentEventMember ooil:ConsultantsMember 2017-04-29 2017-05-15 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure ooil:Segment ORIGINCLEAR, INC. 0001419793 OCLN false --12-31 10-Q 2017-03-31 Q1 2017 Smaller Reporting Company 38318007

695295

249506

351321

442928

382895

130269

13613

174105

47612

144192

86085

42128

33912

910041

850999

161912

181230

19538

682145

4467

3500

709650

1781603

1741879

480064

585597

715281

735379

552818

16327

113950

20000 20000

10300

5978

8702083

7629986

1935233

289831

11966611

9407348

25258

1613571

3084069

1613571

3109327

13580182

12516675

2143

3051

51428976

52684407

-92

-95

-63229607

-63462160

-11798579

2143

51428976

-63229607

-92

-10774796

3051

52684407

-63462160

-95

1781603

1741879

50000

591835

492237

11429

931

0.0001

25000000

1000

25000000

6666

1000

6666

1000

6666

1000

6666

1000

0.0001

5000000000

21428455

30506732

21428455

30506732

1000 1000

1467750

672129

1068427

582456

399323

89673

493510

512801

686846

624530

210150

53653

11239

13600

1401745

1204584

-1002422

-1114911

52759 -2599198 -1072096

202016

189738

2344423

882358

1342001

-232553

0.18

-0.01

7348638

25082031

21428454

7666

30506732

7666

423500 242 423258 423500 2420000 2420000

426114

244212

321

90000

243891

195000

3207139

886700

3207141

90000 89 89911 886700

464027

256

463771

2564439

300000

34600

-3 -3

293980

464027

52296

34600

2546439 1072097 120816 110097

110769

-252626

-157357

-96580

13613

-428

-8216

-42

299036

105533

105537

69309

49100 16327

10300

-540090

-330208

5699

32918

-5699

-32918

-31236

100000

423500

100000

454736

-3

-445789

91607

366

1258

430896 16771 44440 123110

<div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.25in; font-size: 10pt;">1.</td><td style="text-align: justify; font-size: 10pt;">The accompanying unaudited condensed financial statements of OriginClear, Inc. (the “Company”) (formerly OriginOil, Inc.) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included.  Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017.  For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended December 31, 2016.</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Going Concern<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying condensed financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company’s revenue is not yet sufficient to cover its operating expenditures and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. Management believes the existing shareholders, the prospective new investors, current and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing.</div>

<div> <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in; font-size: 10pt;">5.</td> <td style="font-size: 10pt;">OPTIONS AND WARRANTS</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Options <p style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On May 25, 2012, the Board of Directors adopted a new OriginOil, Inc. 2012 Incentive Stock Option Plan (the “2012 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 28,571 shares of common stock.  Options granted under these plans may be either incentive options or nonqualified options and shall be administered by the Company's Board of Directors.  Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the 2012 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the effective date of grant. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On June 14, 2013, the Board of Directors adopted a new OriginOil, Inc. 2013 Incentive Stock Option Plan (the “2013 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 114,286 shares of common stock.  Options granted under the Plan may be either incentive options or nonqualified options and shall be administered by the Company's Board of Directors.  Each option shall state the number of shares to which it pertains. The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant. Notwithstanding any other provision of the 2013 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the date of grant. If the status of an employee terminates for any reason other than disability or death, then the optionee or their representative shall have the right to exercise the portion of any options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.55in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On September 29, 2015, the Board of Directors adopted a new OriginClear, Inc. 2015 Equity Incentive Stock Option Plan (the “2015 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 3,315,714 shares of common stock. On October 2, 2015, the Board of Directors amended the number of shares to reserve for issuance to 4,571,429 shares. Options granted under these plans may be either incentive options or nonqualified options and shall be administered by the Company's Board of Directors.  Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the 2015 Plan or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the fifth (5th) anniversary from the effective date of grant. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.55in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">During the year ended December 31, 2016, the Company granted 31,429 shares of incentive stock options to employees, and 428,571 shares of non-statutory options to consultants. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. The stock options mature on March 29, 2021 and October 17, 2021, at prices of $0.29 and $1.31. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">With respect to Non-Statutory Options granted to employees, directors or consultants, the Board of Directors or Committee of the Board of Directors may specify such period for exercise that the option shall automatically terminate following the termination of employment or services as to shares covered by the option as the Board of Directors or Committee of the Board of Directors deems reasonable and appropriate. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">A summary of the Company’s stock option activity and related information follows: <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">March 31, 2017</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Weighted</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Number of</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">average exercise</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Options</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">price</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="font-size: 10pt;">Outstanding, beginning of period</td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">3,697,495</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">1.505</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-left: 0in; font-size: 10pt;">Granted</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-left: 0in; font-size: 10pt;">Exercised</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 1.5pt; padding-left: 0in; font-size: 10pt;">Forfeited/Expired</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt; padding-left: 0in; font-size: 10pt;">Outstanding, end of period</td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">3,697,495</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1.505</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt; padding-left: 0in; font-size: 10pt;">Exercisable at the end of the period</td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,641,304</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1.190</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-left: 0in; font-size: 10pt;">Weighted average fair value of options granted during the period</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;">$</td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of March 31, 2017 was as follows: <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 19.8pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Weighted Average</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Stock</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Stock</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Remaining</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Exercisable</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Options</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Options</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Contractual</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Prices</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Outstanding</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercisable</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Life (years)</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="text-align: right; font-size: 10pt;">           6.65 - 147.00</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 207.33px; text-align: right; font-size: 10pt;">52,276</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 207.33px; text-align: right; font-size: 10pt;">49,954</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 207.33px; text-align: right; font-size: 10pt;">5.34 - 7.52</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">$</td> <td style="text-align: right; font-size: 10pt;">         10.15 - 15.40</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">32,362</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">32,362</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">6.46</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">$</td> <td style="text-align: right; padding-bottom: 1.5pt; font-size: 10pt;">1.31</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">3,612,857</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">2,558,988</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: right; padding-bottom: 1.5pt; font-size: 10pt;">3.52 - 4.55</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: right; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">3,697,495</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,641,304</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: right; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 19.8pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 19.8pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Stock-based compensation expense recognized during the year is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the three months ended March 31, 2017 and 2016 were $34,600 and $52,296, respectively. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 19.8pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Restricted Stock to CEO <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGA are performance based shares and none have yet vested nor have any been issued. The RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the Employees provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 857,143 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “August RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the August RSGA are performance based shares and none have yet vested nor have any been issued. The August RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 857,143 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; color: #000000; text-transform: none; text-indent: 20pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Restricted Stock to Employees and Consultants <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “First Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the First Employee RSGA are performance based shares and none have yet vested nor have any been issued. The First Employee RSGA provides for the issuance of up to 857,143 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 428,571 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Second Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Second Employee RSGA are performance based shares and none have yet vested nor have any been issued. The Second Employee RSGA provides for the issuance of up to 571,429 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 285,714 shares of its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Consultants RSGA”) with two of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Consultants RSGA provides to each of the consultants the issuance of up to 285,714 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to 142,857 shares to each of <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Restricted Stock to Employees and Consultants <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 20pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">the consultants, its common stock. The Company has not recognized any costs associated with the milestones, due to not being able to estimate the probability of it being achieved. As the performance goals are achieved, the shares shall become eligible for vesting and issuance. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 19.8pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 19.8pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Warrants <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 39.6pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 19.8pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">During the three months ended March 31, 2017, no warrants were issued by the Company. A summary of the Company’s warrant activity and related information follows for the three months ended March 31, 2017: <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">   <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">March 31, 2017</td> <td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Weighted</td> <td style="text-align: center; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Number</td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">average</td> <td style="text-align: center; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">of</td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">exercise</td> <td style="text-align: center; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt;"> </td> <td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Warrants</td> <td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">price</td> <td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="font-size: 10pt;">Outstanding -beginning of the period</td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">506,026</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">5.25</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;">Granted</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;">Exercised</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;">Forfeited</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;">Outstanding - end of the period</td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">506,026</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">5.25</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">At March 31, 2017, the weighted average remaining contractual life of warrants outstanding: <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 39.6pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Weighted</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Average</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Remaining</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Exercisable</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Warrants</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Warrants</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Contractual</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Prices</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Outstanding</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercisable</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Life (years)</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="text-align: right; font-size: 10pt;">              5.25 - 22.75</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 207.33px; text-align: right; font-size: 10pt;">479,121</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 207.33px; text-align: right; font-size: 10pt;">479,121</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 207.33px; text-align: right; font-size: 10pt;">0.24 - 1.20</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">$</td> <td style="text-align: right; font-size: 10pt;">              8.75 - 61.25</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">2,857</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">2,857</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">5.63</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">$</td> <td style="text-align: right; padding-bottom: 1.5pt; font-size: 10pt;">31.50</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">24,048</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">24,048</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: right; padding-bottom: 1.5pt; font-size: 10pt;">0.07 - 1.47</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: right; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">506,026</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">506,026</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: right; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 39.6pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 19.8pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">At March 31, 2017, the aggregate intrinsic value of the warrants outstanding was $506,026. </div>

<div><table style="width: 1250.4px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.25in; font-size: 10pt;">7.</td><td style="font-size: 10pt;">COMMITMENTS AND CONTINGENCIES</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Operating Lease – Related Party<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company entered into a month-to-month lease agreement with a shareholder of the Company for office space in McKinney, Texas at a base rent of $4,750 per month.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Warranty Reserve<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 as of March 31, 2017.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Loss per Share Calculations<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has excluded 3,697,495 of stock options, 506,026 warrants, and the shares issuable from convertible debt of $3,867,068 and shares issuable from convertible preferred stock for the three months ended March 31, 2017, because their impact on the loss per share is anti-dilutive.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has excluded 3,411,561 stock options, 653,851 warrants, and the shares issuable from convertible debt of $4,582,068 and shares issuable from convertible preferred stock for the for the three months ended March 31, 2016, because their impact on the earnings per share is anti-dilutive.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Stock-Based Compensation<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Revenue Recognition<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Equipment sales<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.  Title to the equipment is transferred to the customer once the last payment is received. We record revenue as goods are shipped, and the equipment has been fully accepted by the customer. Generally, we extend credit to our customers and do not require collateral.  We do not ship a product until we have a purchase agreement signed by the customer with a payment arrangement.  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Percentage of completion<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Revenues and related costs on construction contracts are recognized using the “percentage of completion method” of accounting in accordance with ASC 605-35 – “Accounting for Performance of Construction-Type and Certain Production Type Contracts”. Under this method, contract revenues and related expenses are recognized over the performance period of the contract in direct proportion to the costs incurred as a percentage of total estimated costs for the entirety of the contract. Costs include direct material, direct labor, subcontract labor and any allocable indirect costs. All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The asset “Costs in excess of billings” represents revenues recognized in excess of amounts billed on contracts in progress. The liability “Billings in excess of costs” represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The cost in excess of billings for the three months ending March 31, 2017 and 2016, were $144,192 and $174,105, respectively. The billing in excess of cost was for the three months ending March 31, 2017 and 2016, was $16,327 and $552,818, respectively.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Contract Receivable<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $50,000 as of March 31, 2017 and December 31, 2016, respectively. The net contract receivable balance was $130,269 and $382,895 at March 31, 2017 and December 31, 2016, respectively.</div>

<div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Fair Value of Financial Instruments <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2017, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 108px; text-align: right; text-indent: -18pt; padding-left: 36pt; font-size: 10pt;">·</td> <td style="width: 52px;"> </td> <td style="width: 831.33px; text-align: justify; font-size: 10pt;">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 108px; text-align: right; text-indent: -18pt; padding-left: 36pt; font-size: 10pt;">·</td> <td style="width: 52px;"> </td> <td style="width: 831.33px;"> Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and   </td> </tr> <tr style="vertical-align: top;"> <td style="text-align: right; font-size: 10pt;">·</td> <td> </td> <td> Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.  </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2017. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Derivative Liability</td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">7,629,986</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">-</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">-</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">7,629,986</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;">Total liabilities measured at fair value</td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">7,629,986</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">7,629,986</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="font-size: 10pt;">Balance as of January 1, 2017</td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">8,702,083</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Fair Value of derivative liabilities issued</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">Gain on conversion of debt and change in derivative liability</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(1,072,097</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;">Balance as of March 31, 2017</td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">7,629,986</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">03/31/2017</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Risk free interest rate</td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 290.66px; text-align: right; font-size: 10pt;">.01% - 1.02%</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Stock volatility factor</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">4.72% - 189.09%</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;">Weighted average expected option life</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">6 months - 5 years</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Expected dividend yield</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">None</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> </table> </div>

<div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Recently Issued Accounting Pronouncements <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In February 2016, the FASB issued ASU No. 2016-2, which creates ASC Topic 842, “Leases.” This update increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This guidance is effective for interim and annual reporting periods beginning after December 15, 2018. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In August 2016, the FASB issued ASU No. 2016-15 which amends ASC Topic 230, “Classification of Certain Cash Receipts and Cash Payments.” The amendments in this Update address eight specific cash flow issues with the objective of reducing the existing diversity in practice. The update outlines the classification of specific transactions as either cash inflows or outflows from financing activities, operating activities, investing activities or non-cash activities. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures. <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Management reviewed currently issued pronouncements during the period ended March 31, 2017, and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements. </div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <table style="width: 1551px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(Level 2)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(Level 2)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">(Level 3)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 18pt; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Derivative Liability</td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;">$</td><td style="width: 124px; text-align: right; font-size: 10pt;">7,629,986</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;">$</td><td style="width: 124px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;">$</td><td style="width: 124px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;">$</td><td style="width: 124px; text-align: right; font-size: 10pt;">7,629,986</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;">Total liabilities measured at fair value</td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">7,629,986</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">7,629,986</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></div>

<div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <table style="width: 1039px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">03/31/2017</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Risk free interest rate</td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 290px; text-align: right; font-size: 10pt;">.01% - 1.02%</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Stock volatility factor</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">4.72% - 189.09%</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;">Weighted average expected option life</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">6 months - 5 years</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; font-size: 10pt;">Expected dividend yield</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">None</td> <td style="text-align: left; font-size: 10pt;"></td> </tr> </table> </div>

<div> <table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">March 31, 2017</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Weighted</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">Number of</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt;" colspan="2">average exercise</td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Options</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">price</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 18pt; background-color: white;"> </td> <td style="font-size: 10pt;">Outstanding, beginning of period</td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">3,697,495</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> <td style="width: 10px; font-size: 10pt;"> </td> <td style="width: 10px; text-align: left; font-size: 10pt;">$</td> <td style="width: 82.66px; text-align: right; font-size: 10pt;">1.505</td> <td style="width: 10px; text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-left: 0in; font-size: 10pt;">Granted</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-left: 0in; font-size: 10pt;">Exercised</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 1.5pt; padding-left: 0in; font-size: 10pt;">Forfeited/Expired</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt; padding-left: 0in; font-size: 10pt;">Outstanding, end of period</td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">3,697,495</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1.505</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt; padding-left: 0in; font-size: 10pt;">Exercisable at the end of the period</td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,641,304</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="padding-bottom: 4pt; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1.190</td> <td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-left: 0in; font-size: 10pt;">Weighted average fair value of options granted during the period</td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="text-align: right; font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="text-align: left; font-size: 10pt;">$</td> <td style="text-align: right; font-size: 10pt;">-</td> <td style="text-align: left; font-size: 10pt;"> </td> </tr> </table> </div>

<div><table style="width: 1250.4px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">March 31, 2017</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Weighted</td><td style="text-align: center; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Number</td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">average</td><td style="text-align: center; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">of</td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">exercise</td><td style="text-align: center; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">price</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 18pt; background-color: white;"> </td><td style="font-size: 10pt;">Outstanding -beginning of the period</td><td style="width: 12px; font-size: 10pt;"> </td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 100px; text-align: right; font-size: 10pt;">506,026</td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 12px; font-size: 10pt;"> </td><td style="width: 12px; text-align: left; font-size: 10pt;">$</td><td style="width: 100px; text-align: right; font-size: 10pt;">5.25</td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="font-size: 10pt;">Granted</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="font-size: 10pt;">Exercised</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;">Forfeited</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;">Outstanding - end of the period</td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">506,026</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">5.25</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td></tr></table></div> <div><table style="width: 1250.4px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Weighted</td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Average</td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Remaining</td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Exercisable</td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Warrants</td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Warrants</td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt;" colspan="2">Contractual</td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Prices</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Outstanding</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercisable</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Life (years)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 18pt; background-color: white;"> </td><td style="width: 12px; text-align: left; font-size: 10pt;">$</td><td style="text-align: right; font-size: 10pt;">              5.25 - 22.75</td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 12px; font-size: 10pt;"> </td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 249.6px; text-align: right; font-size: 10pt;">479,121</td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 12px; font-size: 10pt;"> </td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 249.6px; text-align: right; font-size: 10pt;">479,121</td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 12px; font-size: 10pt;"> </td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td><td style="width: 249.6px; text-align: right; font-size: 10pt;">0.24 - 1.20</td><td style="width: 12px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">$</td><td style="text-align: right; font-size: 10pt;">              8.75 - 61.25</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">2,857</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">2,857</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">5.63</td><td style="text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">$</td><td style="text-align: right; padding-bottom: 1.5pt; font-size: 10pt;">31.50</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">24,048</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">24,048</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: right; padding-bottom: 1.5pt; font-size: 10pt;">0.07 - 1.47</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: right; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">506,026</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">506,026</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: right; padding-bottom: 4pt; font-size: 10pt;"> </td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"> </td></tr></table></div>

7629986

8702083

7629986

1072097

0.0102

0.0001

1.8909

0.0472

P5Y

P6M

4582068

653851

3411561

3867068

506026

3697495

Stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $0.35 per share, the adjusted conversion price shall be $0.35 per share.

1714286

857143

571429

1714286

285714

51582

0.10 1000 2564439 464027 0.175

195000

49212

1.05

0.084

0.0613

15.31

2.80

0.70

2.10

4.90

One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B Preferred Stock was issued (the "Original Issue Date); one third (1/3) may be converted beginning two (2) years after the Original Issue Date; and the remaining one third (1/3) may be converted beginning three years after the Original Issue Date. The number of shares of common stock issuable for each share of converted Series B preferred stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice.

1 for 35

1 for 35.

<div>Due to the reverse split effective on April 12, 2017</div>

0.10

2017-12-31

2020-05-19

After the amendment the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. 50% of the lowest trade price on any trade day following issuance of the Notes. 50% of the lowest trade price on any trade day following issuance of the Notes.

257048

167048

1760000

1325000

53266

46333

170790

13334

49212

The note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.

432048 430896 0.75 P25D

3697495

2641304

1.505

1.190

5.25

8.75

6.65

10.15

22.75

61.25

147.00

15.40

31.50 1.31

52276

32362

3612857

3697495

49954

32362

2558988

2641304

P2M27D

P1Y2M12D

P5Y7M17D

P26D

P1Y5M19D

P6Y5M16D

P5Y4M2D

P7Y6M7D

P3Y6M7D

P4Y6M18D

506026

5.25 5.25 479121 2857 24048 506026 479121 2857 24048 506026

28571

114286

3315714

4571429

Not less than 30 days nor more than three (3) months after such termination.

428571

31429

2021-10-17

2021-03-29

1.31

0.29

The Employees provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock. The employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 428,571 shares of its common stock The employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 285,714 shares of its common stock. The CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock. The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 142,857 shares to each of the consultants, its common stock.

506026

<div>The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant.</div>

4750

1267123

57021

4924591

273500

1562862

5117

EX-101.SCH 5 ooil-20170331.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Polices link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Capital Stock link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Convertible Promissory Notes link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Options and Warrants link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Foreign Subsidiary link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Summary of Significant Accounting Polices (Policies) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Summary of Significant Accounting Polices (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Options and Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Summary of Significant Accounting Polices (Details) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Summary of Significant Accounting Polices (Details 1) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Summary of Significant Accounting Polices (Details 2) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Summary of Significant Accounting Polices (Details Textual) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Capital Stock (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Convertible Promissory Notes (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Options and Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Options and Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Options and Warrants (Details 2) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Options and Warrants (Details 3) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Options and Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 ooil-20170331_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 ooil-20170331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 ooil-20170331_lab.xml XBRL LABEL FILE Document and Entity Information [Abstract] Document And Entity Information Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Trading Symbol Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Class of Stock [Axis] Class of Stock [Domain] Series B Preferred Stock [Member] Series B Preferred Stock Series B preferred stock [Member] Series C Preferred Stock [Member] Series C Preferred Stock Series C preferred Stock [Member] Statement [Line Items] Statement [Line Items] Assets [Abstract] ASSETS Current Assets CURRENT ASSETS Cash and Cash Equivalents, at Carrying Value Cash CASH BEGINNING OF PERIOD CASH END OF PERIOD Accounts Receivable, Net, Current Contracts receivable, less allowance for doubtful accounts of $50,000 and $50,000 respectively Contract receivable net Contract receivable Contract receivable Inventory, Net Inventory Costs in Excess of Billings, Current Cost in excess of billing Work In Progress Work in progress Prepaid Expenses Prepaid expenses Assets, Current TOTAL CURRENT ASSETS TOTAL CURRENT ASSETS Property, Plant and Equipment, Net Net property and equipment NET PROPERTY AND EQUIPMENT Property and Equipment, Net OTHER ASSETS OTHER ASSETS Other Assets Other asset Goodwill Goodwill Other Intangible Assets, Net Trademark Security Deposit Security deposit Other Assets, Noncurrent Other asset TOTAL OTHER ASSETS Assets TOTAL ASSETS TOTAL ASSETS Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' DEFICIT Current Liabilities Current Liabilities Accounts Payable, Other, Current Accounts payable and other payable Accrued Expenses Accrued expenses Billings in Excess of Cost, Current Billing in excess of cost Customer Deposits, Current Customer deposit Warrant Reserve Current Warrant reserve Warrant reserve. Deferred Revenue Deferred income Short-term Debt Loan payable, current portion Derivative liabilities Derivative liabilities Derivative Liability Derivative liabilities Derivative liability Convertible Notes Payable, Current Convertible promissory notes, net of discount of $492,237 and $591,835, respectively Convertible Promissory Notes Liabilities, Current Total Current Liabilities Liabilities, Noncurrent [Abstract] Long Term Liabilities Long-term Debt, Excluding Current Maturities Loan payable, long term portion Convertible Notes Payable, Noncurrent Convertible promissory notes, net of discount of $931 and $11,429, respectively Liabilities, Noncurrent Total Long Term Liabilities Total Long Term Liabilities Liabilities Total Liabilities Shareholders' Equity SHAREHOLDERS' DEFICIT Preferred Stock, Value, Issued Preferred stock value Common Stock, Value, Issued Common stock, $0.0001 par value, 5,000,000,000 shares authorized 30,506,732 and 21,428,455 shares issued and outstanding, respectively Preferred Treasury Stock Value Preferred treasury stock, 1,000 and 1,000 shares outstanding, respectively The amount allocated to preferred treasury stock. Treasury stock is preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. Additional Paid In Capital Additional paid in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Shareholders' deficit TOTAL SHAREHOLDERS' DEFICIT TOTAL SHAREHOLDERS' DEFICIT Beginning balance Ending balance Liabilities and Equity TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT Allowance for Doubtful Accounts Receivable, Current Allowance for doubtful accounts Allowance for doubtful accounts Debt Instrument, Unamortized Discount, Current Discount on debt Debt Instrument, Unamortized Discount, Noncurrent Net of discount non current Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred stock, par value Series A preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred stock, shares authorized Series A preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Balance (in shares) Balance (Unaudited)(in shares) Preferred Treasury Stock Shares Outstanding Preferred treasury stock shares outstanding Preferred treasury stock shares outstanding. Income Statement [Abstract] Income Statement [Abstract] Revenue, Net Revenue Sales Cost Of Goods Sold Cost of Goods Sold Gross Profit Gross Profit Gross Profit Operating Expenses [Abstract] Operating Expenses Selling and Marketing Expense Selling and marketing expenses General and Administrative Expense General and administrative expenses Research and Development Expense Research and development Costs Research and development Research and development Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization expense Depreciation and amortization Depreciation expense Operating Expenses Total Operating Expenses Total Operating Expenses Operating Income (Loss) Loss from Operations before Other Income/(Expenses) Loss from Operations Loss from Operations before Other Income/(Expenses) Other Income(Expense) OTHER INCOME (EXPENSE) Fair Value Of Debt Financing Cost Fair value of debt financing cost Fair value of debt financing cost Gain (Loss) on conversion debt and net change in derivative liability Gain (Loss) on conversion debt and net change in derivative liability Gain on net change in valuation of derivative liability The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax. Gain on net change in derivative liability Interest Expense Interest expense Interest expense Nonoperating Income (Expense) TOTAL OTHER INCOME/(EXPENSES) TOTAL OTHER INCOME (EXPENSE) Net Income (Loss) Attributable to Parent Net loss for the year ended December 31, 2014 Net loss Net loss NET (LOSS) INCOME Net loss for the nine months ended September 30, 2014 Net loss for the three months ended March 31, 2017 Earnings Per Share, Basic and Diluted BASIC AND DILUTED (LOSS) EARNING PER SHARE ATTRIBUTABLE TO SHAREHOLDERS' Weighted Average Number Of Shares Outstanding, Basic and Diluted Basic and diluted weighted average number of common shares outstanding (Denominator) WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED Basic and diluted weighted average number of common shares outstanding denominator Statement Of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Preferred Stock [Member] Preferred Stock [Member] Preferred stock Common Stock [Member] Common Stock [Member] Common stock Common Stock [Member] Common stock Additional Paid-In Capital [Member] Additional Paid-in Capital AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Loss Retained Earnings [Member] Accumulated Deficit Shares, Outstanding Balance (in shares) Beginning balance (shares) Ending balance (shares) Stock Issued During Period Value Of Issued For Cash Common stock through private placement for cash Stock issued during period value of issued for cash. Common stock issuance for cash Stock Issued During Period Share Issued For Cash Common stock through private placement for cash, shares Stock issued during period share issued for cash. Common stock issuance for cash (shares) Common stock issuance for conversion of debt Debt conversion converted amount Common stock issued for conversion of debt and accrued interest Converted an aggregate principal amount Converted an aggregate principal amount Common stock issuance for conversion of debt Debt Conversion, Converted Instrument, Shares Issued Common stock issuance for conversion of debt (shares) Common stock issued with for settlement of debt at fair value (in shares) Common stock issued with the debenture (in share) Common stock for settlement of convertible promissory notes Number of shares converted into common stock Stock Issued During Period Value Settlement Of Accounts Payable Common stock issued for settlement of accounts payable Common stock issuance for settlement of accounts payable Value of stock issued in settlement of accounts payable Stock Issued During Period Shares Settlement Of Accounts Payable Common stock issued for settlement of accounts payable, shares Common stock issued for settlement of accounts payable (shares) Number of shares issued in settlement of accounts payable. Stock Issued During Period, Value, Issued for Services Common stock issued at fair value for services Common stock issued at fair value for services Common stock issued at fair value for services Stock Issued During Period, Shares, Issued for Services Common stock issuance for services Common stock issued at fair value for services (shares) Common stock in lieu of cash consideration Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock based compensation Stock compensation cost Other Comprehensive Loss Other comprehensive loss Accumulated comprehensive loss vale. Accumulated comprehensive loss Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Beneficial conversion feature Beneficial conversion feature Statement of Cash Flows [Abstract] Statement Of Cash Flows [Abstract] Common stock issued for incentive fees Net Cash Provided By (Used In) Operating Activities, Continuing Operations [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustment To Reconcile Net Loss To Net Cash Used In Operating Activities Adjustment to reconcile net loss to net cash used in operating activities Common Stock and Warrants Issued For Services Common stock and warrants issued for services Common stock issued for services Stock Compensation Expense Stock and warrant compensation expense Stock option and warrant compensation expense Stock based compensation Gain Loss On Net In Valuation Of Derivative Liability Gain on net change in valuation of derivative liability Gain loss on net in valuation of derivative liability. Gain on net change in valuation of derivative liability Debt Discount and Beneficial Conversion Feature Recognized As Interest Expense Loss On Settlement Of Debt Debt discount and original issue discount recognized as interest expense Represents Debt discount and beneficial conversion feature recognized as interest expense loss on settlement of debt Increase (Decrease) In Operating Assets [Abstract] Change in Assets (Increase) Decrease in: Increase (Decrease) in Contract Receivables, Net Contracts receivable Contracts receivable Increase (Decrease) in Billing in Excess of Cost of Earnings Cost in excess of billing Increase (Decrease) in Inventories Inventory asset Inventory asset Increase (Decrease) In Prepaid Expense Prepaid expenses Prepaid expenses Increase (Decrease) in Other Current Assets Other asset Other asset Increase (Decrease) In Change in Liabilities Increase (Decrease) in: Increase (Decrease) In Accounts Payable Accounts payable Increase (Decrease) In Accrued Liabilities Accrued expenses Increase Derease In Billing In Excess Of Cost Billing in excess of cost The increase (decrease) during the reporting period in the liability reflecting cash payments received before the related costs have been incurred. Increase (Decrease) In Deferred Revenue Deferred income NET CASH USED IN OPERATING ACTIVITIES Net cash used in operating activities NET CASH USED IN OPERATING ACTIVITIES NET CASH USED IN OPERATING ACTIVITIES Net Cash Provided By (Used In) Investing Activities, Continuing Operations [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Payments To Acquire Property, Plant, and Equipment Purchase of fixed assets Purchase of fixed assets Net Cash Provided By (Used In) Investing Activities, Continuing Operations NET CASH USED IN INVESTING ACTIVITIES CASH (USED IN) INVESTING ACTIVITIES Net Cash Provided By (Used In) Financing Activities, Continuing Operations [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Repayments of Short-term Debt Loan payable Loan payable Proceeds from convertible debt Proceeds from convertible debt Proceeds from convertible promissory notes Proceeds from Issuance of Common Stock Proceeds for issuance of common stock for cash Net Cash Provided By (Used In) Financing Activities, Continuing Operations NET CASH PROVIDED BY FINANCING ACTIVITIES NET CASH PROVIDED BY FINANCING ACTIVITIES Effect of Exchange Rate on Cash Foreign currency effect on cash flow Net Increase(Decrease) In Cash NET INCREASE/(DECREASE) IN CASH NET INCREASE (DECREASE) IN CASH SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Interest Paid Interest paid Income Taxes Paid, Net Taxes paid Noncash Investing and Financing Items [Abstract] SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS Conversion Of Accounts Payable Into One Convertible Note Conversion of accounts payable into a convertible note Conversion of accounts payable into a convertible note. Beneficial Conversion Feature On Convertible Note Beneficial conversion feature on convertible note Beneficial conversion feature on convertible note Stock Issued During Period Value Settlement Of Supplemental Shares Common stock issued for supplemental shares Stock issued during period value settlement of supplemental shares.Stock issued during period value settlement of supplemental shares. Change In Derivative Liability On Series B Preferred Stock Change in derivative liability on Series B preferred stock Change in derivative liability on Series B preferred stock. Basis of Presentation [Abstract] Organization/Basis of Presentation [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BASIS OF PRESENTATION Summary of Significant Accounting Polices [Abstract] Accounting Policies [Abstract] Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICES Capital Stock [Abstract] Prefferred Series A Stock Capital Stock Stockholders' Equity Note Disclosure [Text Block] CAPITAL STOCK Convertible Promissory Notes [Abstract] Convertible Promissory Notes [Abstract] Debt Disclosure [Text Block] CONVERTIBLE PROMISSORY NOTES Options and Warrants [Abstract] OPTIONS AND WARRANTS [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] OPTIONS AND WARRANTS Foreign Subsidiary [Abstract] Foreign Subsidiary [Text Block] FOREIGN SUBSIDIARY The entire disclosure for foreign subsidiaries. Commitments and Contingencies [Abstract] Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] Subsequent Events [Abstract] Subsequent Events SUBSEQUENT EVENTS Consolidation, Policy [Policy Text Block] Principles of Consolidation Earnings Per Share, Policy [Policy Text Block] Loss per Share Calculations Inventory Work in Process, Policy [Policy Text Block] Work-in-Process Share-Based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-Based Compensation Revenue Recognition, Policy [Policy Text Block] Revenue Recognition Receivables, Policy [Policy Text Block] Contract Receivable Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Segment Reporting, Policy [Policy Text Block] Segment Reporting New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Fair Value, By Balance Sheet Grouping [Table Text Block] Schedule of fair value of financial instruments Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of reconciliation of the derivative liability for which Level 3 inputs Schedule of Assumptions Used [Table Text Block] Schedule of fair market value of derivative liability Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block] Schedule of Company's stock option activity and related information Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] Schedule of weighted average remaining contractual life of options outstanding issued under 2009 Plan, 2012 Plan, and 2013 Plan Schedule Of Share Based Compensation Warrant Activity [Table Text Block] Schedule of Company's warrant activity and related information Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for Warrant (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share Warrant or share units that were granted, exercised or converted, forfeited, and expired during the year. Schedule Of Share Based Compensation Weighted Average Remaining Contractual Life Warrant Activity [Table Text Block] Schedule of weighted average remaining contractual life of warrants outstanding Tabular disclosure of the number and Weighted average remaining contractual term for vested portions of Warrant outstanding and currently exercisable or convertible during the year. Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] (Level 1) [Member] Fair Value, Inputs, Level 2 [Member] (Level 2) [Member] Fair Value, Inputs, Level 3 [Member] Level 3 Inputs [Member] (Level 3) [Member] Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Schedule Of Fair Value Of Financial Instruments [Abstract] Schedule of fair value hierarchy Assets, Fair Value Disclosure Total liabilities measured at fair value EX-101.PRE 9 ooil-20170331_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	May 15, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	ORIGINCLEAR, INC.
Entity Central Index Key	0001419793
Trading Symbol	OCLN
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2017
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		38,318,007

XML 11 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
CURRENT ASSETS
Cash	$ 442,928	$ 351,321
Contracts receivable, less allowance for doubtful accounts of $50,000 and $50,000 respectively	130,269	382,895
Inventory	13,613
Cost in excess of billing	144,192	47,612
Work in progress	86,085	86,085
Prepaid expenses	33,912	42,128
TOTAL CURRENT ASSETS	850,999	910,041
NET PROPERTY AND EQUIPMENT	181,230	161,912
OTHER ASSETS
Other asset	19,538	19,538
Goodwill	682,145	682,145
Trademark	4,467	4,467
Security deposit	3,500	3,500
TOTAL OTHER ASSETS	709,650	709,650
TOTAL ASSETS	1,741,879	1,781,603
Current Liabilities
Accounts payable and other payable	585,597	480,064
Accrued expenses	735,379	715,281
Billing in excess of cost	16,327
Customer deposit	113,950	113,950
Warrant reserve	20,000	20,000
Deferred income	10,300
Loan payable, current portion	5,978
Derivative liabilities	7,629,986	8,702,083
Convertible promissory notes, net of discount of $492,237 and $591,835, respectively	289,831	1,935,233
Total Current Liabilities	9,407,348	11,966,611
Long Term Liabilities
Loan payable, long term portion	25,258
Convertible promissory notes, net of discount of $931 and $11,429, respectively	3,084,069	1,613,571
Total Long Term Liabilities	3,109,327	1,613,571
Total Liabilities	12,516,675	13,580,182
SHAREHOLDERS' DEFICIT
Common stock, $0.0001 par value, 5,000,000,000 shares authorized 30,506,732 and 21,428,455 shares issued and outstanding, respectively	3,051	2,143
Preferred treasury stock, 1,000 and 1,000 shares outstanding, respectively
Additional paid in capital	52,684,407	51,428,976
Accumulated other comprehensive loss	(95)	(92)
Accumulated deficit	(63,462,160)	(63,229,607)
TOTAL SHAREHOLDERS' DEFICIT	(10,774,796)	(11,798,579)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	1,741,879	1,781,603
Series B Preferred Stock
SHAREHOLDERS' DEFICIT
Preferred stock value	1	1
Series C Preferred Stock
SHAREHOLDERS' DEFICIT
Preferred stock value

XML 12 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Allowance for doubtful accounts	$ 50,000	$ 50,000
Discount on debt	492,237	591,835
Net of discount non current	$ 931	$ 11,429
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	25,000,000	25,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	5,000,000,000	5,000,000,000
Common stock, shares issued	30,506,732	21,428,455
Common stock, shares outstanding	30,506,732	21,428,455
Preferred treasury stock shares outstanding	1,000	1,000
Series B Preferred Stock
Preferred stock, shares issued	6,666	6,666
Preferred stock, shares outstanding	6,666	6,666
Series C Preferred Stock
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000

XML 13 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Sales	$ 672,129	$ 1,467,750
Cost of Goods Sold	582,456	1,068,427
Gross Profit	89,673	399,323
Operating Expenses
Selling and marketing expenses	512,801	493,510
General and administrative expenses	624,530	686,846
Research and development	53,653	210,150
Depreciation and amortization expense	13,600	11,239
Total Operating Expenses	1,204,584	1,401,745
Loss from Operations	(1,114,911)	(1,002,422)
OTHER INCOME (EXPENSE)
Fair value of debt financing cost		(52,759)
Gain on net change in derivative liability	1,072,096	2,599,198
Interest expense	(189,738)	(202,016)
TOTAL OTHER INCOME (EXPENSE)	882,358	2,344,423
NET (LOSS) INCOME	$ (232,553)	$ 1,342,001
BASIC AND DILUTED (LOSS) EARNING PER SHARE ATTRIBUTABLE TO SHAREHOLDERS'	$ (0.01)	$ 0.18
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED	25,082,031	7,348,638

XML 14 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Shareholders' Deficit - 3 months ended Mar. 31, 2017 - USD ($)	Total	Preferred stock	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2016	$ (11,798,579)	$ 1	$ 2,143	$ 51,428,976	$ (92)	$ (63,229,607)
Beginning balance (shares) at Dec. 31, 2016		7,666	21,428,454
Common stock issuance for cash	423,500		$ 242	423,258
Common stock issuance for cash (shares)			2,420,000
Common stock issuance for conversion of debt	244,212		$ 321	243,891
Common stock issuance for conversion of debt (shares)			3,207,139
Common stock issuance for settlement of accounts payable	90,000		$ 89	89,911
Common stock issued for settlement of accounts payable (shares)			886,700
Common stock issued at fair value for services	464,027		$ 256	463,771
Common stock issued at fair value for services (shares)			2,564,439
Stock compensation cost	34,600			34,600
Other comprehensive loss	(3)				(3)
Net loss for the three months ended March 31, 2017	(232,553)					(232,553)
Ending balance at Mar. 31, 2017	$ (10,774,796)	$ 1	$ 3,051	$ 52,684,407	$ (95)	$ (63,462,160)
Ending balance (shares) at Mar. 31, 2017		7,666	30,506,732

XML 15 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (232,553)	$ 1,342,001
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	13,600	11,239
Common stock and warrants issued for services	464,027	293,980
Stock option and warrant compensation expense	34,600	52,296
Gain on net change in valuation of derivative liability	(1,072,097)	(2,546,439)
Debt discount and original issue discount recognized as interest expense	110,097	120,816
Change in Assets (Increase) Decrease in:
Contracts receivable	252,626	(110,769)
Cost in excess of billing	(96,580)	(157,357)
Inventory asset	(13,613)
Prepaid expenses	8,216	428
Other asset		42
Change in Liabilities Increase (Decrease) in:
Accounts payable	105,533	299,036
Accrued expenses	69,309	105,537
Billing in excess of cost	16,327	49,100
Deferred income	10,300
NET CASH USED IN OPERATING ACTIVITIES	(330,208)	(540,090)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(32,918)	(5,699)
CASH (USED IN) INVESTING ACTIVITIES	(32,918)	(5,699)
CASH FLOWS FROM FINANCING ACTIVITIES:
Loan payable	31,236
Proceeds from convertible promissory notes		100,000
Proceeds for issuance of common stock for cash	423,500
NET CASH PROVIDED BY FINANCING ACTIVITIES	454,736	100,000
Foreign currency effect on cash flow	(3)
NET INCREASE (DECREASE) IN CASH	91,607	(445,789)
CASH BEGINNING OF PERIOD	351,321	695,295
CASH END OF PERIOD	442,928	249,506
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	1,258	366
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Conversion of accounts payable into a convertible note		430,896
Beneficial conversion feature on convertible note		16,771
Common stock issued for supplemental shares	44,440
Common stock issued for conversion of debt and accrued interest	244,212	426,114
Common stock issued for settlement of accounts payable	90,000
Change in derivative liability on Series B preferred stock		$ 123,110

XML 16 R7.htm IDEA: XBRL DOCUMENT

Basis of Presentation

3 Months Ended

Mar. 31, 2017

Basis of Presentation [Abstract]

BASIS OF PRESENTATION

Going Concern

XML 17 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Polices

3 Months Ended

Mar. 31, 2017

Summary of Significant Accounting Polices [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

Principles of Consolidation

Loss per Share Calculations

Work-in-Process

Stock-Based Compensation

Revenue Recognition

Equipment sales

Percentage of completion

Contract Receivable

Fair Value of Financial Instruments

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

	Total		(Level 2)		(Level 2)		(Level 3)

Derivative Liability	$	7,629,986	$	-	$	-	$	7,629,986

Total liabilities measured at fair value	$	7,629,986	$	-	$	-	$	7,629,986

The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value:

Balance as of January 1, 2017	$	8,702,083
Fair Value of derivative liabilities issued		-
Gain on conversion of debt and change in derivative liability		(1,072,097	)
Balance as of March 31, 2017		7,629,986

				03/31/2017
	Risk free interest rate			.01% - 1.02%
	Stock volatility factor			4.72% - 189.09%
	Weighted average expected option life			6 months - 5 years
	Expected dividend yield			None

Segment Reporting

The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.

Recently Issued Accounting Pronouncements

XML 18 R9.htm IDEA: XBRL DOCUMENT

Capital Stock

3 Months Ended

Mar. 31, 2017

Capital Stock [Abstract]

CAPITAL STOCK

3.	CAPITAL STOCK

Preferred Stock

Series A

On March 30, 2017, the Board of Directors of the Company authorized the withdrawal of the Series A preferred stock. As of March 31, 2017, no shares of Series A preferred stock were outstanding.

Series B

Series C

Common Stock

Three months ended March 31, 2017

The Company issued 2,420,000 shares of common stock through a private placement at a price of $0.175 per share for cash in the amount of $423,500.

The Company issued 886,700 shares of common stock for the settlement of accounts payable with a fair value of $90,000.

The Company issued 2,564,439 shares of common stock for services at fair value of $464,027.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 19 R10.htm IDEA: XBRL DOCUMENT

Convertible Promissory Notes

3 Months Ended

Mar. 31, 2017

Convertible Promissory Notes [Abstract]

CONVERTIBLE PROMISSORY NOTES

4.	CONVERTIBLE PROMISSORY NOTES

The derivative liability recognized in the financial statements as of March 31, 2017 was $7,629,986.

XML 20 R11.htm IDEA: XBRL DOCUMENT

Options and Warrants

3 Months Ended

Mar. 31, 2017

Options and Warrants [Abstract]

OPTIONS AND WARRANTS

5.	OPTIONS AND WARRANTS

Options

A summary of the Company’s stock option activity and related information follows:

	March 31, 2017
			Weighted
	Number of		average exercise
	Options		price
Outstanding, beginning of period		3,697,495	$	1.505
Granted		-		-
Exercised		-		-
Forfeited/Expired		-		-
Outstanding, end of period		3,697,495	$	1.505
Exercisable at the end of the period		2,641,304	$	1.190
Weighted average fair value of options granted during the period			$	-

The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of March 31, 2017 was as follows:

						Weighted Average
		Stock		Stock		Remaining
Exercisable		Options		Options		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	6.65 - 147.00		52,276		49,954		5.34 - 7.52
$	10.15 - 15.40		32,362		32,362		6.46
$	1.31		3,612,857		2,558,988		3.52 - 4.55
			3,697,495		2,641,304

Restricted Stock to CEO

Restricted Stock to Employees and Consultants

Warrants

	March 31, 2017
			Weighted
	Number		average
	of		exercise
	Warrants		price
Outstanding -beginning of the period		506,026	$	5.25
Granted		-		-
Exercised		-		-
Forfeited		-		-
Outstanding - end of the period		506,026	$	5.25

At March 31, 2017, the weighted average remaining contractual life of warrants outstanding:

						Weighted
						Average
						Remaining
Exercisable		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	5.25 - 22.75		479,121		479,121		0.24 - 1.20
$	8.75 - 61.25		2,857		2,857		5.63
$	31.50		24,048		24,048		0.07 - 1.47
			506,026		506,026

At March 31, 2017, the aggregate intrinsic value of the warrants outstanding was $506,026.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 21 R12.htm IDEA: XBRL DOCUMENT

Foreign Subsidiary

3 Months Ended

Mar. 31, 2017

Foreign Subsidiary [Abstract]

FOREIGN SUBSIDIARY

6.	FOREIGN SUBSIDIARY

XML 22 R13.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2017

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

7.	COMMITMENTS AND CONTINGENCIES

Operating Lease – Related Party

The Company entered into a month-to-month lease agreement with a shareholder of the Company for office space in McKinney, Texas at a base rent of $4,750 per month.

Warranty Reserve

XML 23 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2017

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

8.	SUBSEQUENT EVENTS

Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events:

On April 19, 2017, holders of convertible promissory notes converted an aggregate principal and interest amount of $57,021 into an aggregate of 1,267,123 shares of the Company’s common stock.

In connection with certain one-time make good agreements, on April 28, 2017, the Company issued an aggregate of 51,582 shares of its common stock to certain holders of its common stock.

Due to the reverse split effective on April 12, 2017, the Company included 5,117 shares of common stock as a rounding adjustment.

Between April 28, 2017 and May 15, 2017, the Company issued to consultants an aggregate of 4,924,591 shares of the Company’s common stock in lieu of cash consideration.

On May 12, 2017, the Company’s Board of Directors approved the issuance of an aggregate of 300,000 shares of the Company’s common stock for services.

XML 24 R15.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Polices (Policies)

3 Months Ended

Mar. 31, 2017

Summary of Significant Accounting Polices [Abstract]

Principles of Consolidation

Loss per Share Calculations

Work-in-Process

Stock-Based Compensation

Revenue Recognition

Equipment sales

Percentage of completion

Contract Receivable

Fair Value of Financial Instruments

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

	Total		(Level 2)		(Level 2)		(Level 3)

Derivative Liability	$	7,629,986	$	-	$	-	$	7,629,986

Total liabilities measured at fair value	$	7,629,986	$	-	$	-	$	7,629,986

The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value:

Balance as of January 1, 2017	$	8,702,083
Fair Value of derivative liabilities issued		-
Gain on conversion of debt and change in derivative liability		(1,072,097	)
Balance as of March 31, 2017		7,629,986

				03/31/2017
	Risk free interest rate			.01% - 1.02%
	Stock volatility factor			4.72% - 189.09%
	Weighted average expected option life			6 months - 5 years
	Expected dividend yield			None

Segment Reporting

The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.

Recently Issued Accounting Pronouncements

XML 25 R16.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Polices (Tables)

3 Months Ended

Mar. 31, 2017

Summary of Significant Accounting Polices [Abstract]

Schedule of fair value of financial instruments

	Total		(Level 2)		(Level 2)		(Level 3)

Derivative Liability	$	7,629,986	$	-	$	-	$	7,629,986

Total liabilities measured at fair value	$	7,629,986	$	-	$	-	$	7,629,986

Schedule of reconciliation of the derivative liability for which Level 3 inputs

Balance as of January 1, 2017	$	8,702,083
Fair Value of derivative liabilities issued		-
Gain on conversion of debt and change in derivative liability		(1,072,097	)
Balance as of March 31, 2017		7,629,986

Schedule of fair market value of derivative liability

				03/31/2017
	Risk free interest rate			.01% - 1.02%
	Stock volatility factor			4.72% - 189.09%
	Weighted average expected option life			6 months - 5 years
	Expected dividend yield			None

XML 26 R17.htm IDEA: XBRL DOCUMENT

Options and Warrants (Tables)

3 Months Ended

Mar. 31, 2017

Options and Warrants [Abstract]

Schedule of Company's stock option activity and related information

	March 31, 2017
			Weighted
	Number of		average exercise
	Options		price
Outstanding, beginning of period		3,697,495	$	1.505
Granted		-		-
Exercised		-		-
Forfeited/Expired		-		-
Outstanding, end of period		3,697,495	$	1.505
Exercisable at the end of the period		2,641,304	$	1.190
Weighted average fair value of options granted during the period			$	-

Schedule of weighted average remaining contractual life of options outstanding issued under 2009 Plan, 2012 Plan, and 2013 Plan

						Weighted Average
		Stock		Stock		Remaining
Exercisable		Options		Options		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	6.65 - 147.00		52,276		49,954		5.34 - 7.52
$	10.15 - 15.40		32,362		32,362		6.46
$	1.31		3,612,857		2,558,988		3.52 - 4.55
			3,697,495		2,641,304

Schedule of Company's warrant activity and related information

	March 31, 2017
			Weighted
	Number		average
	of		exercise
	Warrants		price
Outstanding -beginning of the period		506,026	$	5.25
Granted		-		-
Exercised		-		-
Forfeited		-		-
Outstanding - end of the period		506,026	$	5.25

Schedule of weighted average remaining contractual life of warrants outstanding

						Weighted
						Average
						Remaining
Exercisable		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	5.25 - 22.75		479,121		479,121		0.24 - 1.20
$	8.75 - 61.25		2,857		2,857		5.63
$	31.50		24,048		24,048		0.07 - 1.47
			506,026		506,026

XML 27 R18.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Polices (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Schedule of fair value hierarchy
Derivative Liability	$ 7,629,986	$ 8,702,083
Total liabilities measured at fair value	7,629,986
(Level 1) [Member]
Schedule of fair value hierarchy
Derivative Liability
Total liabilities measured at fair value
(Level 2) [Member]
Schedule of fair value hierarchy
Derivative Liability
Total liabilities measured at fair value
(Level 3) [Member]
Schedule of fair value hierarchy
Derivative Liability	7,629,986
Total liabilities measured at fair value	$ 7,629,986

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.

+ References + Details

XML 28 R19.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Polices (Details 1) - Level 3 Inputs [Member]	3 Months Ended
	Mar. 31, 2017 USD ($)
Schedule of reconciliation of derivative liability
Balance as of January 1, 2017	$ 8,702,083
Fair Value of derivative liabilities issued
Gain on conversion of debt and change in derivative liability	(1,072,097)
Balance as of March 31, 2017	$ 7,629,986

XML 29 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Polices (Details 2)	3 Months Ended
Summary of Significant Accounting Polices (Details 2)	Mar. 31, 2017
Schedule of assumptions used in binomial lattice formula valuation of the derivative
Expected dividend yield
Minimum [Member]
Schedule of assumptions used in binomial lattice formula valuation of the derivative
Risk free interest rate	0.01%
Stock volatility factor	4.72%
Weighted average expected option life	6 months
Maximum [Member]
Schedule of assumptions used in binomial lattice formula valuation of the derivative
Risk free interest rate	1.02%
Stock volatility factor	189.09%
Weighted average expected option life	5 years

XML 30 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Polices (Details Textual)	3 Months Ended
	Mar. 31, 2017 USD ($) Segment shares	Mar. 31, 2016 USD ($) shares	Dec. 31, 2016 USD ($)
Summary of Significant Accounting Polices (Textual)
Cost in excess of billing	$ 144,192	$ 174,105	$ 47,612
Billing in excess of cost	16,327	$ 552,818
Contract receivable	130,269		382,895
Allowance for doubtful accounts	$ 50,000		$ 50,000
Number of segment reporting \| Segment	1
Convertible Debt [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share \| shares	3,867,068	4,582,068
Stock Options [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share \| shares	3,697,495	3,411,561
Warrants [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share \| shares	506,026	653,851

XML 31 R22.htm IDEA: XBRL DOCUMENT

Capital Stock (Details) - USD ($)			3 Months Ended
Capital Stock (Details) - USD ($)	Mar. 14, 2017	Oct. 01, 2015	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Capital Stock (Textual)
Preferred stock, shares authorized			25,000,000		25,000,000
Preferred stock, par value			$ 0.0001		$ 0.0001
Common stock issuance for settlement of accounts payable			$ 90,000
Common stock through private placement for cash			$ 423,500
Private placement [Member]
Capital Stock (Textual)
Common stock through private placement for cash, shares			2,420,000
Common stock through private placement for cash			$ 423,500
Private placement price per share			$ 0.175
Series B preferred stock [Member]
Capital Stock (Textual)
Stock conversion basis, description		Stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $0.35 per share, the adjusted conversion price shall be $0.35 per share.
Preferred stock, shares outstanding			6,666		6,666
Conversion price		$ 1.05
Series C preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares outstanding			1,000		1,000
Preferred stock, shares authorized	1,000
Preferred stock, par value	$ 0.0001
Purchase price of the Series C preferred stock	$ 0.10
Total purchase price Series C preferred stock, shares	1,000
Common Stock [Member]
Capital Stock (Textual)
Common stock issuance for settlement of accounts payable			$ 89
Common stock issued for settlement of accounts payable, shares			886,700
Common stock through private placement for cash, shares			2,420,000
Common stock through private placement for cash			$ 242
Common stock issued for services, shares			2,564,439
Common stock issued at fair value for services			$ 464,027
Common stock for settlement of convertible promissory notes			3,207,139
Aggregate principal amount			$ 195,000
Interest amount			$ 49,212
Share exchange agreement, description			One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B Preferred Stock was issued (the "Original Issue Date); one third (1/3) may be converted beginning two (2) years after the Original Issue Date; and the remaining one third (1/3) may be converted beginning three years after the Original Issue Date. The number of shares of common stock issuable for each share of converted Series B preferred stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice.
Reverse split ratio			1 for 35
Common Stock [Member] \| Maximum [Member]
Capital Stock (Textual)
Conversion price			$ 0.084
Common Stock [Member] \| Minimum [Member]
Capital Stock (Textual)
Conversion price			$ 0.0613

XML 32 R23.htm IDEA: XBRL DOCUMENT

Convertible Promissory Notes (Details) - USD ($)	3 Months Ended
Convertible Promissory Notes (Details) - USD ($)	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Convertible Promissory Notes (Textual)
Converted an aggregate principal amount	$ 244,212	$ 426,114
Derivative liability	$ 7,629,986		$ 8,702,083
Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate	10.00%
Conversion price per share of debt, Description	50% of the lowest trade price on any trade day following issuance of the Notes.
Converted an aggregate principal amount	$ 195,000
Number of shares converted into common stock	3,207,141
Aggregate remaining amount	$ 1,760,000
Recognized interest expense	46,333
Accrued interest	$ 49,212
Description of debt instrument	The note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note	$ 430,896
Convertible Promissory Notes [Member] \| Maximum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt	$ 4.90
Convertible Promissory Notes [Member] \| Minimum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt	$ 2.10
OID Notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument, Maturity date	Dec. 31, 2017
Conversion price per share of debt, Description	After the amendment the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Original issue discount on promissory notes	$ 170,790
Accrued interest	$ 13,334
Conversion price of debt	$ 15.31
Unsecured convertible notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate	10.00%
Debt instrument, Maturity date	May 19, 2020
Conversion price per share of debt, Description	50% of the lowest trade price on any trade day following issuance of the Notes.
Aggregate remaining amount	$ 1,325,000
Unsecured convertible notes [Member] \| Maximum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt	$ 2.80
Unsecured convertible notes [Member] \| Minimum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt	$ 0.70
Convertible Note [Member]
Convertible Promissory Notes (Textual)
Converted an aggregate principal amount	$ 90,000
Number of shares converted into common stock	886,700
Aggregate remaining amount	$ 167,048		$ 257,048
Recognized interest expense	$ 53,266
Description of debt instrument	The note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note	$ 432,048
Percentage of average of lowest closing prices	75.00%
Number of trading days previous to conversion	25 days

XML 33 R24.htm IDEA: XBRL DOCUMENT

Options and Warrants (Details) - Stock Options [Member]	3 Months Ended
Options and Warrants (Details) - Stock Options [Member]	Mar. 31, 2017 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Outstanding, beginning of period \| shares	3,697,495
Number of Options, Granted \| shares
Number of Options, Exercised \| shares
Number of Options, Forfeited/Expired \| shares
Number of Options, Outstanding, end of period \| shares	3,697,495
Number of Options, Exercisable at the end of the period \| shares	2,641,304
Weighted average exercise price, Outstanding, beginning of period	$ 1.505
Weighted average exercise price, Granted
Weighted average exercise price, Exercised
Weighted average exercise price, Forfeited/Expired
Weighted average exercise price, Outstanding, end of period	1.505
Weighted average exercise price, Exercisable at the end of the period	1.190
Weighted average fair value of options granted during the period

XML 34 R25.htm IDEA: XBRL DOCUMENT

Options and Warrants (Details 1) - Stock Options [Member] - 2009 Plan, 2012 Plan, and 2013 Plan [Member]	3 Months Ended
	Mar. 31, 2017 $ / shares shares
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options Outstanding	3,697,495
Stock Options Exercisable	2,641,304
6.65 - 147.00 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices, Range Minimum \| $ / shares	$ 6.65
Exercisable Prices, Range Maximum \| $ / shares	$ 147.00
Stock Options Outstanding	52,276
Stock Options Exercisable	49,954
6.65 - 147.00 [Member] \| Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	5 years 4 months 2 days
6.65 - 147.00 [Member] \| Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	7 years 6 months 7 days
10.15 - 15.40 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices, Range Minimum \| $ / shares	$ 10.15
Exercisable Prices, Range Maximum \| $ / shares	$ 15.40
Stock Options Outstanding	32,362
Stock Options Exercisable	32,362
Weighted Average Remaining Contractual Life (years)	6 years 5 months 16 days
1.31 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices \| $ / shares	$ 1.31
Stock Options Outstanding	3,612,857
Stock Options Exercisable	2,558,988
1.31 [Member] \| Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	3 years 6 months 7 days
1.31 [Member] \| Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	4 years 6 months 18 days

XML 35 R26.htm IDEA: XBRL DOCUMENT

Options and Warrants (Details 2) - Warrants [Member]	3 Months Ended
Options and Warrants (Details 2) - Warrants [Member]	Mar. 31, 2017 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding - beginning of the period \| shares	506,026
Number of Warrants, Granted \| shares
Number of Warrants, Exercised \| shares
Number of Warrants, Forfeited \| shares
Number of Warrants, Outstanding - end of the period \| shares	506,026
Weighted average exercise price, Outstanding - beginning of the period \| $ / shares	$ 5.25
Weighted average exercise price, Granted \| $ / shares
Weighted average exercise price, Exercised \| $ / shares
Weighted average exercise price, Forfeited \| $ / shares
Weighted average exercise price, Outstanding - end of the period \| $ / shares	$ 5.25

XML 36 R27.htm IDEA: XBRL DOCUMENT

Options and Warrants (Details 3) - Warrants [Member]	3 Months Ended
Options and Warrants (Details 3) - Warrants [Member]	Mar. 31, 2017 $ / shares shares
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Warrants Outstanding	506,026
Warrants Exercisable	506,026
5.25 - 22.75 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices, Range Minimum \| $ / shares	$ 5.25
Exercisable Prices, Range Maximum \| $ / shares	$ 22.75
Warrants Outstanding	479,121
Warrants Exercisable	479,121
5.25 - 22.75 [Member] \| Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	2 months 27 days
5.25 - 22.75 [Member] \| Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 2 months 12 days
8.75 - 61.25 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices, Range Minimum \| $ / shares	$ 8.75
Exercisable Prices, Range Maximum \| $ / shares	$ 61.25
Warrants Outstanding	2,857
Warrants Exercisable	2,857
Weighted Average Remaining Contractual Life (years)	5 years 7 months 17 days
31.50 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices \| $ / shares	$ 31.50
Warrants Outstanding	24,048
Warrants Exercisable	24,048
31.50 [Member] \| Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	26 days
31.50 [Member] \| Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 5 months 19 days

XML 37 R28.htm IDEA: XBRL DOCUMENT

Options and Warrants (Details Textual) - USD ($)				3 Months Ended		12 Months Ended
Options and Warrants (Details Textual) - USD ($)	Aug. 10, 2016	May 12, 2016	Jun. 14, 2013	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Oct. 02, 2015	Sep. 29, 2015	May 25, 2012
Options and Warrants (Textual)
Stock based compensation				$ 34,600	$ 52,296
Aggregate intrinsic value of the warrants outstanding				$ 506,026
Employees [Member]
Options and Warrants (Textual)
Issuance of shares						31,429
Stock options mature						Mar. 29, 2021
Stock options prices						$ 0.29
Consultants [Member]
Options and Warrants (Textual)
Issuance of shares						428,571
Stock options mature						Oct. 17, 2021
Stock options prices						$ 1.31
Restricted Stock Grant Agreement ("RSCA") [Member] \| Chief Executive Officer [Member]
Options and Warrants (Textual)
Issuance of common stock, shares	1,714,286	1,714,286
Restricted stock grant agreement, Description	The CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock.	The Employees provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock.
Restricted Stock Grant Agreement ("RSCA") [Member] \| Employees [Member]
Options and Warrants (Textual)
Issuance of common stock, shares	285,714	857,143
Restricted stock grant agreement, Description	The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 142,857 shares to each of the consultants, its common stock.	The employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 428,571 shares of its common stock
Restricted Stock Grant Agreement ("RSCA") [Member] \| Employees One [Member]
Options and Warrants (Textual)
Issuance of common stock, shares		571,429
Restricted stock grant agreement, Description		The employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 285,714 shares of its common stock.
2012 Incentive Stock Option Plan [Member]
Options and Warrants (Textual)
Common stock shares reserves and sets aside for the granting of options (in shares)									28,571
2013 Incentive Stock Option Plan [Member]
Options and Warrants (Textual)
Common stock shares reserves and sets aside for the granting of options (in shares)			114,286
Employee termination			Not less than 30 days nor more than three (3) months after such termination.
Fair market value of stock grant, Description			The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant.
2015 Equity Incentive Stock Option Plan [Member]
Options and Warrants (Textual)
Common stock shares reserves and sets aside for the granting of options (in shares)							4,571,429	3,315,714

XML 38 R29.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details) - USD ($)	3 Months Ended
Commitments and Contingencies (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Commitments and Contingencies (Textual)
Warrant reserve	$ 20,000	$ 20,000
Mckinney [Member]
Commitments and Contingencies (Textual)
Base rent	$ 4,750

XML 39 R30.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details) - USD ($)					1 Months Ended			3 Months Ended
Subsequent Events (Details) - USD ($)	May 12, 2017	Apr. 28, 2017	Apr. 12, 2017	Apr. 07, 2017	May 15, 2017	May 11, 2017	Apr. 19, 2017	Mar. 31, 2017
Subsequent Events (Textual)
Common stock issued at fair value for services								$ 464,027
Subsequent Event [Member]
Subsequent Events (Textual)
Issuance of common stock, shares		51,582
Reverse split description			Due to the reverse split effective on April 12, 2017	1 for 35.
Reverse stock splits shares adjusted			5,117
Subsequent Event [Member] \| Consultants [Member]
Subsequent Events (Textual)
Common stock in lieu of cash consideration					4,924,591
Subsequent Event [Member] \| Convertible Promissory Notes [Member]
Subsequent Events (Textual)
Aggregate shares of common stock, shares							1,267,123
Conversion of shares							$ 57,021
Subsequent Event [Member] \| Private Placement [Member]
Subsequent Events (Textual)
Sale of common stock						$ 273,500
Sale of common stock, shares						1,562,862
Subsequent Event [Member] \| Board of Directors [Member]
Subsequent Events (Textual)
Common stock issuance for services	300,000

EXCEL 40 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 41 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 42 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 107 213 1 false 37 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://originoil.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://originoil.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://originoil.com/role/Condensedconsolidatedbalancesheetsparenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://originoil.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit Sheet http://originoil.com/role/Condensedconsolidatedstatementofshareholdersdeficit Condensed Consolidated Statement of Shareholders' Deficit Statements 5 false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://originoil.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 007 - Disclosure - Basis of Presentation Sheet http://originoil.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 008 - Disclosure - Summary of Significant Accounting Polices Sheet http://originoil.com/role/SummaryOfSignificantAccountingPolices Summary of Significant Accounting Polices Notes 8 false false R9.htm 009 - Disclosure - Capital Stock Sheet http://originoil.com/role/CapitalStock Capital Stock Notes 9 false false R10.htm 010 - Disclosure - Convertible Promissory Notes Notes http://originoil.com/role/ConvertiblePromissoryNotes Convertible Promissory Notes Notes 10 false false R11.htm 011 - Disclosure - Options and Warrants Sheet http://originoil.com/role/OptionsAndWarrants Options and Warrants Notes 11 false false R12.htm 012 - Disclosure - Foreign Subsidiary Sheet http://originoil.com/role/ForeignSubsidiary Foreign Subsidiary Notes 12 false false R13.htm 013 - Disclosure - Commitments and Contingencies Sheet http://originoil.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 014 - Disclosure - Subsequent Events Sheet http://originoil.com/role/SubsequentEvents Subsequent Events Notes 14 false false R15.htm 015 - Disclosure - Summary of Significant Accounting Polices (Policies) Sheet http://originoil.com/role/SummaryOfSignificantAccountingPolicesPolicies Summary of Significant Accounting Polices (Policies) Policies http://originoil.com/role/SummaryOfSignificantAccountingPolices 15 false false R16.htm 016 - Disclosure - Summary of Significant Accounting Polices (Tables) Sheet http://originoil.com/role/SummaryOfSignificantAccountingPolicesTables Summary of Significant Accounting Polices (Tables) Tables http://originoil.com/role/SummaryOfSignificantAccountingPolices 16 false false R17.htm 017 - Disclosure - Options and Warrants (Tables) Sheet http://originoil.com/role/Optionsandwarrantstables Options and Warrants (Tables) Tables http://originoil.com/role/OptionsAndWarrants 17 false false R18.htm 018 - Disclosure - Summary of Significant Accounting Polices (Details) Sheet http://originoil.com/role/SummaryOfSignificantAccountingPolicesDetails Summary of Significant Accounting Polices (Details) Details http://originoil.com/role/SummaryOfSignificantAccountingPolicesTables 18 false false R19.htm 019 - Disclosure - Summary of Significant Accounting Polices (Details 1) Sheet http://originoil.com/role/SummaryOfSignificantAccountingPolicesDetails1 Summary of Significant Accounting Polices (Details 1) Details http://originoil.com/role/SummaryOfSignificantAccountingPolicesTables 19 false false R20.htm 020 - Disclosure - Summary of Significant Accounting Polices (Details 2) Sheet http://originoil.com/role/SummaryOfSignificantAccountingPolicesDetails2 Summary of Significant Accounting Polices (Details 2) Details http://originoil.com/role/SummaryOfSignificantAccountingPolicesTables 20 false false R21.htm 021 - Disclosure - Summary of Significant Accounting Polices (Details Textual) Sheet http://originoil.com/role/SummaryOfSignificantAccountingPolicesDetailsTextual Summary of Significant Accounting Polices (Details Textual) Details http://originoil.com/role/SummaryOfSignificantAccountingPolicesTables 21 false false R22.htm 022 - Disclosure - Capital Stock (Details) Sheet http://originoil.com/role/CapitalStockDetails1 Capital Stock (Details) Details http://originoil.com/role/CapitalStock 22 false false R23.htm 023 - Disclosure - Convertible Promissory Notes (Details) Notes http://originoil.com/role/ConvertiblePromissoryNotesDetails Convertible Promissory Notes (Details) Details http://originoil.com/role/ConvertiblePromissoryNotes 23 false false R24.htm 024 - Disclosure - Options and Warrants (Details) Sheet http://originoil.com/role/OptionsAndWarrantsDetails Options and Warrants (Details) Details http://originoil.com/role/Optionsandwarrantstables 24 false false R25.htm 025 - Disclosure - Options and Warrants (Details 1) Sheet http://originoil.com/role/OptionsAndWarrantsDetails1 Options and Warrants (Details 1) Details http://originoil.com/role/Optionsandwarrantstables 25 false false R26.htm 026 - Disclosure - Options and Warrants (Details 2) Sheet http://originoil.com/role/OptionsAndWarrantsDetails2 Options and Warrants (Details 2) Details http://originoil.com/role/Optionsandwarrantstables 26 false false R27.htm 027 - Disclosure - Options and Warrants (Details 3) Sheet http://originoil.com/role/OptionsAndWarrantsDetails3 Options and Warrants (Details 3) Details http://originoil.com/role/Optionsandwarrantstables 27 false false R28.htm 028 - Disclosure - Options and Warrants (Details Textual) Sheet http://originoil.com/role/OptionsAndWarrantsDetailsTextual Options and Warrants (Details Textual) Details http://originoil.com/role/Optionsandwarrantstables 28 false false R29.htm 029 - Disclosure - Commitments and Contingencies (Details) Sheet http://originoil.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://originoil.com/role/CommitmentsAndContingencies 29 false false R30.htm 030 - Disclosure - Subsequent Events (Details) Sheet http://originoil.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://originoil.com/role/SubsequentEvents 30 false false All Reports Book All Reports ooil-20170331.xml ooil-20170331.xsd ooil-20170331_cal.xml ooil-20170331_def.xml ooil-20170331_lab.xml ooil-20170331_pre.xml true true ZIP 46 0001213900-17-005234-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-17-005234-xbrl.zip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
G@6VLU3D MO(^"[".JC.2OB2Q0N"QY+WCA28D_-@/8\2B4(R[>09K[P0?M/\@3U]A< 15H MD(<[V/[T'9.>RW0'EXL18-:ZRQYX2J.DN)DHO!3A98'FZ:7:*=LG9/#5H@)'MB$(>.![9&H46P+@J$90@&@PO& M", PS5E;W%[![G#"A-&!W'&?->[']'@ MY,%<,"2"-&6P=>(A^J&= MS- %SM*&L$%R1.$4#$P'L!K& ^RY%2%R;#\> "(&?AS)*\V!FF2,/;%FC:@A MGO7SB%O^*BW%G$P"'XQK(!;2&T= TH]HG"(>A7]LAOA A,43WP-[&FS7D>:3 MA1C=83X"?)=F87,$@>48H^M/HM'7U"2'_>$Z0!DR$@'=#L5<:%3*YLYWP1(/ MZ9 !6\@/T:!%O*- ?+1Y?S8W.&&FEA28>%QX<,/HIU#9.+33X?/&?>FXY+ M.\2'PRQLG_2+&G_;B=)G03Z %!V+?6<2GB(G')I85VB:&/0" W4-2Q,5;,AD M._H#3%>7<9I"5\-9\1R"/(@/Q1X@"O=X! =8CD@45G&0VS-")%DFET0VQE)( M8^+ASXQG]Q-VBT3)AP<''#!$#UK*.C!D,ARC+/!LP'I>#[X7KJ;L?FC;;K%< MSB[H10>$#T:0I7+_"F8 <13NT)'V^M5"5UJCV:\WFY7SIOG!Y X@_: 9F9HW MGE3H?#4V;&+.?2>$C _ +PZRU?SOPG))?E_),R>0_;1O3CRXL7=N3?.MT!2B MP8V%1^Q94/7O]3N_RBW5S\^NWBR\79Z;=;[?3L[/+W;[<7WW[5 MKBY_NS@[OUF^!.$G2/Y(/ 7\[RT>X.A_^8&L5";Q@GWS+/-XX]VTM1.-(M\A MR;<;&I3X7%DZ*MS>@846QN,Q^JW!Z DS.R/G4Q>6QNRQ 5X6'FYN%H-9"A:Y MQBTX,*B2IL>++.5BG_SM,C.$$W?=H MVP@WLL,O2D8!6GXXFS_X%^,Q@5."*V2%: &["QF'4+"M6QM^?$Q< G31$,+1 M*\(Q)A,X!:5#<'=!>J!?Y&6O*[%W^ VGM%;ER4=^Z*ML;\.6RQWWBIS52L>I M+:<(^&PC9=Z+++;;(D=R$EL0W:4*>T$H!ZI9=+<]W/FHGOT'#_WNJ45WTFT777!B]F;NKA!? M11/A@>&E,K-/0.4&YHAI7DP19*!:Y;?";,"Z]AEODF!VEA1_RT!UP@RX$%2W M:U+XVX"65? \>T2? +]FX[>!GD\*'P,WR9BAW"QRL22639AC;@Q.Y/?V>*U% M]ZMX%X0%_"B&T\%P^W0M>.65WR5/DH1@>_!C5W9*^'&4NGC$Q=_$1Q^%0R$" M,N+N3%N$/E+@/S>[AG.WK+EW'AC@AE_8W;."&P9EX91U*U= %K]^I4@H![]0 MJ H((AYQVZQU^MU:J]\FIS EF?@3<>W>;G1J#:.C/8BZV/S,@SM9[%O??*]29+O(F!9.2"ZAH$7% 0@O+NP5BNB MR 9X?4;#8+ "R*Z3O,A14D9)&67Q[43&M'2]UN[HLP*FTP;QT-8W$C"M6KMG M;"Y@5A4TG>6"IMA&5,*F;+Q:2F&S&_(=M4?G#S_X 6L]H3(^H?+BE)!.I=MF MBH#/T^E!TN"!@IU-CR<4)#_:!$9#N8 ( @8 MATE$,.-U2I+QFD3^\E!L#D7HNS, E,U#?YQ<5DHQH8RIM;4Q%:DXH59/FMSK M2:GE\A&L=/M-$?!Y:GE"174P?0!+ *#3/E4"3H9- M&W$(I8L#46HW#S2UH4T.W&8@PZ"9DHC 4?$J@C:XO09F+6 M(*:=86M3S8PTYM!UEODN0RU>15$4KXG(HT(3E J7IJOR\%[3NF,VY8$-WFG) MU5KN?MVR&,A:YF!\-[P3#!>%T7$%X5I81',Q\LPS5=]PE>96[MU!W(M M'PH<,,R(#*)E?,%S@&%F$Z\H3UQ "\^OI-HE%@LH88FBI I?D-@0,M/4$I83;$9>J_&8V9@""N CG(+MR$7F1Q2#M73Y MG##(AU+XLECGL) A]N074SJDS$9 U2CU^M5^+>RD\XC48WT?QG75R*(VD*+4 M#*62HDTZ92%>Z3:8(N#H!_V#9F2BMM4*G N'SG>8\L;7L MZ$:1: P_BY,*NISQ/"0JA%!1$*P"XD2N*+81..$/?)+B/2A\;8).ZLP!+!R[ M-6W(1'+AT'E$FSQ(#R.\1 :OBN-B=1HIVR[Q)P=IKUQQ E]?&_*RW4L*/=W MBW FD&2N9QB \P6_EIZ!5//ID((Q+"9ZNWG3%&%= PPPER90'-@I?N%L-?)] MFZ\PO',F$SP?)09\-C=>TU.PWC#.I2R*0T("1%W[-3G+U+0'#&.,&.('X'7( M=X[U-5*G.G)&+"]W$ MYPM,SAP%C+,!9K+.@RPJ:Z8(DQBG$ +EZ'^QTEPY^I]O1UVQP,+$[!$3(=3H M*9D_E.S8H%(45!OP19!/'/]#X6J6+]Q%MF!ZO9UE!? 2"JE;.JOE)M6UGBS8 MQ]J817>^+=6[SEB;$@>PXP",PXG9VTKITE(U,FB0 @"92H)5]0K$0-,V!3<'GX!%4# MQ$L*U_4M;NUZXAUQR8,9KK%WLN@!848'$V1JEGC$^;@VV-H.NKMYR43^.)J* MY#].#6&.3PHY23!4U_[J/P"A@K0R'%(-;#QN]Y,?/4,\X8F%8.76"<%A?EE0+77-\;G: DFE'IP(AY] M3[F"/^FM5DWO&_3]3WH7_FBT:U3HB9>"=7D5IV2N>9IJ#^9S 8 7?X(/38-_ M^U.[;=1Z>F]F>J4RE,JHL,IX_>JPQQPGI% CE&VX6W&C@= <@F666,%@H%%3 M,2%^"H41-]BIQG@FO^3";=Q8AQ^R,)$A2=A$- 0I***P\P_/?P#11IUEPS0< M*C/-T89D9(3&7A(Y8L^([K%ILYF@B!2$,(;_B$'P6A-#7B85Y(NQ;$'IQ[3!24Y2=?*A\50 M+S=[+$Q;N<'O6-PY*=GN2=BCM/SD1,!S]Y,*?3.GJCQ>\C2804@E9.P1%U51 M0K:RY$N\)=)55N;?H*"MG,U*G:Z$B2TL2W>*1>[E,+_$JDTM/+(F'Q@6P$>3 ME@I&8'> ;-\G5VSH.A 5KU+7TXPP1V,Y"9:<\-:L5* _J:\5QE0L4]P_205+1/@\$J68))[K1FJ9&DE9:DBVZI1>:DPO4Z%Z;ZC\I2V MJ]X&4^1;@WS;I\%C]J^*Y%HSZ0@MO)!W+TK#?@JN A,;(T93)HG8$4[8[&\I M4R*)%TK\=CPOEVYT)E))5MYW"HU+R@_.P]C- MY_G,>0O2_JQX$&?4K0G&36.9,H1PB MS!$B)R*'2&;N \N/!3I,[&F7+-8<8KE=DR[G1%P=)8MXPG>;QN1)97,?[\P8 ML/-V0\L"IB=N4LTK:R3=@8Q_S>H@=GZ ;NGVI,]HCD0Z6_U.[40.) M@&P(@!7XB^?ZTQ9YJ#T6R=?/:5QAXI?G[N9FHV9T^MS?W.P9M5Z_CS,]06[KO\C24/-$E@OLN1-=08K&^5>R,8[1O*ML-]J MB5D::G;:Y3)M5(3O4]KXZU18B6V<&-;V.!R!&Z[P0A#G @XS@W,&B6D50HY>!ZL-PA+022T*1*O:14JL M*;&V0GJ::?N4](1QR[?^Q+&TGM&0:YI0\Y:L)$1:! 0CB+(-24?C .NS!SRN MB@['^4%M-L0NS])K-919(!P<$&XP(IRWS3$CKP8"P*>BF_ELH@(_RV:]Z"A4 MX!'.[[8LN$/1C%R:62K9H,2+$B]*O*QF-8EM&XKM;XL82U&Z4&JX,&#IU3): M,R'=G"=U%D$*V7J+@8RXS@R@LIBI<\ 2,CD*7#'?R-1M947'C#\K#B$!6,Q#D<;Q+# MC''(Y5"1;.,NL6P@;';/7[YS1G>,EWOTJ6DGH"'V3/M?Y/?3_HQ]'N9$-:E( M0I*'DR^9NQDQD9C:;"=ALO"='!W[UF7WS-7TG)A[EWH47?]A'@!_@(6P1.8# M+4^,TLR/DO04C1SN*:?0W0]JAQY^ARH!6WGRR32@?NT)'<1D>J/9KS>;Z90; MX(D6.C3'CCO]L&JO^JS!3A&:!R2Q3^BN:1+"D\FGA-5HU"_2. /+G-PW^ M]P2;]_"_)60'"::IOCZ(UH11(W_R47[0GB-);]97'6#9LQE:G/ M("8_<=D0 MOFQV\+M9W"[7>;JXP]#X*Y#\H-$8)S./0 M=TK6*EE;35G[9B+QYD#F:*2:?"/>-#:_\7XD[Q94!MH ML8)[QB8MV)8K;;=9J7G2J.OI7DVDIMB!:^ZU)[?5/@F4UQ=U(Y-'BW=4,[>C MBD[I:;H5G/VQ*A?=/24.$MN,S*RZ&-XV804!<;F%#@O8E-2"FYP -D[I3R@8 MSG\@;TT\3CI<)3LMC3M#)U! #AZ*K,KBT2)FW7G.GS&3@ .%28D'.#N6N7*& MP%)8_4O(B"#W+??"V#BZR'B05SY;"F,E?E8&VR$,-KH@E4VV?50I4_18(PQV MZ&.T( 6HFJ*K'"\)D)3I=CPLFLWUWFQNO[@0%R&3:8F<[D!GCY+/\"^^J$D839&_8%?70_LY MS2T4#:4ZG+V8L]C CR)_7&SI#4SKQRCP8\].IB8>6^,84VP8KO)F*8OJ[#?XINS1%"0*\@/ M#/EZFU.;WXC_85F,#8?+?>9T$-Y\$\O2$SWJ"V319_0)\9R\WY* GJ?=V3J9 MO<^G7VZ8%2']:04ONU'O=!;<.!2.V:UUC'ZMW^ML&=;UD5!]7)XH'"HY__6I7 M@*UBK&_"!,\2>"^5S+L":]FI5A%7$5<1MZS$/:!XWE6:UHS$:#@[NZW)TJ\Q!%Z$%(L$8!&E2PUKDJ3GI'E!TK="+O"2 M&<.[3 Q6!%?!<^4.GCOPE6VABOPDXF=YK<^_F5YL!E--Q+J^G%N=7JW;,&J- M7E/=ZJQUOY\OGE:@/Z@[6QC&S%Z7,[<)YK;\=,\XDKP\G]DR9^&OF$/ &[!@ M,H^P/6PVX)VP+.H#Q>V)>5-$.97+X51^J]<:79"6_64*8C,^F8^%++>X7/U, MFE>X^=R2E^"*.!QW*Y^$.BD=PBJT">!)', M?)]8G8L\%_FNZ.2H^.1X_ABS$%TSBAS>$F$;RC39:V(50>BN M4$<7S?U-^G%O>2BB$5#Y$Y3-+'M1/^T(;8>=Y!ZF-Q49 4RR)A#NA-7&=@ MH]]8TZ^X$CO6&_I_:B? 00WC/U=E2.6,G%_?3>1;/[1['TPQ<75%C6J/QO&X M$C.UZEV#N*G7KS?Z*_-3"5AHQX[+PO7\P1#?&+,'<)HCWH38HK[(9.S#:6*X M3' =(0-U>!N\$'BHK4V9&805XJ$RB*'SA(5LYQYKQ]G:U&'N\=Q_K,1%W^ 8 M=""^4;6]RGR<5M0X8&^Y&S:B3@C7U!8*ED'449WDRD(GM6M*1(W;!;7L!G&( MO8ZP0W00P/JQ!.V$!=1QB&ZW&6">[S/>GSF>+*YD!\L>F9[S;P(#2PM'06Q% MV%XN:<_Q8$ZSPIGX!9^,/-'H2!Y3>V1>2$^T@6:VZH9; @;:RW96+7 +]-PU ML_C&O*#0(^TT:R-V%?@>?+:8ZJ1:/OHI_5^^77Z]<2H"1UE!8QTH=1HJP4_)EK/:'S\C8%>#.OI-_I'[?;. M"4%18HLN["(5T!.\V=<$M)QG37F &&K0( E--\<^[&A9@X)VGJ:-5G&[NSA0 M4G26"M;2%[FRM07-6.E1T3(0A_G!IG)O5]%!$,>BLME!@'%KO'T@7\HH=G@; M0_C,AD/>I9YBZTS"+3Q M #[H;0H5ZM6U/_@]LE#Y^.@#%I]W $%65-.<(8PN[L"I$61Z%2U#]^"XKG9G MWE.Q73^6.T-:OF<[O)%MP,+8C2A@*3,^:M1/5AOB%;:6ZRDIM5K<;;5GL8C0,PJTE1O"VEJ@E2Q96%J-!LY87KF@G2C,)5DBY^)6MUG MN#_1%'(F0OC1-U?F5#0ZS$TT^24Y8FJ8\AF@'."#)>8UCD?> M+QP1A0OST#>6B8T0>W87=^!^#[H"__K+^S@\&9GFY,--%IJ9G>VO?->Q0 ;? M AD^N;[UXY?7K_Z2OH'! 7>^:X/2.?\S!KWSS8_8YU16I2\A<$C(:S;\^T/__C?3^XZHOFTTOO-_;B^_-_7O0(C\]V]^0;@%V"6,(YR+QWHQ M@85/-95+XK2??_79K*]Z\?G\.5HS.VHI1$J4'RPMW'1R[S(DQ]'Y , 9._)HZ?XI2K; M75'J*:WYZ7!:4\GB2N\M1;XG5.DEJ$JZ%B.EULYG_ \=%\,BZ3J47QS2;>1G MAGG]_!81+^2273JO^I++S!MFP?(P# 8U923&^<;N3=M,PS3G=&G!@*A+A8<_ M\K.WA%<:W[T*_!'>M.)MX1_H2-=N,9H&W>(U[<*SZGA9:OF>Q^BZ,X.1!M+8 MHZB@9,(HY$RO:Y<>W@$X8%Z\U=\WWR7F@H 7KP.H:_M@2E]S6( GI]J B3)- M$94[ (@M?SR&2?EJLCM*C'A]J[^C9"%Q84G%&IP@I)[S=+LH;K,%H#*:9D[R MVH.9E S3WN(XTEWW9># I+"I**Y/^PQCO_M(\\LKG ,^ S5Z\+6W!@FJ,]UA NP*\_ K;R^F^UV\UDX9*8=NQ C=("#/,A-PF6(R MFWXAZ\&SKDN@FJX5NV;$*4X92LG5$EW V**NAF '46MC$C@6J\U]DPU+-SPB MA4XP6!(Z!:+)9OSYU*B-'H UIR=#9/.W1OL=<,DTQ&=@;6)GV&*;T5!9M3#/ MYV$"EVDPA6[4I("*E/&)C2BB@>\VQ[/+/)IF M2S)NL "'%4E(-]YXOK:-<-(R/2W M(/A1J%$0TT*YE4F4&E[G8R:H70/U^L#@:[I(QZ=/Q18^$UOXBJ2"$P(^0XQ[ M,CWMIT:]V<9[?R[PDY >(6OF!5JX,48QK>>6=,UZQGGPNE( 2QA3* MA8]0E^2_AAA"E(_?"E/EZCH_ +8+#V/, M1+Q1]#0HE@AQ&\:P6*"A=4#BWV0F%, M"H]DZ]0ZG@6DMYZX IJY M\R$7@,=/C7H-D#BO+<]FM26H;E,TWT"+$%[2<[:DK]W6M6MG- JU<^L'P2,=#$PG,$M>?\D-VXG\2ITUN74QB6!Z:AKE#[B(0R?J9 M@PVCXF%MC(>@F@ I]MN;'QE>U!L$I(P291B4@-&5G*H\^18$7YUQWU1I(J\4 M(=4^/&KR;9\&C]F_6ZY,;C2.LK@$WCB U>%J7=EJF[ULM/*7C6E*9>*6,3$; MP>4VF^/!A!,QIW3=.'/#R/-H1)*?F?>UK7R!@#E &LU$UB,93,WVW 7;M1C\ M!@>7\D/?<<,N]S/YNL9,RF\4WI_9!?@)YL153;>N_>Z1@Y-2DAZ<$%^U"6EV M34,'%#:<5_G<, MU&"!.Q7UL%*?9"Y7*?;,V':$KU5D+<$GJCE,%S(%*4SD0,-Z".3,H";^SD?:5>*!> 7RKP\"C=XR="F1UM&L]9N-'9D:BJ^ M*%?M#D6/C?=ILV8TNC6]V5^T3X6B1X$LZ/4ZM>YBC5TL"42EG5";F%/R$I$G MT.3-#M,NAS_UR1A0>[$4M%=[L63T4%1X@@J+VM\<[GC3[K1JK>5F$U#DGLP2 M.,_,B,,6O-TPNJO4"ENU\I=<+NPS&T2J.)@J#K;MXF"M?10'N_SVC_/KVXM/ MOYUK5]>77R]N;BZO_ZE]N[P]OUD^N^I KMRGRGVZ9E0 9EKXN,_R?&(M8['\I/%*<:9,;!J6,.\#P.+\>-"4]@QUD"D8!H8 M+8J>C5:]W]#>%FF17;O#+I%2F6#^@>-)64R\KFKH@':%M <=$4'L&7PWVC!&U2QE8^:0IA-D.8 H-$PNP% MJGS-ZV'/L1V&^?(BK0,6/6!L0B1%[P9I/$1:@R9?"R;-8LN9=B$MB'@=BWOS ML!86C('B/KJ>S7O83P@#9;=1-C#]*J\2@0YC8*]%D.-BZ;TT=4K@WYVFV79) M1EZVGG6FH/ >CS\R SA.+O .HI6@H+2I&K)C;L9\IZ<)I]0 ),J885QVE(<( MT;T,I+E4Y9FL,CX*(@3C4P % 84DV6FN&OD5*15.5/\&THAROG*]7RP/SGCE M]22=30*Y07EA<=4 M^$5A>4',A0P739E'=$EJFD#IG6GG_;%918"D:PA-7^MV=NFD49IY7X;53KP[ M>R'7HI*YN?JXXCLLVIN=:2I+Z.+=6VQNS=VTS%48N?@\9V:]6R8 LJN9G"CH M-FK=?F.9\-&;M6:SQ""_@4A*1F!+3/:9EQ5V' JX-8S,@ U0$G(-6\W4W0GYC-E5_8CD FB MN CJ2?@A1*T7X"&#>F&EN,G/*!N,R\T';^OF0VUM^X';.\RP(!\0BG5>LZ JL+13"\YK/%UK,*W!4@?,8T,G M:80W*P%QI-3F1Y\?GKTPH4](5&E2V[')/3G&IK)T5 %UA_VQ*/)'DI8\:VT> M1OQB.3@)(GG!0W'"T_Q[<1QPG>&,6/3LM$4NPB\%#;+'"2:X)40K;,Z%I1?_ M9GK4%EB72R_2X$^N<\$R,U+T GU2E34#&IKY9ZJ!>706-_8HM% MX*=N.]632>%$[IL46I,JO(6FF]:J))V9NS4QVOG";\YXS&P' "&OLR@"EX&2 M.!9GF5+@:]Z)2*K):'=Q>VS!B?I$-%J!!W59G"F//ZMAT^-[GHF:OU M.SM1_#=L$N5:Y'8.I/DOO0)8<@I2Z<=4/ZYO)B57K-S=S:L\YYPA5;&BGCY< M'^1L+0.P=V7>ZM2:S>::REPIC8,K#:7"RT2-/]*N\*)N8-;J7G8>%HF05:L< M4Z-IAI$O(%ML'F46+15H2R]A]U[^.%6=GH_B"-M&@X)SQD[:KGJN'T/:?R&D M*\5I@3<'"DK7\A6R\\*785V8I+6 D*J9+N+&P<0$ MI1V8DSLDW@G\8[1/6I)M$U$UFH?$ZC(!2GR%4,Q5IW;GAZ04@$^L2%!94CD) MIA?"EMW:\EBF00AKX\W"Q\S$2/H,:, ,$@J)"IMDF@_QKPF51B8FL:H4_B_I M%31$S0 /T>$B;24OP06><%Q$=JZZ),+DC"=QSH "8OB60YLH+^,JF@;J@RC52FT;,RC=84/X4;F 9O;S]#:6NP75[=7EQ^ MN]%.OWW6_CB]OC[]=JLRFLHFH966+ $-E,U2)FHD9>XNZ4 ;SA2S*Z+.MG'W M?+W<%):!0!^M/C?J \,F05LCTXX)PF$F]P#\+W L#RF:65/RNP6&1EX%J7BA M4NPH%9M:*GI<\HA-@]]W&8L[FMC^)"*O#%*!=T.]=%S1VQ9?Q4_HEKEGHATL MEYG:E6MZ MY1Q/&I(#+ M4.01TCM)&0KAKA%.IN2N QU)0>(C#1D=,AV;I7"D=)V::_-$=9L)2-.>0/SHS>HT',^<6QQXG3L 2]S$%/2-T',O"(3$_#F<@_C0- M@Q[E ;:;Y-D<:8:L%]UI;_5&=/<.(YT==&EC -:2]&SB$17>6@KQJ,SQ,E$# M QACCR7]MYK/UU;-=;55L[K:2@=T&;W.5M05QT^9=15YC(MO @&M')-.A-/QTGP! W8(Q=#Z5G\7510(*V@ M9UD?O#,:3QO!_NT^46_"NXY+);-P673'R*DG6&N8YY'HCB4M7 O7XOE2:V)= M@H+NYT1S^'3*[&[+3 .Z?9:9E_/4I=H:R6JH M% <@FIN=?D!%(\P D(PXS?BIV>"Q;*"@I.V7=0(7L4D\"G%VACV87VUE?AW< M_%+F<(KOUZ]6-<&R*%F#)Y:VU[+#SEPX-V:66%OCI1W7-4#3K$* I?3"Y(+DSC(1.8V9=DLFD\*(3NG MTE)UQ@-]6W-^:H]6 &>%"&-XI3PZQR(\.6G&SHT0 M0ZIEZ?@,10*W,"9\L.Z*(1+8?B9 MKT&D,^2$EPEP@] 0(=RI4T0JJ,)=+^GAGXK>T))XIP^YG#U)2R%0+4PRRTS6 M1)*%&R[5!D$8"D\-=XB O#(G(!)!D%%A,+5+2K!+U-50F:AQ"E)A/,9#RI+T M8]F0T*A_,Q7@HX105V3A(MY,D;W$_?D[)*\BX"[*Z9M@LIORS,Q&>9)1-FW;L&S)!AK00L%YOHSHH+\"RHK(HQ;\@7T3L ;ZHA"D& M+O#)[&_)!N;+SO\F^#ST7<=&+O:1B;V?WW1VA8V"WM;'0\)Z$\[@]X?5QVUY M(2L+U9.*8(F/M*J85;:I.H16[!"ZLSTM)Z,>(^TJ!_ Q,QM=GA\9Y=93)@4= MN/_#LA@;#HOU3$(^NK512B>56E+_R050#MC(\3P1,)< GGKVLR3W\K#8 M C!E28%=W"H >,^H=SJSL%.<__Z ;]8Z_6ZMU6^_%*0KIEX)\)\JR,N@$QO' MRL<;*U9).5;O^)98/Z(]YUI5P#8$]E<>C%4VG;^9*5U.'B^&=<]"Y.08\5E> MR*J$1<65I=!D2X^(2IN&7B MOYT(S(.M?^UKXJ?E9LG9MV+@'M5N6_GR^;@VV5KWUQ7=8"_['GM%HAW^BH!7 MQ^ E/X2Q(DK2*H.E$K+DI1LL1JW3TFO-1NO(Y:G:;67@MA=KL.C]QI%OL)?N M1UE,M@-8)TDRLY8DWTDML*52P$D!-3LK#[F>Y5(V)JS2C6@I;IB/&['EA:P" M >O;X,K7KU3D@VHC7.5*;JJ2XO[)AQ67'V8MF("-38WOHE7V1+>S!#N;W2#GGD65R@ M]^O$54?'"%O.%3)%V6.%3%'V2"#;6CVK-2VT0O,G MYV7+UG+*C=6J(OMEEKA2$N)(("M+Q3OJ'EA]=)87,D5H1>B]$OHZ<3Y5%:4O M0K.7A5NDV+"J\DL5("L+N=A)87,D5J1>H]D_K,3V^9JHK4O9O%>0VTW1^X>/G7JG;9VHNFM;KVQ<-51KECZ!;!TN]YL M@?W1K;>-(\6[JANB;/W]V_IZHZZ38=^NMS9(="_;9BKOU4XUL7C(_EU&K=E9 M6>A7":GEA:Q*6%2LJ5BS K#NF34[]=;*/HWRHW3&-L[:!Z@B-8>ZWMC$;#XP MZ'J]J5<6[R_L(E-5HJ]\)?IFK:,;M5Z[J_9<>0%6>^ZH]IQ1:[=[M7ZOI_9< M>0$^ IR7S[AKUMN&=J*UZNTM%AHO*1W4E4$%RZVNM7DJM()*DJ!BX!Y52>F2 M&&FJXXS:;6JW'?UN4^T22@YNY?&MS+DR'(/*5J=9E7@]0*EF@7-5K'D9 :D& MTLG #)D-2!E/F!?2PQI[Q,]8N-GR1QY0--=G I.P-"?4^(OP.'Z9-JB@3A1^ M0./ GZ$TQ\2!:N$R6%8G#+DA:891T8HKR:Z"QC3QD"$NQ#[@,$X,R6D197ICO; M J;]U&S5.HT&??L3I@[T.S4 (D3 G7M81+U,S/WZUM%FV EE[IVZH)%<6>"KJ?^%-25(.M0@0O4X,?< M9-QN$2_A@,A,VIUYCU941"8.PR\#_AT"-&#,$_TOZMIM,C NRK$9-K+@TQ$$ M8CWQ!)>@U[IZJV;T.LE\^94FR->['T.TI,#B$TPC%#K*>_@I4U8N%'S7RG72R;TJ,;;Q-7/ K\, 2KZ9YY M,:MIENE:L4N_P'BF!6QJT^*(24;, \/-!?,0?F$3ZBP"C\1 =+#A@#A@[$U< M% XAP,H]2)\>#)Q'6;7-/9G;+J C@!L1HLQL#Q_TMLUV.OX;XI0V/&.2T;A M W/OA44H>JIA!Y& H56;69E%:X2)X)$ )H=!3<_#-B=%UFA^:STXP%A$<4') M7KM;TUM-B8[(E3+-/FJ#U9$M[%["E3]T8&^BA'5HRZ<_7?&??M:RKZXY>;03 MF"*,$(Q??1^P=^.[-GR9/7C.3?$0OOS,)F"0.]Q$)Y#P7^UTC">"?]/7[VHS M.H @V18+%!&[UGXNK5>D^\WY&6 +G]N'\FG'/S: H)@7YO0 M1US#EX0EG#G;JC4XY3"<$]\?,%PNB2SX!IZ@$Q<_K 7^P!P /J(IAR=YV +! M?(]2Z#1,^@NF@FWD(Y91&"2/\86+=<'_P,(' /08Q# H7 =G1O2CR*/101@F M,FSG)R:E_96IIXB=-_5.XQ&@!="]"VM/#'[T1I^TSIW8?O+X>S !X:BMC+]9 M@T 9:\I84\;:OHVU9ZAJ_N+1Z>HC,\R4#;:*TSMSQN#>.P,-$;L1V%SAOEWA MRHY^BH;;I\%C^F_%:?#ZU7ZHD)=GBAZ'/EON[AKABQ. =9M(QP4'3-/3F'BB MW,?'@M7LY!A9-,\*Q\EY^W>=PV1" G6B//!U0LOHU=I=79U0C^^$^C1IU0E5 M60$'L8R5358B:NS4)KM!F\D^&J.L:#D[LLKN.S MNF9(F[&"NBD]O*K;*(KA]2L5QU!JRJHXAHK3<,?' D6-=:@Q8[G4E/=@#V&' MJF1$:03%]HAPU+572'O^80;!?O5ILU_OJ(U2BHVB!-?*]/B\1L67&D"F/8B- MQ:N^<'^0-IC*1U#0>EH8CX$HTV6N'#$2:,'(N4<-BGHM8,F!G/0EG>F'ONL" MIK*C]%. ?MBI$%:\,[^7%^YJ*CJ68#]M/ FR4FJN,:M9S'4%D#^_:?"_1;DY_%O"[5.%K8^@?K5%OO[RE=9;#FU% MRJ2OA_*=M'G _0;,[OW\IK,K;.1UPPL@ZWK5[Y604- ^!]ILYQH5@UQ!6VFN M^(-A#6%F'Q.6E<@N"2&.&MH];,YO\7C @A>,XVI!^_K5'GC"!#%FCM@QH5G) MZY(0XJBAW%%% +Q._U8)V#]S 'EE@.:$2U4I4*Y=I^5VFNSMBR[?G+YF@ M1[&(8^%*2GUX =377;/LBSF4RA.?U68TWMNO \N&W+\4]'4L'>,^H=SJSL"]HR+@KX-N- M3JUA=%X*RA5+KP3X3U7DY+JQHFA57RISES/X:$#>YJ_^,&0.6LBH%[5'MMY:OB(]MB:]PV5W1_Y:R0]U0((_M;522I M>'4A"I]3B!>(/XWF:@6AR?<@4G4UD0*F!6QL.A189P&L@6E%V"7"=894##JM M+>1G-N0N:_GDZG8I6CZYB50QGW7QJ8KYS U3RKH19;,=*@F9HNRQ0J8H6Q[( M7K_:>8)0&:NXE(W:+R*M5 F"%P.9HNRQ0J8H>R20E45UGZY7SZ=L"%6:N[Q0 M*L@4915DBK)'!EE9-/=U5%T<5U1?JD"9&4A][I%G\J+ MT?)"IFBM:+UO6I_Y::1%59&JU/XN\PSVP(-76+IM96E3D32#"@-\S+PF)2 < M+?TJ!_ Q,]PSSDF5H]_N 7[]2K'/C:<*YY^ 3S=J!LM,$#TNM$X4KR_[/IBZBA0E:- #XX L!,[^D8)[V7; M?>6]*JHF%@^X68Q:K]T]1IR6%[(J85%QIN+,\L.Z]UXIG>;QH/2EE\LK79W# M36SL X/>A/E6/G*6#O%EO!>M0/$T574 MEBLSP$> \_)9=HUZHTM7"JT-SN05H8.Z7*A@O=6U-D^%5E!)$E0,W*,J*5T2 M"TV5;U=[3>TUM=?47BL'LU42W\J4*\,1:(?="U0-]@,W,NC7*1=&9M-_Q6'D M#*>*'D_U-S!'HX"-S(C!TU'@>*%C:?>F&[.DYU511P/X,M1^$HJS/DO?][9S MCW_]Y7T:'47AS9P;LDQDR M^\J?WJ+[[ON!^^^ $#\M[$@]"Q'3.8IH]0,P;XXYH- M?WYSQC]_;WX]_][0O__-]+[C@F\;C>_\G]O+[TW].Z C__V;7Q!\ 3V)P*)N M 4:[46_MOUG G(6U7O> A ?U)[EMI8K_R[U*D3_)I/]3VS95%W.%$FL*=2XD=J("RJ< MH.U B6J\'=8KGO,_A6"[/CP=NEIGYG%Q@,6)/9"B]L+ MJ+Y-;ZKA(K K$@ !.F:J^0\>_!FFFKFF7<)AQ_'.7&8&VMN__OU=\FI-^PTD M]-O+,_BN!E:']E/FJWS+KS@&E&T[IVBB P M,M<07F#(>(CUCP+J.T65 #0PES33#7UMXIH>(+^>9_;,"GO"=$+K*C'4 .EC M)R+KZ]2ST8Z""9EG.2S,;#AE=+U(HZN[7#@ M2U,+T3<#=A[HN<0M)-F!\-40K""-0$>#[JOU=P$(#>=+T TNMZ9 ,2&\Z002T(POE "'LS' C$_Z$\=#2.$Y M0($Y2G27"ZBQV9\Q .].88A[/#4#(!,?X,6;$_8,'/LH?Y#$J$NPU4NF1VQECZ68L )(S^8)G";8S\6^M!HU(!U-8[^ M_#W-PG/]\P[M\G$?O0& 'WCS_#YWX[+]D[VX4RY3^^4-#_<5[L>'XF\>Q#>#=S_M^_GW^[U<[_@4Z#75QIO7:;3(I<$@;[*!@[.!]2W0'9VMX$Z\"X%\<8P@*RG_ 0>!XVI=.2PJ=6_!^0CO"_&(Y S!AN)G*!.VJ$U['':N M@UL9#2R7T:YU/)AP(N;D+C0<\B82+W\#F6";&AOB22[F9QX3]CY8:2%ZT5PG MFO&RY>XT\281QH63!-CIY%JCF? 5G8Y^S;;V%E].WC(:'Z_%X#/J]_O$= M/Z'E?H93CP7K$_#A]:@XKLPNP$\PIQMS)Q4E7XY?OI30(U,^:B@:')P&GUCT M@(Z&OMCE'K M=0Q^5<+50#0CJ_'"Q;("9CL17<#<,_0&\1"1W(#H?G-L)A0(N8>ZS5J[T9B3 MZY<@HS$F9%ZD"SB<,(QI,EB<$VK)\V0M@GU(CD: :X+-C=#3%3'N]".8\'[& M\6V$8-Z=B".3 T^H*C$A]Y:138NV*?>9)0Y&RPFL>(Q1Q!;RM8QO\M81M!KZ M,B(>3)-A,X?)@CLHSY??RV-06-=H#UN!,P!5QVUF DZ@2_J-KK\HN,?4T!EV M$D_XLD+RF?(E<0>DA,)DC6B;A\1< 0'2$SG>+4Y.&"!L&[/CV"3H[L25L,7 MYP0K+MX?X+1%-)ZE(>P"%[0Y7;B%.]?5AJX2(I1B+BTU4K-?[R?BGU]P)Q<@ MY#-%;S5L_3$()O3;PSYE8?(CG@MDJ0VC>98S$?)&A<>;E%/6#)T_DZ4,Z#@!)$,N/W! MM)'OVUFP"R ^/=$:O2*;4!A3LUNW#=9?[RG++X% $C*SCZFMO!GSO'Y5LJ)E]ZUENC#?X[9H.![\%=C4&JFE4U8@.2#92 M N7"SK>E8@.U+:M'C[Q7)5&8F5>EO42#HCZ$8W'L1I19/*M06[6^T:JU^_J: MMC >@5V'Q;2US? N[P:H*RNM3/RC]G.YZ $'8MJW11HTM^,^^69 _J3/3@#Z M%SV8Y@3]8W0?G7<,SN[L9H/'N:VYK]&3A5%YV(%]A7(#"\/:\JEN'A59)8Q< M81#BKJL)*"ESF/L7"NZ^XMX9<46;(_[N(\ C)8?6HMB"T+_>*A6 %/D.2CZ\ M3,&X)I+HE*V<;C70#T/' ]6 D=D]8O+/%@F'&$Q #UR$5"ZB43M54VK/V$%>!IXLOO]/,>]-Q*4N$G 3\$)"EGX;X*I4E8UA*D=DG('@#<\0T+Z9J M)9)7CY\QT@'K<&!Q:78F1*4$JA-FP(4@P%W0!@# @)95\#Q[M-@D2N-O-2": M3V(?3BH.J33,I>*NCD2_A3EV9%81W'C 2V48T@]8M M2 %1V8%*WI4=Y;,IBU0F"&\/FK5.OUMK]=LH9$0LSH2$6TT3M1#3:HGZ@>S9R3O*;6NUCM8_+CO(E^[BE8\"F M/KN).VW8@FU]HTW"#J_Z--M*:FD-$YER2=K MKP >'7E NI""5#SX;\BBQ%\:CV->:\S",MJD.1[$QISPC8G:0%05R1>O'*#B MSMY! ;BF*6821R!JCJ15(G+4!@D#4 M/Q.!.[F"(O *YKE.DOPY@ *S+?( /*65EJF:7(F+M*RX7'C\DE3^J6=?>%A- M$S!PY0+Y7[*F.L9-E&JJ&S2N3H@--)D/E,HJ&[F4RJHL^625Q;..L.:,*Z*^ MPOQIBQ>M2GI+@.AGXXGK3[&<%/Y"]9G3;T /X1>6.7$BH&%@.B%EF,DW<'*, M" V!7XC[1KJ&!.68KT>5WC72JQ)P,FR\]G0H.T$Q;T\4;LI!P5%OT#UK!G82:/. J6,FU[NYQASF _X, MQ[DQ_!P'V>Q)H2^"G"!.#0AX!HM@T5AB%9Q26\?,' %YL0O"0YH2OP!/8H&; MH8>#;4G"'G'%R407L_B00!U9(H2V?'D-,]*80ZYY\UV&6G2K4_8?)=?A)B>H MK;0,%TX$0%EWS*ZA=W_P3DNN"7+OXS<>0[O%#*:YL9"UX-C-S_!@*T48Q(P6 ME+@Q#].":'7MFX1IONH3OLK=KPQBKH>>6F*MU(C:$S#2UA.4$FY'O8CQF MML/+N2&<@NW(4>)'%%6P=/F<,,B'2;XDD_,C"QCB23OT&?:E;)YBY04O9M=\ M@U8\%$UIPEF[4Y!7D^B[WWJCBB3EM2T5G1;0R':HMLI.%AW":\]O5LL,,Q9DP_"P%_>,)053!8X]. MB'=ID1.YC%^I!4Y(=2SHKIF"4R;HTLSFZ$#%$Y.<$I1^ND4X$T@R1R4, MP/F"7]?-0 IVLL4C6%T3?:.\A:&P-P$&F$L3* [L%+_8VLCW;;Y"+-T\P1-# M8M)FUB(X6!A]EY\@$B+HF%9-^8*(NL\9+SB#$?AQD+E::Q\:36I08 MX[RZ;81#%*(&5B!>H#K36!K'MV,+R[Q$CHM3$C'A^S@ BSO72B"$C3S[>?KEB 9U",D..Z' MPNDJ7\N*3)#T$C2+]47=+SEH8^[:SM=YFRS8P]J817>^+95_(P,L]$$EVRGI/;Z831LL^$3_"*FP8()/UV MEBQ8 G8V)9LF_9WJJU$I,[ZZ6HJLQ'#*(QAOM+V0S6$R=6G*;L>\NR\=& "V M*9T539H).D6SNG&<@(YGQ63Y49V(/$&X\Q$=I^.9FWBRXP"#P(S3V4GKVEDR M,L6'"P"2Z_1:\@7=J-[KF]Q*]<3[XCK#LQ>BKV310\( M\YD7JV6);YB/:X.-[:#CEWSSXG$T$IFAX/1C EQ!.>6 C6;4%!P.Q(DH:FXD3T6N:GWUU,JA)X2EL=+?$H59,B MB239GX@DRG )*0]S #L1 T!E+1.P"6Y:O)A)9;(D>G/O\PIX(8W#;RDSY>=0 M9!+E:?(K2-)&!#4)J-(^1:+Y MK^^-3E *S:CSM. 0WHVA3$3IEXV6?"6/FK0$DE-G!Z9+.BN\8XRBD>F:4XC& M >+JSU@DUHK7Q98!K8UEDF:57&8W<%Q3&%]"W\TVC5LJS3AU9K<*9]=S#5/4^W!?"X \.)/\*%I\&]_:K>- M6D___]O[MN:VC63A]U3E/^#SR>ZQJR@: ._Q65?)MWP^%5LJR+GW^2"T8= MVQO: YE:*ZJIJ&1@,.?8C8U[O^"8L3'ES/3D&B+FJ,]M5HB:,GU\L\&==/@B M*9284^N:3&B/0)D2>GSTN^,^@EF[COHTLUL3EQQ]1T*=S]!)ALEES?;",.-A M!^L@^"'\PQ^"]Z:\3^7M/<8L*57^XT[3VXT.O9 T@F;!W00J1CN^XG7XNL&( MYV+TU&.%3M&Q$48]V.T8-BR0<4]J_E@L=K*3VV"Y">RHLR6.[0,;&-K4X"?4 MHX=LHYT .XD;#==;VTUEZ9+EP1I!&F!?JVD<()R&2G^\P5%1S(1J%2 A+>FH28R'4'")]#" MN(#';H*X*6+DJ6/X9E_MV=[BL6RE62Q432LQ$\WL5]LO)E;[A$/GK1$3RBJW M];1U^PE>-=5^)/^)6,%3^1EU7*%]UA0^+M'(2=]$:T2(2U'P$W/,3U^JP A-\6JKT9.T$PL*P'$PCL>...-&24@#=!-,-I\$\M+.G M%#9V>K0L";<]N(DBV+D&GQO7G<#;0R=Q6+['!>EF5(L"-$W-\N2;.LS]_!7B M 7I^: &1@@MV]!DW12#<<2%2XLDML3 (?1&VFXMY3#E! US +%Y;OW[Z$\\[ M9 @1C8/'S6SBKH&8+C@Y#'!O8F2-.;:_,VA"A== T5)WA\?=PO$."$K[/"7]#S8CBPX)TBG#N 8LBJ>R,&%/[>C#"8L3]L9Z9SP9X-&, M UZZWT_;YGJE';0/AN7]@2=8KN;QR9>/R:&/4YU-;48'[+9NUJF3AYQ7_H@. M+R7'GE+M$[H"OF)8_ Y\"SZ_Q57V.OV>' M#2V'AGJC& JAAP7I.,(@)WB:2>AU^$$YYE@M<;&R9I%'$KDSS(VA[\*$Y.:J MV$D_&,,@6+S" RHX Z&3MQ+ZG>VY/ZSL)DO#2NIJ.LF*S8,EG>W).^8NX)S+ M,%.:DRSSZR2,^A>EYAX""AC:X0T23SF 16J%-&KM8-^_L2VG2X\%8(7?%W=I MS92QKJ;/P=,6ULDQXOC@..;;$X6D&Q(/^Y-ZK J!;DFR#S4)/)*D?]9!FP7& MP0+CAA/3YYZQ('0OB0"P5]%<5MIX;NQNTTG I&-_ZM!R=/2!6]2O#AVF2T>3 MLR@SF!SX7]ILP_6I&P;I-Z>.^4KS(LV+-"_%?":NMCY7?Y-7)/%64*F&PU,2 M)V30F^&SC7FU&9@#ZE]@!2D_486UH7'A%YH%1\&\D&=GVNS#8]G,*6#B=X*G MK#QPF:PEZP\0Y!_@7S-<62-%JXLNP,GPTM;A'CZCD[7B:2) #[M4T 9<=,*- MLPSAC:'/[%">;6.!B.1!=T *]N-[Z^Z>L/99^- 5DB%TV+@Y@K$DEQ4&T#XF MU$+2N!)#F05W\*@=^HIV5%0&U]*U9,]M\D!L1IH?5KJ#2PC6=?F@U-NKU> M_,HCZ$01G1L+RU[]NI^IZPWF\\@\I1;[@D;XES[<&?VUE=BG)JLR@W6' _FO M9RK[O,3F]>QSBMA>1&G:F1=,:R2H@;M\E;[1W&#)>#U![6&KG#5>7# 5X"^_ ML,D<+O:&>"VW>7^>,F<5T5\MIJZ]16+3RC[NY2A[8.[ ::#'>;VLO=CYJW%/ M2\OFNJ(71G/CIM_9:M9)>QV;RQ4MT(-OL@MH=KG,]%!:7UKW4.EEX*4_T#2] M-)CM6.^DK96VMIFV]ME);-!.$YZ'/C/1>L9$<[O,1MO WM#9N[>A&T@Z78W?:O3Q? ?X[/3Z..C=ZT8V/\P_SD;0--J/OKP5[C5 M.FE4J21[ML_:W;[$':"F.8I92.'6[>:%VM5B;8WL)M?!DMJV5['.R:#LBM'5 M$XNT7:=Z&9W*VZ?'1Q1@]X^=:VCV*0J1F$9@)!UX,-^$IVUY<@M#%J"6=!0A M#0.8^$IW28N0W$<:KPD7T72,2-?B>A\, WDTQ$,K6I(ZH(#,[AWKKY"D@(,E MDQ;LXMNQ%8PU!Y'"#CG<2GB9JRP.8^+3>:5P&O,=D[RERR:TRR8GL O$C2]T MS@S6:-&R0(//HV$':*/6KI:#C5;9JK=^$G;'^.XDX<1#E$FNB?-KRO$1PLF=BU)A]O_/4C[G^]$7DIR2G**2LW<&%P2\8A]YFCSE"?=";C8<6PEB="\VEY(6DH:2@ #6O0Z:,7AI1QK]Z= M:Y:GG\^!D_CY!\&W1?3$ 9 14#)=,ET@IB?M_R3;GQ#;)=-%9_II][2GV,:N M(][?BC8-T&<2H$E2,YW'+*$)VU]6FQ[TMPH9-O"PR7Y/^R327PRL(L[Z,2)P MD+F33*X6K%V[6LE E<85/>3!8,EP6 MSXE=/%=SRC9WB7S#ZV=9A\7_-9S0\%8*KW5].EF=<6>DZAUUW)-9G5+Y_6SK MM)SU@\XR\OV0F&4ELTHPJXK2'; E>7H1LUVAPM_P# $;6X!'>;CO89(IFQTS MHY-3F#^QZ8K(D+(8(>7G6D<=@;6<[%H@CI.3S5I(LTO6Y2YF-*]!8 C_,_!#YG=MB M%]D)PC14\<9RW 6>0[2-(+!8*_I%:!NIX\H+UR0V:]B6/H.<.OP<1SWP\06> MN DB'F&F4RTQ*N/+?FD"")X,FC0E:"++&1NS-3GKP2H*H5V@@YC:>]G37L8> M]XY^(0TOD*GGT,>-Y7]7YCBGV4+N8W-1L!.[ZF!JC":6>; ^44O&%0N)8U?5 M_J%<@ 2I^C^*"J0,1F[B=QO@],('%QPQGKJBXQU;$W@L)$S][DBGTC2>=-5) M87D20(1.'+C,Q>??!.F-%7L IW''1G?2*=0N=?5A+S'?9;A:*$!#-GS,!QD: M*"MB>'Z#9$@$,_0^$B'3>L#.<::RLHC=GOQ'(2GZ#)N@FN1F/7*V.8"MT&BU M]"RV6W*'W]S0:3K@];$[FC8W5X8"RDYBXWQ78L93>7J:DWC%XU).P$;RHKX2 ML[R^;]/0Q[E Z2'N; @ZZP6)72!]KF.IP>[;NLBYWIWA6']3,+ -+QCL68"# MV*)1%H_&*FDQB1?2$]<][/** UQ9TSD^J):8>^=U%K+^Z>7B,WF\C <777NN M W_.2&IM.?G*(4;.J)KQZL()>[P\X"!7*M,?:86+DC!=R7(];]F0D7Z1%@[) MC;JX\=%1/I"I1^L.V3!E--P?+F_?\,(QY?+VJ_+9[=)O+_0.-^\SC]!E)#7/ MJ0]?1@N&KK[ZG<"2XG?C*]HKYXB0H'%;DT3O83*DE+!#.;,7'DL/B MXT45T 9LB.\RBP\L;*MXGB>JNXT/BGJ;TKZH]$*F.VK.S$]Z*Y],AX_Y3E;I M$:)\4!T^B_9F]CPLCXH'O ,J=Z'%IN7A+/;YG(V@IB7;-/1J+=CX3 MM(#A]'++-0$+ B)+AG> 5F*V%)MP&VI 3;%3)M2O:=F3.E;&VP;K82( M%/PM;PC]%K633K1?.3!(H]@^9,( M#%\*EIDMJF*RF:5T?BNU$ H8:KAM?;X\=5E=9)L;@ VQ+?+ 9[UBD1T;[^-% M&V/VJHXR!3<6[U^!SQN;JDYZO+,?P(,-S_2I64F Y4.L.WR2++4C!DZ#!QA! MA-C#(N<:GT?#1OA$-"XX;=Y,F0T?!T/GCWG>C/N4#>.D0T!QBN'-BE=\WZ+# M_YOGADMX6G.2!H)JE?4WN6!#7#18*"^:>C3YKI2]ZLYOK@(I^NV0R=$)^E]Q)/,ELR6S);,ELR6 MS#[=SK/ZS>9)QP#LEOR2O8-.+_?E>TR?0=H/[^94'>L/,&N2N:?I#2^9NDZ_ MGW^2;&TA6QO*U!,;XJV.1G(8&#_)NIASGY/:=:ZN:(U4;EW59Q(DL?]+/'@1 MQ_\_;_V9O"^[($O>^#+'O@EM^O']>\Z]28P MTP-L=D_,T"97\\ND$_A7GYB-VS7K<$%C='(UN!WLC5X.5[+UN ;-\G6X$?B)UN#WYVF-?B1 86">_O\ M<,#MO>&1-]B]%GO6$L>GNQZZXERQ)UVRSDVK\T0*Y+BJ&C>D!]B7/)TI3-\B M.EU SXIK\[DA*[63$@%@ 0[S#T]%C9Q0?7M86,[#D(K^="';.*,O))02LDIL M]3FX'>TUFTI1:3HE9$(KV.<0.]LF\+OSYM-67,A$X7H2N2/>S/(+1QU$HZPT MKW(+VK MZ,ETFH?46LN[Q@'<9F%;>M:L\*K1$,X)4U,@@O">BSE784 ;G(-\ M=+9 F8QC<.>\ _L.P O41(A WX-J$00"?*Q7,?#]..![G>%DU.E/!D^%Z%*H M"P'^2P-E&=9$M:UR7%^%@@A*$7D_R)M?%=5RSL>@WSS#:7#P]*!JA]I@_?FG M2HI"C@/WHDT4E7)Y*EBE5(JY292KV0Y@W_-@M5S/I-UH,#W%A:Q)5)12*<1J MUHJ=V5IZ%@HF]@XT6T< MP%+7I*XU2M?D)CNG84R-;DDZ28O#K]<2L8=B))K8"=$!233TS]QAZ03XETX3 M']O!J7;^-0S<5FE;X>1SNY2L5/ZZH0KVM*,E!9E6?X* GO(V B6X)Y&S@G]* MAZ4IMD0@AZ7(K) 34$#O#/M:IZ?V6VY1I;Z)H&]/UF71)FK+%>RI1U*VLZT& M_V2C<58R P^=%-8]RU?N6-6>8H;8F_< WT4T(6Q21E2(#'.["2LN9 TH69=U M#Y4OBV6ZH!W:TBS3("WW&9>>A^,M%L0)WJR26ZZ-%5ZZ?#0\D[_A#^+#\G#I MF%'3O"\N7DH%Z>EW\5[XU,W5*//S6JOI [7;%[VS6M1-3=O;3:U0-[1"?E9R MI\"NU!ZC+42K'U$7EH;")7G:/K@D3QL/5V5=8]B]A:>CL'>LS1')[&033"[9 MEK:)A$X-Q94KMR P2KC.8Q&.A)MN?)I-2E'ADBR6+#X3BV_(PK"PP4H3R=GR MU5L4&4G%DYHH)>+#)0JC][21:P8Q185+,EDR^6Q,QN"^9\R"T+";2%"YL#>V M.^0U=H=2DT<)8". ;!QM]?ZD6W=#X8'>T4?#IT!M*F:1'';[!:,3HI/S=('M MYGF^-6(:P9YVAIG?&@Y'4-1'! M/4[7-GJUU2YN3US;],Y@,.Y,QF.I;2*"VWAZB^?&];H#7;E0^MW!UEZXK>"! M#/4WI M@:85I#/P-)'^C@&U5AU,A'#%Q!R!(+1-!T*26-1K[O3V[I9:)(&@- MI+5TV^K=XB0-0NFGS?:@M3;TQ-:BKFO9>[N4_MM B(+\!J6R+:AL"WJD:F\] MZRXPK(V(M@AU[&UX*EJ -9G=*SVMHZ!-:3E+97,#">NI8!6POV/K:-PD6,\@ M#W$_V)906)IG"6N#U?%SN)@2[XG2MTFPGD$6C#*-N<4GL+3,$M8&:Z,[?Z*T M;1*L9Y #PJ*YTBQ+LRS#G"*&.4^W5699F(+=,5O*S!:@T!9Y7&*OUI9S4K:> M2UYY!J:D$M?*Q93<60X.E\ 1Q_MG&>>35_;%.1W8JEIQ5YR??RK=%T<==E1= M-BL3"TCA^]J<3(++]W72"];6"D)@>G.($2SBZVC MTYM*2U'A:@X%I32*NZN3"Q1[)*\YEDN4- K-HZ6H<#6'@E(:Y0[J,,FI.2K\ MP?7FQ"J\M6I$#%MVI"ILE)J$_L&&KF%"VS!PI8Y)'6N(CCW=;7"MIX@S24Z% M..8A^ECM4D99FQGM4-*!$=[8.RP8W4K *- M,8YO1U&\J04_>7C)CKG"V6 MZ6@@7)*G[8-+\K3Q<(ERCJMC!(NR=.G#I?D:>/A$F5UCH/U321GR]=G460DU?:\B5(B/ERB M,+I<7Q11J2DJ7)++DLOGXW(J^=Y$@LJE?7.6;F/Z&5UC/Z."]J41];V-!;?- M7;-2U;^MY%W#P&VSJ)7> 36,=PT#M\VBAI62RO,5,3S_18N8)]O_98!M1G.O M&@^?IPA;^U]83*Y<*+K>';6QQ9CLCW=&L/7^I#NLN55>?S3I:+KV%,@M15F* M!E:5U=;2/*GVH5'^OC-\/''X-N#]@VU(PZ.BJ5QHF9V MFDC!&I5$[XP'!TQB%IN>HL+5' I*B902*2ZD9^_]/^RU@YQG;"3U\T_"N\HU M9S8.]Z!K!KP'[RNXB12.Z$\H=2F;&C80_(T"MOG-5$7SPF3#8JEC M4L>DCDD=DSZ#=-E$!K^R+MT5]-?&9MZA?W%G&,M?+WV?!/X'P_+^,.R0O+/\ MF>WZH4=RFW!?^M^NYKGMMK>VX59"QV(/^7K[[IEBDIFU,&P?FU&_'@WUR60\ M_)^7>Z$Y)\C?XD>_6<5__G\+Z.W-[E>_DP=B7_ZP_.2VC\XR#'SZ1>\364R) M]\2PUO*Q_N%;OSJ6#1KKA>39RZ9@HY?&YAV8AP=0SP?RNV5,+=L*++ C.S%Y M1V8(\7 =D\WK)Y;&\4C5U7$OD<9<9([$5ES=*X%M_,ZK>7+Q,PG$1;V0R/X& M"\B5DWRN9/K"J?FHJ2-=G8SR^+B.3QKK^'5@?\+%$A=4_\;ROW_P"$ 0$(_X MP8T15$2#&\.Y(Q3-3\8/:Q$N-A!;@L5+8]9_]EKMJIJJ)X@5!5D(-,$5*8ZF MJFK5H_G^QY+,P#_ZP[6!^Z#.JYKYJ77'$W6R&]%\H 5!M11/^Z,]HGL%&R+\F'MTZ72[O>X/ MQKHZ'*?\_RH0%91R1X+R9I7_ $I_OLDM2O?AH#<>:)+LQY+]_6)INRM";@-W M]OV*&HRB+.CU-6TP; ,/"ICJ2HU&;SP@'[N*;/OAV2Y8(X" #."!T-0O6KM\"#0F^^ZUM M^/[5G+Z,\O,6]M?$?Y,%(_)%Z0?%=>C\9?AE '_ /DYYWGNA!)Y!9S2;QLI7 MEI[E>DK@TAM-=#+=.0+/D>G #2YZH&9'N7;3/ MH *XV\3WX0[#47Y1N[T!SG]6J&1UZ.\,\S] "&*F7H-@P&_A)MM6IF3]=]V$ M-SNIGF8/_?XC.-3@0X-\.G<@?)9K4OGS/Y-'^M5./JDH2*O-Y5[3P5P:, @[F;S03$-W!> 3WP/Z+F->&%ZR^X-A+8T8]_S>K]#=LQ;JW MR/S]#U T5+BK^1R(Y1557FVD]?5TP*T89=I*R\@,^D7I-QX 7N2?&ODNW)( MX14<)7!2.P4OP[L<"JHYUZ4R-X26I959I]I<+_FTP;?+94Y*0A_G7+\-IS[Y M*P3JO'^ ?^)-S-KUPJJH#<;Z(>C3U/AUZ,WN#9_0E?YJGEV+]]JO')2U?MZN M;8_+\S;7Y?Z=R!1#F=%)&,2WV0Q5+80SPR:9 M,[Y#-MCE#ZX'@#U@=^EKFNLAU[8QHQA4M'^/"/+^K] *5KBG.\-AE02U$.C\*81SE$\1#O3W1-+XAWA,5VM%/AQ61[2H5% MVU&GD+OYKS8H4&R%U+KJ8!LM=J!6-3U*U6UL224>)R0[C((Z[C>81.FLY2E( MQ/+00ZW7-!KEIPNN/.O.<@R;KG=8)H>QR\]ND+/IV*E7@VY/:P=%OCH^QGRQ M+#:&@!+DRZ,;[>'V%FKLHI7>'6]=A]I,JBV%'KLW-*.6D"KUXFO/75B^[WJK ME)X=22B=[OR>&J$.4+Y^=W(HH:B?'(=S$'#_'?%GGD6S3?4X?J^O'*($]Y9G M*L^UE[T7F-_ + 3;(2H>F1'K@9C*=$4OW[NV23QE8:PP#\$R%)BKL)S A8_X M=,6GX8XI@64!TUH*O!^>_4+!,1&*,0<'D3YJ;GG@[;*BT P M5TUYH\3.FL+B*(^&KUAT$]7^0)?.#33AM3@[*#)IQ21D0Z8 M@%/FKJ<0 R@8TR]Y?4S)94Q)]NLXGS0S[%E(8X?(9Q-KJABT( ]S??!B M1P:./BI)CSEN _J\IWH5@W;B%,R:?:9JMQ@]LYG^=_;I6W5M!-[K5%F]@9K M8$BZS'P M%)^"1N9S,J-%[""V\$;+5C2]H^![LV>M#B1/=CU*UR53.31ANXXSB% C:UV$ M=]3IQF'H\CB)2(G]+NZY:?')"+ B9?6NLF+L W>&K_$I%YI^L7WGEX:U?HP* M\!)PTM4+=7"A38KB1!>M-7\Q"ISB29YID%K#JBGX.9ACE['38@ J)HW1KRW& MS F8W:.7;496$&M>F"?S"^Y>TS4OL"!,7X W. ]6>!G%5WD^4/\1NZ*V^XAQ MT93+L.$'@9N*Y]_!L;&<&7,\W,BI2DQNXCU8/OH,[.6S%^FW)'>S-\6 *G>8 MC&48&0X%U8?WH]_E!,#-E#^7?6/DEA3FL%@RL=>2OP9>[6*50\G%+H%'!QZ M#;>A$TB]5V<6>W3TJ0TG5Q$3(0#!\BW3!V.VJU[S@+.AAY48;^8@],%([8^W M6=0$[N-QJ]#S*8B;-FP@;ON\NAPT1T-U1P)-)#Q+^6PYF/;T7:G"?$PC7^[2 M,?%V/. $4-19Z+^)V*"G#U/%5?D@"X-4>1'M#WN]7A'\J,'-]9:NG+77BI1] MV=!(=32):E^*89/5S:7K6T'J6/KE;.:%Q-R9RA8$=6!T)DFY!Q6!\#Y.PM=S M^:7P3ENQZB/7)8S4:QH=!9R5>\-7_B:>&P4JK8@'GH'^?12MW=B?Q$%*\E<( MFP1PZD>#V"N+@I8L7,M]-'I,P#?L.&Q)/313,6GE#_V=/LB>'K 6"V): (B] M2N*8"2C=;2O$EIAEW0S8XO\_*5ZLN=I7*). &/V.B>C7_@K+Z.Q55?OKGFHEIC9*0&UI, MJO?*H!$C'YT$>P<*=NV1!\L-_2]N0LD:%H9K??".X[0/NDQ:(;>7V26>Q+RC MV9LWJ^067NMV^6AX)CLIZ%^% 1@]!\T->VU5&VCZDACI*@\I5HYRC?0L[E,] M47K2DR3^1X>5:_[FN7Y%QNAP>NYHK+'SW$7JV?[['V"W+)\=EA05F2-9]\'U MYL0*P'S[L!&%3:CET2?$W&PQ[IR_N @+:@;T85_KJ?WJS, &RB4:UN\=A46XYRPT]C;7;00CORG%/*&D]\OM0J69L$9;.H: XXQK?N($>'[ M5.AQ[#+[M,F36I:::+JT=-'NF6AQ.O]][:WT2ZPFB3OE-54>F8=_&0:PY;?^ M)N97QR1>ZH77MI$8+DID6LR-,0J/_64MSE.XF>G2].T(;-ZL-O%AO0#PK[PV M$KNJTP==?>\:70V1)3-+,W-+]G@K,\9>:!=^H8P?386[#8@_I=[-_3! MY?QL.7A.V4E=^O)([ =RB7\DU^XM+R"$HB::G@^[0RD:3T,TREH-3>UJ39>- MK\ME2]> LHJNZZ=;!-:H++EYF^H M2W%YVN*2N^IL$YBAADU\I<@T0&0J*S)L'C=3*=2V<%,(]Z(_F0SV%J-5SCLI M+B*)BV#NA107P<6EC'NA#P;CR7@L1:8!(E-9\?+IN3FMZ)6;GLQ:J=1-U+4/ M&>H9LR T;#Q:I%=U5.G4+L"!G8JS0^5>7^N?]-&[-;[7SX3VRH4(<>M<&3*R MLX6U/_5/FBXEXVE)1JHWT?7@S]$G3=J&IR8!B1.X8X*W/I1R(>4B;]48?-(F M4C;.)AMMW(:FUJ ARI.T-5*>3KECHKY._Y-T=J68G7A3-?IS^$EZU%+,3NZ? M]Z2@24$[A\/?!T'3QF)+&A_^QS=*5]X-/B+UZ,I:')<(O.Z*R&-_576HZJGJ ML'TH5(=NB::4]:++>K7EW4A/05?5">@X+'/./6^'N^(>1F>$G+=,:"#D9^Z# MY!*Z'.8:6HC7N>\C=6*2TYVQ3.EJI4ZR=MKB5SS[*E8P><^*:N/81/ MM_MB[ZMNJ(<(:B748IA#;,G=EBR'DK>M7A"?*'M%6!*WD/[H[I/1\]?!VT%F M?0#D7"$Y]0R9&H_14-@O+<3UEX7J$7663M9[W7L U)[CW^21C/YS=*T&" M5&I"5A&4"\_SN"%^ M:0$QZ&Z7[]@$E'_Y,QUX+Y%YNB$T'HQM>L/H"#/#J62R!V5]?;P["LX&4BDH="M*IMZ:.QY/I4(5.^KIO MG15_7@G#>?':A:9>:'M[-I1&KPT46YJS1PO) M=>C-[HUM*?\#$LP5&;G]G:S.2YXGP9#MMG07.]1N)0I0FAUT#[MFHVD&_/(. MO(@B+]H-9OU4>U:"8VXMPCNH&;QAQ2EI[[8.&@4;@C,"Q'65C@706N ]\!J90%"12X&GWKXT!%_Y5BO% ^ MLFFFR![#6?TW7;)]U[9,.BGUCJ[B'GD@3D@ZRLRP9Z'-9Z@JQFSF>J8!SI[R M: 7WRAUQ@$FVO<)OR!+O,MC 2BSS6L*".K.6 %:'OL/R Z *WKQ47;=!1517_4^8X&14@!0?/LNDP55J1R'Q#9 MRV5XEV-@U)SK]6Z4WKZ_DD:&":KY0VO&.6!&VY5&I]O0.2*0V(^ 9DC57;6=NIQ++L/I*[&1.>;B1%:,G3 M1P=>&5)7]PK@]+[<&PX_C7MY!Z^^ VY]= JT(P9'3I;_6'3;"Q\S^G1.O&M M)%%!__D#. T/I">4\O.ZYR@;^*<=O#*MAW_>!:_H#I(7GJ&N4:4$"9\28 C\J$[P"CK;B/#E.EN6O;[J/_:V23V+WXO9\J1M#4?T2: M$;@![+A ':;T%0\N4W<<08@:_D ''<.]8!F4&9[P8G:0+3!NQO!1#64:O 47 MQTW526@I*.:&Y2D+P_L.*U+\2OR"O#I8UMW=CO)!6L[; T-YQ4.>O-2-6U'31:1SNI?=Y5[L*N M@P2^-?Q[S,V#5\PJ$G:13<\C#Y(M+K(]F&PGJY?B\PGT_F 2GR YC#*9U=:P M"6= YIX;,B.PQ&&".X7%3IIJ6VBJ'4U3O&J9EN&M4N#2^Z\]ZP&("LOO++7K MVBF'^J@WR,R)+$6!+;3+%CHRTG]T&DVY;<9N,-3'F:$'):A0HE0/C0/SL&YA MN[C;E\.]>BX!\ZQC*0(6.)R@92K/RB$%] "*_+^+"^6#ZP;@X1#EEC!YN;A M8L$^Z_NO<_[=[_!!^4$O!0#UOYX!"8AC$O,9O^JY-ER]#X+EKR]?/CX^=G], M/;OK>G>3:_B3ZQ?\5_X^']02P,$% @ ;8.O M2EBW*!DX#0 AX8 !$ !O;VEL+3(P,3LXSANLYN@Z2*?18 D#I)TKV\+6J)MHC+I):DDWK_^9JA/6Y0LVEE<69X;IJ_];Z M_=///WW\5[O]]>SAQKD0;C"A7#NW0#-DU'->F!X[EW^W+SVFA73^"&4YW;W# MO?V]?0D>''_H'?<.G--;I]W&/I0[IA/B M:")'5-^1"553XM*3UECKZ7&G(R0;,2Z8O^>*20=E[/=Z7=#7IZC1E9"3"SHD M@:]/6G\%Q#?JM1PPD*MC 7Q+)1G2A.KEY67OI;!]&/Z7@>;!T31F!Q;/9TP9(D_=,+&A-0OD?OU!@1GA;(28L:5)MQ- ME<@I'9G8/3HZZIC6F)33$='4*Q1^U)'"IYV(+.8*5'M$R#3A&A(U,!Q1 \)] MV-[OMA/ 8Y8VT;J8#1HE&P2:JIC-%0'7RH).H,72BZ3#PH%VV('6U M32=TE Y-( MUXS-(7%UF[Y.?<()!*?9%?Q.D!.'ZX+X9"R)X^XI]RZY9GIV#9+D MQ$AN.0S **5(^O3HD'%F](&8YK33@)ZY)-QS0AE.1LC'SJ*$6&B@J-?GG\PU M>$>!#,.!@2KBBDAL'*G :O0N\=W +^Z@,P?N2FB?"^Y1#A+A0@F?>3C>SHB/ MD?1Q3*E6(>85Z.S('P#DPU W46O%&1R>Z:WBJN<=[=9T7_9Q==E84G 5#UA_TIE48#]863 +)$3!8* M9\\R3KO3WE=S6BK<$4,G%>^\2SK82==E)XR*,1)#-89!/1:^!SD]JN\R73+3 MEC#:'?>AIN/0;X\9Z?]V+D+YN^BVHGES3M3XRA8=X< MO1*20@Q\# :*>0RB8HAG_K8=SH-%."-&)^7<(3#/Q63"M$F:8"3"E,6'">4N M2^- ,8$=X%X^$"0BS)B=$[)#6., HW\%8,?E,TWB0.ZN'=7W^90@YG-"QIU" MLD)N9?YCM=*QA,7N@P\KIV7.NUCT+JU *F'^1"!!J..DB,'NHL,U7!0*WB4' M19D$!.67*(_0&6\4MMJASRT6;7G*+J)<:51?4$V87V<>Q!QV;ZR^A'3>19)_ M^,B.>+>^D[H%7LHM1^M[R>G^\),=](/Z?CJP^^D@M[A=P4\'/_QD!_V)ONH@ M/E9;A='NL]RZ>06?13WLDN>RFVCS <_:8L<^M\B>VV;;R2=,\8;:W*-_.9D= M<&Y!;D]W?P"=(ME=@G11-,FMNTNAWJV$J!#, M@R5@%Z4ZN15T.=@[E=44@ME; G:O .R*:^88[-X/L!?SQ:54=N!SR^-RX'S"^<'_#<+X M#Y9"/-"A8VH,CO%%Z9.68I.IC[4)YM[8O 2.E1KMN";C3S!I[W7BQR0HN:3: MP;AH$86HXUA$]&YX>0T$"!%3S-6IZL3*MSH;L < KVO/O(\:98U/!G6M 1;J M-\X0&-=U#5F8"ILUIQ/7"L!56D$ #6")D-KAN>JHLM*?L+#J1KA&3 D+_FK' M?&V\U>X>M'O=O5?EA8K5Z#^QJ&;_,5^]_NWE5!5[CAFPRP\5.BLM:BKHT_1G M9>Q07ZOX3CL55=7JDB*A,ETL;-%U.Q515P=;W545);)\\8\UH+"6<572(\N8 M_%I#DURQ5Q4M$B9SM4;O^1JP*MVG7.%E.Q505X'%FK(JW<<\>+%.UXN59I7Z MCIG,5;W>EQ5(5@E&OI1S7!B1CC (=@_7T:!B*,STKM?MN;P&KZHV62F7J9!Z MRI56:U89%3$/7K13YKJXY"H$*\&PR+6&8^QUC?64$/QN%3W*JT97?V8:6=8( M&=6%&UW*RR-/!TI+,RQQ%8>9X9_5R,/TTM1@'\,]6!I?:SK!I4_+(1'524O+ M )-/0P7I'A/>D^'S AG5 '#F^_@21DRK8"4(G0;8^EF*8!IWPD \6.?DS(LV M2!Y@Z2.?Z;EY;F7M*6C/&C 1,.N)G-E,&!)?66T(DT4=-T75=BTG4*ZGI/DA)8*<_,@=4?Q$=QB7VE5&]FI4<';VFD*712_0!?\^'X28:E M!ELXYL:H:5[-]/6-O"),&H_TAQ=TH*\8!Q1!QW.ALD.UG&QM7Z:S[JV<^9DP M?B.4ZO/PQ ^_AX&60"RYH_I\3/B(7L,=R9Y!DV=ZP\B ^1!C,B"L(6,+$#)C M]5JI@'H7 8;->]-]Y/6PX4I(+!C+8%*+Z^U0V%QH*S#(3.*:(-AXUISYFWP\ ME;GND6H=$O>'T9L?ZI[,L,.*SB^5L.T#0:V%3P41#1HF?3VF\EQ,II*.*5<8 MUR &9JPL(MB"F)=&= C@UQP'KND1GW+5G@25^+9AN..##$\^+/J>9E['P!:P, M#"OP;L.D*QG_<9)I0Z,>VS8 4363> RFT_":^.%C=(5TQ"9D&T J66%@.)2, MJK-D"9HI^ YGT K,VP!*KJ#5LG%40M.H$/JT SQ\[@Z>5AE@A/<--'M/MUZL)8A$%H"IYL)J\I9]M0 ?>. M-20]$,/)"+*@":2:9J.%&S4#XM^P(=T8>!OIKK$89[:MHBTKXE]S4"8(2[7S MH6(%WN:$D%1YS)Y!8Y\5+TM*C:_%WT0 T'NW1'ZC.MFVK(= /0$-@F!Y91 \ MZJ,W-6T(K,;?' "R]3?%9I92-<>8^T"Z8PC:]Y*YU'R,RI[=+:&+ C1$9U T MW);\7L&Y5--<2E^)ND&;995V@B';?C;?43 !A=[[Q#4RZNXH%\MI/B(FJ&X MD:IRMF$ILZBU&?3WT82=.V8LI6O09#\=26I^/U$Y41=4N9)-0^&)-24TU>+P M/V))<<'A+9T,J,SM5961SN7+GL"<^WL]8/KF=7K(;'$*Q3NS=KN6DS;(KL@) M).^$IQ=1Y+)RZ@99]X4KZ@;2?#0TN]EG-:X*<8-L*_'%&")%'=]EZ9MGH25 ME.2KU7F:D[VFN]-SCZCPO"83Z95UIW\I3X,>#];8V.?6;T86!U,+PQ:\#+;D M;&;E0YVM/,B \>KBP<((1FRTJ=8?FD!T(UZHTN>^4)B\RO03N&%.5X]O+L=# MQN\V\N\"C*\P//D6:I.6*#>.&W#-K\Z(;]'C+*'K'>,XJ8^J\/5E+BPDOLOSA7N0T&'T"[\D@%-47;[",XQ%FWS&QFRHW*S8-!Z$U,CEI0L_D_JO%V*%N[; [,UQSW M2M@S7; HEVDO(VQ0XEVDJFV%68%V"RRSK4,KT&Z#9=;5:B7J!EF7G.B>OC)E M.^D-[__#YQ2>/O;8! N4PCW%.6!@'^0!$_5T?OQ9C,,]$WOXM0 MA;I!UEU.IKZ84]<%A^I M5J!MSE%JZ:2UOUA3G:5!!ZFW[C?&.9WEQMUB0X,&7W.& MYN(7-LO>+5Y"V2"CRDJWYVKZ,2 RC\9=5RO^+I/P7;<*.^%7?S[]_-/_ %!+ M P04 " !M@Z]*^XO"Y.X) "6@ %0 &]O:6PM,C Q-S S,S%?8V%L M+GAM;.5=[5/C-A/_WIG^#W[2KPTAT-(>N=>NZWZ"#'Y?HLX>%(FPH]:4R%FAYW.W=W=SOTM"W,]QAOIN/Z7M=OXY/[ORIQ"A-B9<(.(_[._<\:"D;,!K")8R]N/M#L9S!48OC M:!8JL>//I@S&1RU*<=A6=MS=7W'_TJIS+7OMSQJ2OIQV$Z!;"N-MOQ72=FJ7L(S[MD4#]<_+?'"]0**7@ M/=%'C"WE"/X;A7/02&_'OPEWCV451,Q/^Y _9K#.#X"$HL/G412WUL8"HI1_ MS&BD,W#:+WV*'AYE 3 YRSY/IU+82_! M!RGX;0A?0%CXG8[-?<#T6B@Q]&H;Q+U]EI(+)B,"_@)AN6GRU/MWWB%>T=^)>O[GD7@\#X"MEWX=$JJ/T MMAG@60;W@2W3-$'E=Y=0N6 P0SA03B6C0O-J6$SO/B8E>B:0'+@$R4A,@:V4 M^D*);X2DF+[S:4LRVTFJY-N6PV@-O.DX&U._J0"$0F6,;2B4K:0+64I2EXE.ML%\;6B<\52&6P6 Y@1CG6P;)) MV10TEV@IIB!4IK)[L6Z:D7K,4:F4E1DC M/5\C<#*H[M[\W)]S02-@251H,9+*.!J!3ZFZ+QD,YP]^U2??OB+&9"!R"1S8 M0I,RTQ [;6.=DG8IS#H=?P!CD,(%E[ HCV"W:1T&H12]>PREK5NN:>4B6M@ MT3%EC-ZI:5.W[2Z@;@02A6HF:/SA#AH#8'@A-5] I;A*R]8(?/2*)T#]Z0Y0 M?4H6K,FI?J( T:+=8N/6,C0#+I'P"UP=WX%K3S>I4IIB^9IDIF:@9:P"W MPD[H8@8W7,J<&BW3U[VM[YK_IT*OCP.[T5_(V12LC!9P;S^\II_=P'<$C-+A M4KY.FH9*,[0JF ,<35='']B")*K*#(D38"A[R"+SF 2S([#^!?,T!\SI9: QM9G#:T M66%SDK-=^XE!$."5$!<(!T/21S,L4+CF++JC S.STXA5,8*#-0&^/X^482%8 MG4O1:,9@"H3+'?M05;S*.)"KLI+1^!K=ZX^ *K74#%"KFL>]3.PE"(0)!">( M$94=6U-I &/L:ZMQ+)@;@:.-$=Q+X:[%S#T25 I,C:QN[!:T:FFV$$W:$572 ML8C2,L3J;%Q(_/3S3]G_7OIJY960_U<%/WPT'LV Q3WS&X+FMG2 MU' ]UR]-4M1IZJ[0OX*A<"3$S%]P=LFY58O*A08-C[Y"NUQG]U))GX%(O4(I;2^(,,%< ML/@4U0R3B;,)6!FU=R]OK&IRI#W4-?R!7"E"&M="F^'2\S4!+(/F[E7E#4!N MXGV\,JETL8@R@7_$OVIK,CVF66P6U#5J%T#)"Y^;ZM;C M'\=WM174*G!+RZBM3B?[0@G-ZF2>L,MYGGG.<8HPBY/\H[$JE3C%!!%?=J+" MW[*##BW/%CW%:-C,@8=><_.@J. W);;_C#!1[CPBJPH(]8*7$D5.E.IAEBDB M$QB2?#%;40[NF0TV!K5GV,S!J6!(!##@%A';)F43 "O5TL'C1.D\5FM^EFZ; M*!0)O&EY#52.K_I6ZA6&!L_/7+]FSEJ]EG8:TKN73ED7M%M_QKI B)KS86H- MD$+(T':!I6;'RQLI[I \.$K/EXO"JLR-$OG!7'[VF&?7C_OG-%QW7O"IT]D6 M<[(O UUN!LP:PL4<^FMD!MX>+N1\KEY2'8WCXU4I)E0V(.Y>902>L.FV:>0-0?@4$YI+U2H=HI;@JA(" \SC%S#D?'$, M)*ZW4H61:<[@%)"8,QGE^W1"\ \(>GQCF[K2Z@J$"./X=I4F*O."U^SRK?G, MJ\+CXC..,@)51=4P@-6_0Y(^YOKX%+/AY3CK)MZ0LU0WG_D.]A9J-/+B)T^* M9%\4&8W30M%*;F!JZUWX@]&@=G>^M^T7Z6O!^EN%>KYW@7?&4.8+XDX,^NRS MPY7PW6!]%Q!OFNLA<^,XS.LOK1D?O[1B?Q=P%YDMA=QT"+MMR#?>VJN$]R;O MNP [9[ 4:;$5R;SS95Q7K3?;W G?.;"GB+Y2G*TD$/,JB"Q3+]O26W&\( MPTI&2R%T[*M%-KW/_E4X,^\;@KJ"P5*@G?JVDA)KJ)T!?XV37MN&:WZ* RWC ML_=KVO/_FV,&I0]D:S2NT,AV*T)> /#<(Q\5#/BB-8&O.@H>BAE?>A38-ESW M-8A9 N-H_/ V8TFVWLSCGH]7A#-_5Z+4/ ZZ=/P=61#P4VF=M9?!#'#JN-X< MH%H3N7=+:5W<%_11-8QG^-?"/.*)K*>@]R;2D[&8_#5Z=V]'U_GN$0"1D0I MJ9DX-$P-!UAG#LL;E*6U[A\[JLM;V;O\Z/]02P,$% @ ;8.O2DO?0?<^ M)P )M4" !4 !O;VEL+3(P,3 MFM=U54FJ/F-Z)WQ5KR-W5T7DRR1/_C^X_O/Q[1'^]SE$[#Y7\??0F71X,?__MH^''PT]%@^.L/HU]'PZ.3 M+T?'Q^P;$8[_> A3=$1EBM/?WLVS[.G7#Q]>7E[>OSZ0Z'U"'C\,/WX6_/4UQ;72+Z-UV<&'?WVYNIO,T2(\QG&:A?%D6XLUPZLW^.677SX4?Z5% M4_QK6M2_2B9A5FA)*=>1L 3[U_&ZV#'[U?%@>#P:O']-IQNY:)EIMOE,M8$? M/I1_?,?4%9()22)TBV9'JQ^_WEZVJ^$X^S#%BP^K,A_"**)?8C+\FBV?T&_O M4KQXBM#Z=W."9D*(Z^\SR7]@,O^-M?:AAS3T9Q2S#G,\1;,PCS*+LK7;MB1I ML@AQ[$;0LNE> +TJ?>39/&A0*?1C"U!)Y4O/)1?2(LO/(6$KBASE.%)&)E) MK=FF"PAT,A:+!S)J<(?"#ZQ+/]BE^$/KX@]W*?X] M>LURS<')YG9 M.%2WTE/,\1/;_:8G\?1;2 CER$@\<6U78ND1*JGN2C"]H2VI[DJP43_!1LX$ M,YE-E(WT'JV+!<[8^IR&,=LUL4F*'IFQZ7!5-M-[NGY(T9\Y_<+%,S(1#XOOP8=LK9-(6!8-!D\T34I>9'H#6K:W.0D;&A1E= MA334M?YDHA#V*"%T&_S;.UHC3ZDD23'.V:10GJ]^I7OHC/:_BZBH1D<)>F0_ M;/\>);2C_?8N(SGR1])9%*8IW>JP#<3)*];J7,E[K!TADQ M&S1@"+I#A.Y33F]HDX@0-"W$_5(S./+F,W&MX),3JGB6T#9-_,$@F,^D&( 1 M=-:)(&ZMX(>](DB$84W0P#M#)VE*=[,/C1(P\F^[>6V-!4 M?Y839B'69J!1/OC)(Q%MY/G,&*GS9/LC![= ME_1 _,\PRF5'&JWZP<_>J>)0(%C_-0&!87!EJ$UOT011<>EAX!IE*[BR,26I M%ORR/WPI<,"9]"YC9LAA)F$DXZ5:+!A\W!\BFH*O-3_TKOFS),W2R_CB=8+8 M+N841_03C^DX_AI/$F;(RPKS5X$O'9,;DCR2<)%>O#ZA"?W3?7**SI(H*O[Q M#6=S'(]C]&\4RG9RSKX9#)R8C1Q-IBZUL.Y@(^\=;-/UOR7DC\N8PF!X=09Y MK4(P<&)6,JZ4YPB]9K(+1\,W%B7G+ B1+ FY0?O MI-00Z6[Z@X%/^X3IEJ0I^5KY/WI7/AVF3XADRYN(7?''4[;%?6('2OFF1%8M M&/BT3.@>Q%0(X.P32T3723PQ/!^WJP0#G\8*LS,R7WHXF\AQ-D>D%%7"1*54 M,/!OH! HE<]#0W8P!]S?DV3Z@K?7FARUKXL$ _^6!B.=5P6',P45/>$RSL+X MD7DSK7!)5PA1E6#@WY9@/@H$0.#,1G>((L+9\AP])2F6$=,H&0S]FQ2,^.#( M#^?@5YDRMZ#TEH=M^6#H_T3?=:&HHX!S\E,NU*MU;NC_Q*V[06*RPNGY5SA\ MP!'5&&*.?L4=W\I-GNVLLZ7&KE6WB6#H\P!N876Y9<_ C20N"(YFK8Q MRIGBUPF&/D_U77D28X%S[EG?3VQO+-@%AIHJ:;U@Z-,.T(DN)1XXB]=9GF;) M I'5\4!C7 EJ!$.?IH-.-$F0V-@HM@,:V&^"55#'+4H1>996&S MJ,PXTRX=C'Q: SH1(D !Y];K'!'\'&;X&1GMP&35@I%/RT''<2.'L^;K)^]\ M52)IB_C9U?9>8VV75@Q&/@T)W99X): U:S][9\UH;/&Z(!"[@3X[?!!K1GZ! MQ(C1?;*T7C "8B:P8-_AHX-S(+U*XD>VL)ZCATSK@H%?(1@!L1@(]"W@28@% MC%VG,CVOI:U.TWHK%:]F, )B-#!B3 ,4H+'% VDZ*08C(%8#LY$E@@+'KE,1 M48^38 3$J-"5"08 SOU>IQL]R7+\"8B9H>NF00X-SKBIAUVJHK!!LK/H"<_2&_'N"PC0G2ZF>556" M3WY]#0STK0,%SKQT,IWB\M,W(9Y>QJLT;I7.(KL*558./ODT'G0:)WJ@X.P( M3B:3?)%'+#]4><^>+)X(FK-4',_HDL5ST4U_REPEQ[/[\%5^LVW24O#)I\&A M&[?F".'<)=VR5&,QFEZ$)&:V_ J8\W5J52&WZLK!)[\9%#K0J0<*T"54"Z31 MICWXY-/XT(DA/@@X-U"J$T@/-\G@$Q 3A 5[K!"@8AG\4,^(Z"I'HF:NZT/" M1%V)#PD3#PD3#PD3#PD3#PD3#PD3'<]FAX2)AX2)D G:@X2)492\L#WOYX2< M)_E#-LNC=O8MC< &DW;V)]VB(2HXO#+_BLN8'M.*9^6^QN$B(1G^"TW/<5K( MK^,IJ=>$UYR-)FP: ()C8U<*K>7G8-"*U[R.5NFL88)CM>' L:;712[D2T_R;)X0UO^TJ6M6])L:LCMG M/!QP#.<\62_3-#U'40+'A:6?^@#H8#]?LAVOV-W3-7CJ[,$_!)$;LR1'-JW9>O7V\;A?@ '-! MU9!/>K]D-B> )#^<>5A 0HJ1$6L_K_;DA/2H@<&Y:->([U+3IMN'UTMR4 M0@-0<*Y9F_$=2N[X%;Q>AQL2)40 Y^:T;Q3+OEQJ4[H]VX0P4EY'S2>E7_XG!#V#JG(5FG0!/R;Z"Z('&8Y M%4A2])(^Y+0;\'/SW$G=^HSQ88(Y\3!_L#)9$3N0K](6H>G61>QDP;S"!I*I M3K>)_;F@-D$$9Y>@E+IZ2=B+T%I#?N^RC:CJR'8+KH71VV$MO$-95AKNQ[-& MNO\NZZ*D.?A7X'W1V7"TZ[!>IO8X5+;GYY*\-S&&*ZM* V 66IE.-MN#.T2> M\42:Z,VH'?B7\YUAP?'$E'9/"]0*&O+[PJ,Y7T:\2S"#&=$GT__+TXSU[_0^ M$5AL"QP/8=U^PEZA#5N@6_9GC%&=HA:O$?(LFR6-)I"HYFNM/^WVKTBC8 M; >:L.%$+-@LM$W#+!N2:"O +^WW(4OMW9I8>#B.OCJ]J9+:EYT531/26F*K/(K=>D7> MY8M%2);CV1VFL_,,3]C;]>5NG^T9DHCM#L[934Z4[MH=\G.(2;%6K%XQC:NO MNWTIO$W1=$S7&Q972:6E!:Z3F*S_>1JF.+W2\*2T^AT/3I@VY%?Y;UK[A@?7 M3]O\"D:V317MM\/I1A.GR\V/_XL1H6S-EU?H&44*SU.]!@"XH%KE7-&M5+H MWVZL^30J:-<%^[VP#\:/=,>WP'&TWLE[&3WF6 M%I '2N\F22VO;K?&HU#!*A<>:.Z&G;@; O#4=G*-.Y(T ^/$Z M)&\+SZ6OU62.IGF$QK.-"/1''(?Q!(?1]LH[E;QQTZTAK[Z[CH]6G34"9YBZ M>!C6Q_U4=RI$SB%2@R+)C;^"R;%[T:*TP18OJ>'$8MLV<#)UBW,&Q90X. MQLR#,?-@S#P8,P_&S(,Q$Z!YZV#,_)[8/A@S@=%OS:;R1HV9(YO&3*5)A?F. MT7-*A O_LO&L?7:4/1WQ'@(%1)0#DK+\5 ML&*&V/[R&NG9Q$25O=A"W1(I@0IQ%/Y.-36.M__6HK-9"8*!TS*-'(B*VP@X MMK+A/MK*6/V"NGLTF6M0XD'9A9!-]=D_M;HJ.X= 4)U'D M?EOG;L/X$2D,<)LR;\3&)B.3WX6J&@"S%RR$4N=!VI;R;16K:5&BZ(VT^ZQJ M("8I4YW#LRE]H8I;Y NE]FOEO-J-&IV8K_6FN'#T';[JZ;M:SJNE1T_?#7%M M'/ZT?)F^A.0/E+6.H!TL;R:MP7!&V]E>KY^FX!@"JIK+%X44Z2U.__A,$+JD MVTB"TNPVS'3/#;(F(-AZ3'E2;_ 5B,',LCR9+UZ?T(0].)1$5 4,>P>J^8U ML BY(UN(&?; 7HM]C\BB(\NL*A2G.+?VWT;6G M$DZ7_ 849ER'7P5@&+;?Q?A=V:T6P9Q/^%)>APND]-U35?5MAG;,H$FWJ2GE M^^ >B%T<:"> 9WZ_6#Q%R1*A(A_BN)!":1H6UO%JEM<9@GS>9'C $/4M)(2> M493DU,IYM=MW)Z2) 8Z=YVZ>D(S9*EBVN'OZ-=4;D;SR;HSW(+=3(OR &54N M@H(:C@SN^@]+BE2MR,604][K\UV2 <%G M1P3!8KDS9/52")RUK*>"RB=+W)F8RO9]WG9T M9=B)K6BK#D"S>)JEES&%@-)T/#O%4<0D'L=?64[>IPAE+)=Y7.@E'9,;DCR2 M<+&]Q$M.T5D21<4_6"YEYM2/_HU"^4K@Z)M^7EQST=&@U>3=KQ\ZZ;$Z)-8<-YT^\Z9VIB87Y/]%3$Q+PK M;UBE3PX(*_EYV,T%IW*,BN?=W+JTK%^=859L7VF\SJ*0+4R%#%<:#BC<\EZ] M20I13I>%8/JN(:U:'OP\1+I4.FWPA-]O#XS-BR.--]E5/A32>J"\(+B<"8A6 M@ )S^FS(I[3VEEU:=9=@IIUW-SE[W#YX0""8WNJ"J>Y+FH-E1Y4V X MB^E=_I#B*0[)\B[<+%&JL[:HCJ/+YATV,@ 94C0PCE<90#*+660' MR@IEC29X2U(ER.8ZR5!Z$R[9!&$27]2N%PP@!AH-="*-^&#BG^)/>KTFD@&'H+/NG&I3XL0 =DOLQ%[^M! M9;U^,/06!CLT%0V\/#II1 MUQ?DFLD?=\9D.2_8HU+97C#TEH?>'I=:*-=D_F2?S)N<3.9ABFX(GJ#QK+Y^ MBQB35@J&WC+&=Z!%"66M^Y]WK/NR8W1BH*P:#+UE=[?-PQ;0FHU?=CNME;_^ MG)"S,)UWF<=J#02C/3&!F,/:GJIWNX,8S_I0Q&LB&.V)S:,+L U-+MXPTNDO M=X@\LS3XS4O17F-+U&@PVA-+B!VH&W+[F$DZC$';Y.HU&HSVQ$1B!^J&W#YV M$]%^I/&]8BV6V++4E8+1GM@\]*!LE._?T,$N^+9W$:M;/#2]C"G$G E?[IG* M/C7@D->MH6"T9Z8/R1O)6T9*T:1($W=/0G:W M<1XN90:NKDT&HSTQG-@ NND"?:PG+KI N5K@R4VX7$U0\00_A9$VX:(&@M&> MV%+,86W([&,]V0&9Z_<&NW*YKA^,]L3^8HQJPV0?6XSCF7F[UA2[!]7*J]5& M,-H32TXG9!M6'=AT3AX)*K9RS"#3GEAQ##%M.!08+A=_ MSS/$68FB )41CDN2@%H!&C!>DO:\]'VG@Q-I6I,8>(G@+%(#.G["G".;T1,B M=WSAHBZ,B-"JYS7EFZ33<[;-&E#'VLST MKP'%AMNV? "$;?;O7Q*M,2"KZBB-F\-AH$!CPQE;P,37PC!+BI7EL!P5-XM.YL/#S9#E3<%=G\.XYS"=;,$Z#;@YSTH4Z.Y.28X M"V[])GA]F7\;9J@,"[VA&Q'ZA_!1=MFAWXC'QZ#,".*/,C.@8&:]NMA?PHP] M5[H\IQ)KDUJMY"B!E!\2F\"$SL9*E M :H+$XXYSU<8AL>$3+O@N@761CH#6XP744+X&5WA\ %'5/DH5;]3+*OF,U.3 M%3;ET&QD+W!Q4/D<3E YJ6@?4[95?&9FLGY(J<.RD?' #E_K$_!)/&4"7[P^ MH3B5'2KY%7QF7K+ E1B4PVP(7%>,<=P 8>23TJKM,X]2WV.D/D(K*1%LS7]/ M28JSRC1],IF0G*V\&K%'BKH^4RM9F1$U\%G)F^!B+9.'MBCK^$RE9'TU:^!R MF0YANXEMY6VBW29I^.VH[6XZK?C,KV3/^*:+U&F^@XTYG4I#/US\4'CS7"4O M=,2?171&B!\+.Z$X$Y-)(SYS,O7ESABHE6P) NJN,D3^^3 M;?<2L:6JYS,U4U^"=+#M0W(#-R&T>V\PT<8)*'M!=;ZO9')3F\/D%7TF=++ MIAHTAZ[/\6$A+2K9*WZ%JJ ME-,P98[H"V9\"$M:"7,=8A/2Z7);9)6WX>0E)-,KK4CWU#2_QP!9(%0U1BWK9[T#C$HHZP+A6#EA@<6\&^9VD"1F,KU1WQ%M(\?0F M"F/V J%&?*S]S_F.>VYQ*UG*[4,_]"2;Z@3B[N^U2\&+'+A8/$7)$I4Y9\IM MJ-*E75C'<_RWFTF WS]D.@!#;N>]V>H\4GE'J[0XN=C%/W[?:?$S)#.,O9$X7Q].+U"9.BA;*Q'.*$;SK?JGK87O>3RF^D%\J:CMUIMA,+ Z/F5 M X*G/JXI@>_L.7![LX$" 44'V34%-X 7?V1)4#Z'F!3/'>[,@*^4Q$_6H'WH MR!T4J0J1\N0S.8#A-%G:QT_R;$Z%_PM-OU)PI&(N9S?-:6V2*/*S775VI.S[ MP8-SY9XX5UH@^N!P>7"X/#A<0G23.SA<'GK2P>'RX'!Y<+C<0X?+-1C%IJ%: MS(V;([0]0P,Q''=%[3FZT4_=. EJK]--?89 @5!\435F;SE\]XMOZ#_,T?V]_QZCW9 M'B=U/ETA=M<-*A^^IL?^II2%Z'7YJI++J;?1ME>_12VZ+:&$L]+UL"6=+MO6 M).5+M]:_YL;/$-I.R8WB 'GIVS1I=CQ9]_J:*W="@\> G?00Z]U1ID P&]&W MT!V![(G?0+_K8ZUQ4I4?967C ;_2[:!K*Q-E<[O&O/CL^E^K0* M-WLR7_$M@>&HO-NCP#XMLYHJ;PK\)HRL'(>]Y 61E>O> LM>;'#Y63_/QWGS M@'2LR3?:5;\^/?GHJHW/^GD7[TUT58XF'9XPK8HNO**V^1$_S_#MNFNYT1N< M(Y=5:.M'&"I9%%8Q*;N:_L02^'EG\$W,A'*E0L\9U!-T)9S14U]N2^#G_<4W MU9?Y2@66B^C!$NCVP&U$,]XBQCS]\UD2%Z]$Y&%TC\ABJ.KK_B7T\[ZEU[$ M0^F*_$>>0EV',$)=#^^#'$)8S>:,P_L@MG/?AEDAU\6?.I7"_+'OB0*/6FWO+0 ^SC8L*$Y96J1 -6=K4>G/) M__4PVS#!F[#4/=%Y[S;?7&I]&QJQ8;;NL-99XUZCO;>7LKZW.FPDH.^T@EKC M7:M%B*$^SI?>721N[[0N6^->JT6(T47.%_2>>&" M9L\N:!Q>ZAXN;0Z7-H=+F\.ES9LAYW!I<[BT>=.7-ON?.NJ[B'-VH[@W&K'D M)5>/Y_AM1QW$>F^4Z.\MS(E0.B.4?]TJH::/@W>+V'OX<^V(+-+"<4?!N M:9VQ4 4-,6$4O.M4=U348,/)_ZES J@D/'%R#PIMXU[#"XPJLY0Y;BXONR0H M$MJ?&_*"V5!VT3:0'9RYVN%9ESHF*/)Y8]OLR7S%MP2&H_)N"8I\1@-KJKPI M\!NUH4!)4/3=Q<0ZU.0;[:I $A0!?'YX3[HJ1Y.'!$751#N.DH/"ZEIN].;0 M[]]U:IK5G>%.NICX\WX3=>YOYY-KU&&@@^LL,VMWR9WV2\[W_:8SW?^.*5#I M(7/0_F4.^O[2N,)0.LS,0?>T)2HE##?V0_Z@@WNZVQWAGM0.YJ>NF_QWX-UW&$SHB\3-J;,?D#A[R6EY] MO]M]F'-F4\J_>X4K?FE]BH$A^Y+HL\K'?5SF0:52$]8F^H_AH(A_;PDT?ZH6+SQ=]IM@NY\9^$LL_DXG4X]VP^)=S! M\(HY9&A:3$Q%3IB-' HG M7W55/^ET1!V3HW)-#&".0;4^%3<-)86<\75;_HO+RU6[$D5\I ME#6@FT( ^0E7I%,>C-N%73E1ZGL-F^E=3=X6%\@1VXTC(!8,=V3!\TD^FV/$ MKF G.=NRCV(I>T?0^N4S3')&T3/9Q3S^NV/?J5'?D4 =MQZNKBOWA7KFWTFO ME=^:]IY8FYENQ&Y1@MEL[8Y9(#OI75$,;U^]7K(K1G#EKEI8QZ]CG<% X],H MQ>5NE]UV3%MYI)T\I(4+G6A3HZP(\1%P"UETM7!##][2T,/:\[CIJ^G"[T_T M+3^/?1O0S!_*3O0 9M)>^]8RQUH<%]#.HA OTG.43@@NQ))9132J^WDUNS?O MNM S0YLL2G6JNEY3G#\>(,(3J9E_VM2I/*4N%T:]/.R=/]QWADL MG#N#SG/5Q>L3)D7A\S"3.CW;^8*?%Y?]K05M]' .WYU!T0%2_*$1MU&$>*R7 MO9N<3.8A_\FLW0H0#'U8/OUU.6/EV B,=-DCC7M0,/1AF'7$. ,#+$"P2Z]< M*:82_'5)MUDX3O'DGV&4.UEZ5-\,ACX\#/W-##KZL/$PU YVM=?HI?A3YUWL MIH%@Z".FV>VNM0;.X7-/4D6A MM=$M;*27,06=%W=8XVR.R/T\C-<:?*3@'^DFN#[GZ#U6[%.L8.3-W;'W*N%1 M9>L^_0N,/MUEO2S^\T\ZCBFDXIDU)^'2[:\$H^_+8,K7P-:^YB/4GT)8X*SH M_[1/,YL@%0[%$XS6,?^[#O8OAF%%K"N-&'YA'0^A^4U95&'VW/(>0N9E.A1= MY@I$W^^H]B8JE6,.ISB *'$;;!&\[S^Q6%T/G MK">JXB,+6UT494(U3G$?N='$"A19//B"[_T<\R14 .@#:Y@A?"T!!6&;[ +>_U&"D=&EH, MP7LH^QYG+%[N,I[B9SQE&TKY.L0M#^&Q:J-52(0"SF&Q)>$WG,V+>%1V=S3' M3_?)!3T7:*1&,&S)]XO/0FHTF52B@SOT=D?K-S3-"$?B(]FX>8+"0I7_4J>GUOV1J'2HQP%E>V6S2NHD]5E/6=E5@CVC@[F0 M!0%Q6JC S);N&02RC7%%);SMRPW!SV&&;J)P(L]S*:_@ZM5MS6.\WC 2W&$) M 8$AZ6Z>D"*R]AP]:)F6>>4=I3ATN:R)8$"*!FR(J)X&^35<9<737[V$RM8D M9XL#[KCIP0Z4E^?I]6QP-M2[FKPM+I"#KQM'0!8T=V3MP&^V M3QI4GV9>0>>N*U(W-+# N2$LS]5L MUEA9BLND'ZOC-IH.)*-%6==CTD8=$F26!@4J,/-<2]J319+'63?^FG4])F&T MR!\/%9P!>!EGB':O;&706D6NG,33ZR2>"*-Y#&I[S)+8G41-7(!N\?DIE(ID M)N6O/R>$KLK/>-(ESQ2_'8_9"+M3:XP0T+66+$^6!98%#7E,06B=9@E$.)9> M61?MD2RN7M]CPD W@[>&#(YIY>VG_G,T2+F)__JDL//3\ZC88\YN'K,5J- M(0+*!5GQ1:L]:5%VU,O8F&5E,QXSWUGA6 O@&\B,N$H32.>J&<)9SK#&Y50F M]4BR_K5@M(?6*D=Z4.5+W/7^;9Y$T\WC6;>(&7C*9['NGB(L,Y!HU Y&>VCE MTL2UX=&_H4OQ-$I#^!XORC1;"D9[: #K@''#M< :QLEU\X%]FR7MI?_X?U!+ M P04 " !M@Z]*O\M!O:I? #MQ04 %0 &]O:6PM,C Q-S S,S%?;&%B M+GAM;.5]:W/C.)+@]XNX_X#KO8BICE ]7-6/Z8G=N9!MN5K;MN6S5=T[T7$Q M08N0Q6N)5).4;??@&X7 1^4'X]!_??)E?O?WK-__K[__]O_W[_WC[]K_.[Z_19;38 M;7"8HALR9AE@'[T$Z0I-_O5VX@=I%*-?.2QT]NZ'=Q_>?4#DG_,=3GQO/T(W MWAZ=_3!"'S^<_8C./O[M^T]_^_01C6_0V[=TC740_O'H)1B1/87)?WRS2M/M MW]Z_?WEY>??Z&*_?1?'3^X\?/GQZGP_\AH_\VVL2'(Q^^92//7O_7S?7#XL5 MWGAO@S!)O7!1SJ)@FN:=_?333^_9KV1H$OPM8?.OHX67,BI)]X5:1]#_>IL/ M>TO_]/;LX]M/9^]>$_\;2H,X6N-[O$1L^;^E^RW^CV^28+-=TVVSOZUBO&S> MPSJ.W]/Y[T/\Y*78I_!_HO#/?J#P_RW[\[7WB-??(#KRR_VT%9V?#F#Q2>__ MCFSL\ ['0>1/0K.M'LVVNN>'U(O3#KNNS+>T[WF4>FNC'5=F6MKK+3:C;3'/ M%DV)#L1F-"UG]KC7M+Y/;4*6%*2:FO[[FJQ_L#/\FN+0QWZ^-SI3H"T98*9E MF?*/%@? UE3=1O$AGE$4K-]2Z_'A$]>9_T;_\L_<*(U#(O9ID.ZGX3**-TQ= MCQ^3-/86:0Z(;9V!_^?G7\Y^^>[S=[]<_?+CU3_5 ;W_>TZ!@PW'.(EV\0)K M8<\_PN'.O,=_3F\^W?PP_>'FYYN??M;8&35L! PUW3A\^^7AF[\7YMH+?<0G MHLI,]'L^]__\.]],?[@1I^(Q*L3 HKC1A2/\1K'AWSFQ8M\=^2?$L2R$>\7 M$?$CMNG;@^^WC*--)\;*]Q5UHM![96G*T&0H)GCQ[BEZ?N_C@*!Z]AW]!Y6T M[]Y^.,O\DW\C?_HG7_<>/P5TN3"]]3:X0;3^>O7S7W_X_,,O5__YW?2GC]/I MYP_????/UOD6).K#S__YX:_3O][\?/W#+V??_?++].,//[1OJ,YE&6.5XQ = M:%MH[&!A0T3T&.1(,O3(8$,@+HA4QMYZ2LS?ZR]X+S,V[1-M&Q<1"BW>Q1^,##_O-8U3[/B+9/IP(J?6/43CF ME.QWQ $$"!5XO.5C?BA^1W0 MN,+KMET0]=;(%*UJK8DCAF+7BUT!+ZE^0PKJ/96F% *CD! M8L<,DPU%?"RB@\E9RD=TN#-.[D#X@&IS&?-)%;N$\X82FOPH.B=@553\P7@( M#7^TX=8H OT=7+]WV2R(=F]BAU;EWL +0[-I<2>@J]B; 4!J]3:46IF$#W1/ MG?>-"*@>%S*:5(F+N&QHT>"6@Z]\1?Z6Z*CS^F1(W=Z$2BLW9:Y!QE1LN#-Z MOV]$0&U"*X-)#40;=]D1">I,M0F$5 \<@W#!8M31DO$4\YM!1,,J,DY8CA:F M4[8=S1PW;-C[*ECC^(+8JJ^ @>Y& MUI&$N9OX9N![G6BSB<*'-%K\\;#RR->=[5*:149CJ?K7GD)H\)>@$F3;;E/8 M+,2FC1"?B"HSG;$<-I%TX I5A745+U05^%97#)=>\L@PWB5OGSQO2V7QA_=X MG2;Y7ZA0_E 1RNS/_WQ(B0*@!F^VO I"+UP$Q$6,DD GV4<+EFW[I(GH,<<6 MT]!LB8J)*)_I2LI/;UA&FEA:MWDFC-MH" VX%D LY][C6CG$UC(;RA:V(M/. M?K^S(=9E:>#M@]DO,3L)[960EP $X6+M)QQV35#5Q&&R$=35N P1HK=N(E(R_^$#W M%%C[%U)28JV?QZ(BPW& D_,[ A+',?;97F[PYA''RJI, ),F0G1JEE*-AJ= MHV)\SGA\2O^&/ZT\'K&)D1NG 3-4M@4JB?#CP-D=N2R)+8]4D&SKA0M%O2#V M\@2@H*V1&,T65KQP1$]8P,RM$X\92EO%CP7N32C(G-K92"IP >EZR#$4_)/ M_1-2.1/\:%1%0G#1VCN#$0(,/5/2_B(,L1O*\9#4.??H_DS]WP;.W M)KM)QNF%%\?[('SZU5OOM*]3U(!"&PQ5U&N<2":P@@;L'Y6I(^2E*)^-V'2G M3$P7A'M'9%LK6&,)F?'#S^A\\GEZ>SN]_8QF5^AN/$)DQ0MDO"TR3 M!LZ#-5GB*9F%7$%1*L%IM@O+.8LOHNCI]C;))-7:O%H(<=S?!&MU^P_?@O2 M51#.0DQ?DJAZ2<-M ,K%&I*D==- UD)!B/AJU$/)UW/)1;--$DH17%#DD2_G MC,T<7.:$!G=H@0.PUK]%\1_3D.R4HF1LMP^A.&/!CY$[YG?Z.YJ&B'TH,L1- M:ZZ$!9':;0L6[ICW1F;3,_1-G&9/;.YBO/4"GPITF&#-H$;S9"A3VX;*,7=E MXU VT(W;$]W-XY;-@]DQ(2,);9"(BX N$ MOO?Y;#Z^1N([Q.X^;:66O?WM@UNW1E'02 2 $F%B0[QN&8[T;5(ZA.@7( #K==XQ_ZZU"I@/J6766S'OW9&?/0P!5":U!G M"7L<_#F*_)=@K5POOS8/6KE7$#CFC?PGA]XX&>P67&4?LXB2BC[B#\LJ>1JF MA+3!XQIGID+]Q-8Z'U19-R/4K S+L2@/S0!?&6R S[] 2HB[YX8AF*H._9!&8E&KQ\@PJ6Z:QZM MASZ>:_"RYN&E)@6V8UAF$2MP&]9ZN(5YCF>V5\[X7W*8V!P]4$+4M M>->!]QBL@S3 R3CD=1M6T=HG!V0:TT[WNN]GE>%!V5D-A(]9KC*UN-T@CIUC ME4^[(#@=GT^OI_/IY(%=0SW\/+Z?_#R[OISV624R:V;V3 K9F^(0&87&_*+UM%+PG7V M!"E_<%,^P:$O_GXPP=L=(Y+C]<,L3I\@[8@4YRQ2THL M*+1,*OQG\1'K+DFC#8ZS*PI3R]0&!MHNM:-7/VGPD?D]&M0CT+[13<)X M:@5PA%RG(D11%*RI:/SXX5,F&/0O__S-BV,O3.]Q@N-GU7=>@IFVK8H0B=K[ M03X.90,=,!]&VX_YP/YKE62='CU:KF3(G;\#-W)RWF^T;%+&MV?.+K,*R_?X M&8?Z%?R.IT.;KSHZM7:K>2GM;(A#QDIC\P%]/^].:W$)-RG9IF96LI@(M8KB M=([CS7D4Q]$+]3A53TA-4\$J?3>B4$E;=$/?MT8W0G-K.KR,OS(-O M(Y3E%Z MF4JL#;A!4& F<;'O5DZR:1+BX-FCQ=.Z!^"$L."-A1#1NO+-AZ/U M@%=%7>R'B_AT"2Z:8Y2/[[](8EY9 ML-H29@^2)(KW**231[3F*@T54Z&GUWZLW.QW/WTST5\_?3\: MMN*L?G)M)SKB"+'D1IN*"+ M2J53!@>B4,QQ.B55#*PJ?$#W5 M0TN2 >NHF!X5YK,H3X3:E-@TL"5\Q276*\U0P"U0&W)-/%<&^$8TYV&]\VFN M0*[5;[R4/K9S*X:A@5\U#KBF$L:P!8P$FO"3EJT2L23(X3'?4=7A-#@]-H)Q MX/C8@I[&^7' ]Y3F+2&Z8:AVEOSITQD_1YZ=C;[[^)/X&.G"L4O$RJKG+@$? M [N3'+AF_%M04W4BG0MNJN/"3F)('Z<:ALB]LX"VV2)!T#Y> ]KJR"X/3 MI MG1[&(.Q"4%.\U8WJWCWZZ!SV /NP:;XG%%4I 7Q&+"Z#H/*]]6'DQS@;_ M)7L][)2-T\/&EA!\%V>)5VQ/;7U\VXKRUZ8"MF=H0*.AOT&6 M0<>&C7CWW1&:)LD.^TX$%W412>@P]-S411BR6T,;3\EZ-;0PE,WPQF83A4)A M$.?I'\^'MBD-"-7/]W2($S+1$RH)1^5_?GCWX<.',[3U8BXB(_0][:.:_Q]* MJ U-D+=+5U$<_(O(TZ\DNWJL;'^E\D+ M0,W@-1^2F.*2YKADPG=6="\^J\J:LM!T#Y%JOT310WV^PLC;L)@G;>=,V)]2 M(4+;%I*\*S\WM]I!4AF;DV=)2(;(KFDMH'3EI>@%QSC3.I1@6T*&E9>0&8]T M ,[&CABE"0BTPFOZ0@ %:5)LP)&W,@IRW_YB1B[T%DL4^#Z+O7OK.R_PI^&% MMPW(*;^B*77]!@6(T)Z$$M*U1__%)$1GT?:!V3RG7(NNN+&V:43H%LVX@3L MZ@RK5N- E5NM5@W9;79KJH1Y]9)H0Y3K"H<)L2Y3]F#J.DIHD>79"WE PW[(BXM18$5A.G)O[Q9\7^5D[.)G[KE 4V0K2*E<]']8?43QRI$#]1^$XA!>Y/J,NBDC^A+(B0 M%TZJ+D/#3+#GP$U(U*Y>*H/RBR0T3M,X>-REK.X=.=3>>8Z\A%%#Z>!NK'?- MT.69L\KV>35JI2LQ@.MNYU#8XCB(_(?4B]/^$3G'3T%(E1)Z]-8TSVZ@[4_" M5A-COOD)B[.U[1SN?7RK;A4_CV]3K.X4.-?U0*7PH/U/!835"IL[Y6P:8,45 MFE%-\V%UM$.(@KNEJN*IF[\GDDV+(:[U.GJABOPJBB^CW6.ZW*WSPKWW>(&# M9X-GW'I P<);FJC7SE3Y?+2,8I1#0$6%YQ*&2Z^^^\7:S['V,A!..,26<82+ MV)D(KSA>9R"Y-NL(/:;3,$EC=@?[)?0V]&G6O\B!/GLH8EQ32!$NM.>D08!Z M;93'%)5S1Z@R&^7372RXV@7GXOU02 [L]:)DX+Z%+D,KUH71XF:'Q%>_0Z(. M2"@_0P]M0[EUK,UB-YQOCY[_A41^6[ #L[T&S"RTO/J<#)70?>?%L_@AI8%T MEBESAV,6&]6UNHI0H6VN,O+2S' R%Q%_DL_FB7F(S$<,@$,6MP>,LWR](DG6 MJ4C-*>"G]!9[&"P?<$S#;.-J(J$$77!'2D]#*;E16NH)2A>S/23C(M=@TT,:N76]*T73D656; M-M%X8=6B2F#U(W]WU,T_/8#DED]ZA*2JCASH-59??JKI?;4^MLZ''3186/=9M#,!A\J> M3*,-(A!P11E%:(G%S\4@@Q$^3H<7!L4(L$"D5)PDQ2%EL@2H&LP.VFU@'++4 MDD-;DWIPO=R)&DHG<0B5\*&NZ04]?M;V87#V%,)PQN"*3V?-(C7DF;,7&Z6$ ME/)YLS-.IL]8-/$ZYX]!T)L@S+#J_R&HV9,64T2^A-[.#XCS_:T )W><"-U8 M@(*&Z+T6DXHZ:U3S6C"AG 9-Q)7K-T$'VX9%]K":D0V-**O@!(PO2%6E[E*G MXFD9B+$]MXO7HF#QEHU!LZ2VZ5#.5CLZQ[R9E6 IAKK6&6D03, ,MX3-A#9; MS&,6JQAX:YQD/=5OL7ZM[*/IT*?\.CKUTB?L1U:?R 'CJ[UQIR(0\EVS$1GSQ$:XVP_>$TN,C!\?;KY^HD1;,E8F,0'>2$ M[5+<>"3:.. 9LY%I),?*)HZQQ^B?XRA)[N)HJ5^WJSH5VB0=HG',,^Q7Q']V M2K4#;MN\FH'YIL%-4@.W*YFC.JO;D]#9%L?DZ!T^35ZW.$QPHGO2:@< 99Y$ M*!WS4S$6Y8-=.V]UP\89ZR7E,Z$=DS&9Q<,67A.83^/0O_'B/W!E3]KGKG9( MT/9.B&0]S9X-9F6 BN$Y SIE#XW1VA1H84"Y,N4FK9.1C"DM^HXX)$*_)EL9 M^YL@#*C TRX"[>+6J'AD8*"LE!R]FN_#9S"./)PSF+3IISUU0\L[1 M2VHR8 M2<66J3&DS9++"28T69$-7>)GO(ZV-)II:-3$P*#MF@S5>KR.CV>\69D!(V_# MH>974*,A ^M5HZR@UG\&1)0$5')_=1 Y<(=$2:TH%HZ6ZQ2;17.V,5X$[+J: MZG!>%J3Q]KJ]5$D["+BB."*TZD5PRM$CHAFW:TS_R5V3RE16!V<;1_YN0?_3 M ?_$'$_NH%3&Y^Z)$V&"'O%RZ,UW!ZQ:/@Y@?2*IWI#4(Y(I#<"@H:Z;6 < M[1HVH:0?7@/UDU10X(W*+2!B?@'0)QK@7E"KI"AY/FUB B#I96\@[8N!RE3P M*X$#--KE^Z /EA/V70T#^F=$63.7C2A,T"->1C'.^GWQZ>_?Y!S5/W;ZS2;, M<1NJ$=#<(@Z:WP?^!J>N"M3N;FIZP)X:(Z>0Z' ;&7T%MYU"O2X'".W0J*!< M4X 5%LPYT*T.8D98S7^>W*/I[<7L9H+>3/[K;G+[, &1JXXLI>,ZJ#)HAUD5)K?>>?8RL6UAE:6IOG*T@2ATD_;,7A-1N MS\*+*"3J.R',1Y<9A_XM3B]6A-QX2OX2!\_L*BOOJJ+<*JGC*J!OS+H0IW87 M2F!EIPY:(W]1 .1\2R-U(4[1@@&EO:C] BQ:YW =N)7Z_X0P)I[,,*0AA#C$ MGRH\'@AE2L\",F?R\!\@8"(:^NGWJOM<>&0QM72 Y584K8 MQY:=S9[\^657FV?S028Q S@1)(:T/+ [G ;W /-X^_7GBGP$5.IBUVWW?AMI MX)_WMVW %Z&-?"YY"=K$Y Z$MWH+:[D;SFK@K>K8(I1_6N&L)L^&]>RL!K/> MY\&L!\M1_ %Q.L4 73^!.?M: Z?ZMWJ'DZ"L^?'6FQI6'=SAN=OK7@65-;LV MBF)VD-AC+T8X]&F[,;S FT</@V4Z8.97)ILWD8A!AMHC!=)1FW/Q#%G;'[AX'8?4LFY2&,P3%,B3(_ M0O&&I?9FTORC,SYQHZ40>L1-9L*>99MX,6&?IR2OT7SN)<&"I@\'ZUVJ7P]5 M!@[:-Y:C>\R+^8RR2/D(L5G\I0.?YY2GK(_C^?AA>L'ZVE].K[_,)Y>Y;IR, M[V^GMY_1'7$Z675].[A_^XIP?JLC=2MZH M&FO;D]S?3>Z-%B9S/QZ"7G#I>1IV04R=:TG@^JP];*PN(WESB M,-H$(14$-S($^^.6R?3SST1?OAW_.KD??YX@XDK>S&ZY5GQ LR_SASE1JT2% M$E8Y5K+]NYQ!LB!NTR[&N@Z9:RSCEQSCC&?73=\*7\?A_9&BU] MN8K6/M%.DS]W0;HW30]4 PKM-ZJB7BN-4%1TI :D,O,OB,\%K*$R,,*1-L+@ M[J(6@ZL5B=#@;@!!YONXR*_BD_%KH!S>% .!<@1EJ-6.=YPIRW&$/\E(-PH: M#84,F U58CRAJ53A.HO1D\--7$8;+VAZVRP^I#8"@;9X;:C)> []SH>Z9 [J)ZE-RQJK6J"&N>ZT9VT0$32DA3]SD?V+RY=^Y#"8]"] ML;L"#JR;@3,&4B0-&AU2#T0!I %4JR"K=L.R)\VJO;5:F:G:[PE(GD\$AY[Z MO\FP:)1I.^&U$_D0^-7;;- M>-L@]=9Z[I,8")0?)4/MF,_*\8A.>#L-43;%+<^D*UY!@9C6*\PF$2/&.>I&'FUZ@#AO9W=$A0X]C9Q;0E>]!- MEZ(3LN7 IGV-&T' &V\5!I: M.M".N3,.]GH6"]LO=\<#/P4AE0'TF&,$UH*Y,S(3GKHBPP3LO]S%!.0=^U99C0[^PU447WC)2F:YM>&!E,[10[B>84$C0WP4XO,1 M!U#6U\E^)4 0A0)XM] #PM5 $GT)$.V>5K0FP3-Q#-!V[2UXO@E]*[ 8 EG] M0D)]?." ?T*??^"L)$)1FR?[-<>YQVH(QL]7^O[2%$6F2=L^+$SQ(0-MU5Z+ M2%]5]:]GF4:7:=GVR@_J4$%+#^D@KZ%QV7Q8=3L,SII*=Y3YH0Z5RNG^Q1M5 M,,/3$?UKX=/7M+![CJV9@R=(*@W":T*$#Z]K$:+1-)801 M*J6[!#+*G]AR. X1T M6=:C'O2J0V+(@>A""Y\02A 0N[A"@/[Q-S]K#D.$.D-DKFQ 9V=RW!9OI+/'T:4O3]S9J'@Y[61NI9GE5+I],C*; UU-/10< M.EN.%POJI21WWI[F/76^IA+!=N[*2DP([>NK$AR]RH1H.\X> M:CXOQW\[$/XZA_BA*5 X199IT.\-GQX1?LVO] X8@1I[+1JX=QFFH!_-+L;D MRG&@2[)$3^6;!:N%BSA[A28AC>Z-6N*4%;!"$C-S,-B]FW&_#G"2#'=\'N8N M4I,HM:.!JL6HW5&Z>V&GHFB[W=\I:%F;Y5C:C5UQT?B X^=@T=@_NJ74A@Y0 MN'(M>JBK&Y(1/TZ,\A^IXL@!.7#/UQ7Q)MUX&#'CFG(@A,VJV9PTRN;5]6 1 M!RSV8Z#6),5_]'4:N!JOAJ3$>EQ2FTP+.O2-D38Q=#1[_H8#7+4/2P)1? 1& MKUO&5ZCG!O3S.U\ ]$R*$*T#O&,7(30#CRCC)/"SINC.>/7=U*!B-44#'6BS M*,/_W24I/5,D\ZCE93O;ZZ.78)^^DL5APC[B/>;=%G&V=X[7/6^>2 TVQ1 >C$@06,'E5*N-%WV[:*DQ0-L:+?.MPBU,L@M#0.:X^/M8 MO0%H1>N8C54+8L"%J35161R@,DB3*_/HLC(NU8(*=8RHCUV/$IOCU;6O,@*V@&>5!;J!;<9XVD'?:S]31+YW] M20WE M*0A;Y#O%I'+TD/?5CJL."CR4)$A4U(Z 3$9@S9:Z5+F-@0MYDMW'KJ M(Z."75O*1T!42$AS](FF@KGB,A<>O0BG5 JM=KVFF[B+H^? Q_[Y_DM"4_N\8)\$:(L<4)4(?G#COPM^S$*18JHK7-J'ZL!]MGNAUA-S7"9G.>@T?D> MO:'0T33\%A4+H'(%YNAE:Z!R$4 =89=D%^.'G]'5]>RW!W1U/[M!L[O)_7A. M&YF.+^;37Z?SZ>3A;\[X.OV*F:S7<'\R!G3:I-&ZL@JMKH&O2OA9K+-%NC8G/*M;%//'*ZCPOBA7F3=/)7 M^F]V-;Q+>"IH5!#/:R4>N-3J;M*<=IEAB2=1@U0/*)3/I8NZL-<&K1F23Z]6]'(H:;0G?),"WY<H=R M1GO%6 %),"?02(J%OIZ)"%NN/GU^?#^K';1JA@+M5K4BUWS=7QV$)J_TWRZ\ M<#+$IJ)7#A,9\$"8=:ZVK8Y;M&686$=1L013GZC*Q#E$O9]VF0#HD M@'SV@I"ZC[.0>9,TK81!GBTO,2NB22]N ^\Q6 ?I7N:4&4 $*1*@B_0QX]'Y M_#PX"]EYD)P""R TW%V"004<^ ?QO:!-$&2'N!7Y!=,3W'.!."N(4R"^'@QQ M_5?PO6#.SK 9^BIX6\]0:75?(; MZGDMJ%P3C!RB-*PQIF+ 3VJP2.XN IH-E%[#A=_A:7 MI/62HNKJ8"ZQ>;JD70+>XRV9QI*SZK1\%"7C2"A:&,YZ[3QG/'5;*E>>-SF\ MOK48\0T7,29GEDO,_[<:CTX(-VA?O:L#!(OT:J!\+('Y7/0FG_WMT?T2@^#: M[7@7E"\*IS+#[4T.[5N4PR._NG,'KLW2XM"G)C]#BBZ]:*=;(6H'$W?W<8T3 MX@CK!D*5X4*'1C4(H"+'-+DYFX\J $8T?.!0"+4#UOG A+H#V5 GWFA8P@T\ MRJ@KLDIQ1TUYA510Y\&:K/(T#2>O"TS\G^5%E!#/)^]>:NYCR "[XVO(2:"H MJS) ])\<%$M0)L#H_^;@7+AH[H$$#*V WHGDB#YR& X['8J\KNE\J#$ZI(Q/ MR1DH)*L%^G5IQ,#<H"!JD[[F*\]0(_"Y&8NP-'<-RQ_C4$%0,,V;S!,CKZ"2I(L(*-+DK4)GF,'^MUT9*]N1A6Z*4'CCFA#Y8JR,+>C#;#WLJ6D66WFS0]IIN8KH3D K@U01)&@RJ#+:K=*5S:2B ME5^>38O+LQF_/'/@/-P-V\JU8'E;UE3WM3-FYEF3QLC-5]3[SI6E7RA+G]?T MIUUN8[R-8I:*M>5UD0DAZ-^+S',<3!S!-I5Q&,<[ MY;4@$S)BY3UC\BL.Z2[H(=5WK!.2GFZ0ISIJ*09(A^(2+S']'O?X&8?JYHH*OH1^424S734B9#C5R 2L)H*#CL0+>RHZ3TT\^*I%.W2/61W7 WZ M!-Z96+5B79,Y8M6GOCQ,+M'TMK'TE /^RG $,*E$ QJ=^%IX($J]]0D3 #R@ MTX_B5(KV]*(UP4T*34-)K-6!U%W-L3J0^L32K -9+/#5U('L3K+C.I#3VU\G M#Z=6!])0S$SJ0)K)F#U%=)>=^N?1>/'G+H@Q08#L*MW?D<].G_5-R%^W=(BN M'ZL!&=IGU2)"+0DJCYO,(Y1-1_G\$6(01NQE:@'$*5^M&^YDIRMZTHZ6:!F\ MLE>U_:;3])"!8@5#<%]+7Y"5_"IM*3X5'\J.[W2B/M.@OM)7X""IG-":/".[ M1U0[B#.DWV18?ZN$]HGZ@Q;\0%>4Z%40>N&BRT'4)#"@NRJTW]@;\325;;& MTP=3&-(='U"OIK?CVPL'#J@V!**'B)F9#-I36/+1]649S.<;QIJ176 M: /: 4#Y:B*4&FH?Y>=-6%;,N+0)\9!-P_F MWTB%0^BZR"3#8E0JCA88^\D50?>H39QV&$H "MI_$*-9?VW'1R/*!%EQ,]YW MLJE &> -J--H=8J5]838EOPA2!+ZU#J,4@?;B"C(GUKT2"I\,#JE+.3/NQFP M^MRJ#H0<$)0CH8*BF$OS6;R(2MG*PP'/HAMRM.%A!;=%M8D%_9$F6#ACQI59 M56C.5?GT5((-=H,,X,Y!9V(-%U1PRBCW3Z<\DGMW/_MU>CFY1.?_: PCN)]P M!$ $<-^E'R5C(81B7?U.EDN\H%6R7GF%_'MR0)Z%% -5UT< #E:Z%Q%,0Z>0L3>8(2+/<(9?B%/&%VNHQ=GG!HY M]PF]&2GKV9,CNN@X].G_T-OO9V]-8R9W[)W-;M];TQU>$3LQ#,,\$]WT8E5P4"Z".KJUOFU?[NZN M)S>3V_GX&EU.'RZN9P]?[B\"TV6%KH:>OQL\[DG;YUQYP6^KE]Q,!?:;SA"I/Y^,VO+ M0G]WR@U0W?BV8>/@MJZ)?10KJ=1XQ^H;YVB#Y]XK3NCZS8TRC'0LCY!TDDX1#X*[?N!@.>9#: M0WV(J,@5Z23U'=27H(OC+)1KKO:23%J 02NL:9*@5GE,V"UW%H(K+AN8-[1> MI9=2T&K+7=1AZZ692+V\:IJ!R'?07"REB>8Y8?^2U<'CP7;:_1Q7^\M6HWL/ M*R^6UUSM"A[$%>M$CMJY@N7)<6B(@T,<'F( T6%W[RI,Q($"7JWW3XZ+:O9@ MP*E"DPB3*M[),'CK>V8#<$*&<%^[=TU;=M$G6^5V<%>5K2YUN-S8&X$']02-R MM/1,8&4HL]=0LY)'2."E@0J==VR!"$R"_)4-:DC2IDV!9D2 8A@[FO M"$P)QVKMFFL+N0=IK"KL!>IG\9,7!O]B7$1\VB1:!SZ_)@Y]LK4DY[#9,HLX M$CU-_L)4MG8AMWX6@[H%ZXM4M<.7EP3L.6P5"%APWRKJ5;CO=>D =BW7J\P( M;_+Z%)@3T2F70;)81PDY9,_Q:WJ^UG#/!EL?^BIQ (**))$]FRD787>/!S)) M9+18")4KH7(I]#M=#+'57+J=M$#)\_'#E-U8WMU/'NA5)E2BF5T9T;G/'$A M[6FX[#:#GFO)WA<&C00%$*#\&R%2M4#*;K/QXCVKXA$\A<$R6'BT'6D! S$@ MV+G2LEI8'J,3"/$!D>UW#>#0+[%WF\>9K 3!O&[#[(78=X-1I7;IW&G/* M8[0\2C<>*%AK8J'U2.^,$6YF=_&CT"9>MVAL*?U6T=HG',:W0J^R>SB JP,& M-[D:)&B\2\SF_@7QV2PCQMHYN)/I[8#YQ?AN2E-T'^:SBU_O2?C8WH29DL=I8O9[:^3^_GT_'I"JP#=3!\>9N3$>#N; M.W@JE#"BDH42?02[.<=.K3M5K=5 MP.Q;5^+4+FZVO% ZO:3YS8MCCU[$N&7_>D?YCCW^0N/;2_3;^/Y^?#M_<-(^ M]B((8CO:AQ0XJ!K.J]LUM\L=EP.WWYW)5;/SI8GG)5(+F"@#BAC4$<][?LO8 M!A4]PAR]U>V?3DTJQCVGH1]I4G,N>A&E#EF]6;&XA]UC$OB!%RL'EB6S05XW MB)!IJY)7#G;)UJE]F_9$<=F'Z9-CM.V(# QH7K<0/14FIEJ'F;5 PIU.M5%O>EE63:?'4@/(+ADMCI] M:^&)S.1#.\;;QNC0QRMM8NBQ^RF$4[N38'9S,YW3DCW\L'0Q8^DWD]L+ M%XNKF[&_6L54$]ZW63/U,<%_[LCV)L\FX=;6^7!545L1JN>JYD,1'^M:3NI MN !6,Q4SFZ1\J9#3X$3&/!VF%1"T!12A*.4\IPR9%B;DN#CYWU^(S4*37R6LB+A.YMN9^61!\M,%09C6EQU 0RX Y,0L88,CW+XB"=H[]'OV?\" M.HE]('<7!\3=V:YQPN\6*I.=L4PJC"@YWDFYT&*&M1>'Q,ND=?E9[%TN64*M M(P,';:WDZ-8:YF0S:+4??J/EDM#UC.QUE"2T$@U'%%UXZ\5NW=SQ#-S *7*N MDIE38UN;);^IM8WB_6]1_,M'@8*^Z6J[?///EI'-*>-/3Z MY!G?D6_3+FMBI]M@"6B3:$:6VH&(Y7HP, &#%3W3Y>[R-XJ(>Q[ZC M<50#"FTG55&O';+X/%1,/!'#V1N^SEE0+296.S]J<+#%=G7XI5(Y)XY"\L\% MKJ@/PP.D-EPH:VM @'H[])>#XE,'0)PWN3T0@/J)8;K>YXTF6HGAC TV97NA M.3;D>0 G^GQ_[I$ON, /*XS3SW&TVY(M&QMG9;C0]EF# .T>Y@B=[U$V';'Y M* > ?I^SAF>NAH0[X/^P6&%_MV;^]9+2XCGWMI>%MQW >MO]\*B.3==D? !) MO\5I68-_G"0X+0KQWV"/9N;ZLY#H[UU,>Y6P0N1?PN@QP?$S[U:WW:4TVD8^ M\#I@$6_&X=K^@+T-@1_;+9!W% Q3E'_JINC ^I1?Z2KG!SJQ#ZR.UE%2Q6Z!H_$[)](@J4+.Z. MEV1=BZA%.RRI$(L1DXQ_9DN"S6[#ZYI\2; OU;7B,ZPB6&BO3!U]D>!5YB(Z MV0%%90%KYHIMO/@/HN0+CZQ)VSCGD&DRO5J,18OC(02\.8N )5ED]8S&"_+A MR []R9OXP59?P@:=33BFU=.>6*CJ?%\K9C-^ M\6(_0^-7G)"//@[]R>L6+\@_YQ']TXRXK2GA"N)OL=]PO @2AFDW#P9VM^". M$?3':DZ7?*QI4%39$WK<-Y700FQCHU+)\LTQ59)O#Z41^S,956XQ&U%LT@&E M?&(?K:+87W#PM&)D)RAZ3YAH\8T7T$<$M-$YRVO9>6OB-2[9\"CSIZ/*Y\CZ M_^Y"XF4B0K*?6%;LB/SS[&/V3_K%R']^8O_IGN,)_8$T_%D7]%^7UNX2 YF5 M[31S>7M8 :;!>T>B2%U<5'=Q\P*ISKJVPU+FP*5]R4BAZ\UVIH=!!_B>"4(& M[-9>7*VTE04HP]WFD>AS2HK<1KS-;03F"@*C;\H6?\1/01CFMAZ3_\MVM<=>/$+/ MI:> *Y[",_,4<,4S*/;%*\EGT&OP** *SK15/=MJOOG#O5>V_D1_QGZQ*(VA M%TO2OQ,2+'' _IGM-J"!=I\U@B]V %+$K&_5*3H?]::9AS0]&9>/.9/?YW[0 M1>D&71,O2-="M=>*L[(AT+J,EDAN9O]RQS=;'!6KH\KRB*[OHJUTE^CZAXJ7 MO%9[Q1(X5+T2B*!*IODW-4JG.-XPS:E=9[RZ]> YPT7+Z2 ;=1&!_ 3,/H2-[4$BYYD#22QM?CGSP'1 MJ_%BM6?)->/7(.F0UBJ""GU+H(R\*&NLF(!^IZ/=<'"M8@@>E]9C8MW\5#D' M XAK53'7-W@949=(VU-0 @KN#2BB+N+H0[-6L7<55N> '+/VL+C#6W,=ME>S MV!H\#R#F+.,R8?KF[ ;3TZRQ*6X Y8S];413Q,1\PBA+_SU#O_-9CAI?)?3> M9+A\VXJ,.W:VG2WUC&LK3\**VL=641-KIP80X-:R$2UUT?H()EH]H)6)U$=8 MD=+F&2W[U\?ZMF.4J8I/ M)V9]/_5D?3]!JXX.@;/K(,33%&^:HE2#Q0;+1<$M?$^D$RDPO@2+^E86*=]# MSD)1;)@MA7ZGBR&VFF.^A ,$C#H2$-Z/Z5. !X^U'TMO+]DRDII2@NY)*A>S MJM =R6-1)X8H*:42G9JU%"<#ZUMOB0J'12-6>6#*&>^DFQ#H) /H28 ]'X;K MH6)W9>YC?;2BB0Z M8X"EW"R'*5]6"-D^&LIYMJ!SS;9.8.F$P MG4)@2Q:)_(?4B]-!D,CKT7DLR?<_O7#GQ7MTQIYE_C@0-A-R:!T>EQMZ4D"? M6E !\UB$DB[T5D1B#J&I*B>2\H^W6-F+T8 (??FAA'2[?J@>#UBA-0=\D$ZH M'99-;_ QZ-&!/_AVQMG09V"E^P1E[H40T<]>$,["\K_U/8H:!'BWH@$ID>C1 MX33"7/[-@8YY6MCD&%3>SC*I>TSY"YP5?=5/NP6J./OFR/[$D0WQ$WWQ?"+H M.F#GVX10T=BW2.!IW5+2^;QB(EZLPN#/'6Y]SJ-V"SS$7J"]C($)W<-#EQ$J MX*-R :$#!S O-ZI=?- MPK7H.V8(<2N^(VZPS+AFF7G5J=!FXA"-%@X!>K\QV,;!;4D#\ZCUPJMQCCV& MOPG"8+/;Z.5S'TZ"TMC'6S_FENQWM_*SNVX:3(,W,HI0BS=QB47&]EZ%C"V4 MY,/)T-K\&)4:S_#?WR$A*>KV)BT[^3'X-D4PLW,?SZ*TPVUJ3F0_ 4!LM@P2HV5EH\[&B)+UKCZ''M+?Y R6)%D$I86E-+YQ5G MK+0MH1\\ 5E!XGO+2;YA/2YJ]S)]Y5YI+>%(\I4F6:0IRAQ6F:EL.P&KAQIX M?9&$*(^:L@E"]!B$T8:F;J^]- T6F"J@S6[MN:9V>N=X%8^JNT3!^%WY5[X/ MDC^N8HRG88H)^Z;W7FI4IDP(SP4_2(*PP)^I3";N#)F.Z'R4 T 4@@.WLAV0 MO0^(,[&D2,5#X-+5Z=+&)LFP"?)/U(26$YZ0BA@J>S0*,@BK;/*"_+]&Q)0P M7=BB;I0OQB20H>,C6D1054%%XY 2 H .&@[O K_G8J037E8[Z/A+4_H&].*$= M%6Z\=!>[DKYO@$BM/';1+B)K8$=+D#OM_#1)F;;3TR!B;NB.R^ Y\''H]^WJ M',!UV=$Y(D"KN<_'H7\$>%U+O7;4FY$@5^"T'P2GH=P8U4_F"]%SVHEI$LO. M+DR#3((TU [3P _6.QIV>J#!:Q;?GKPNUCL?^U>$>+0F_R[-WA).O)C6X$_N M<,RJ]FO5JN]Y5?@^O#T13]BUN[($*M= ^2*(\C>J+$,GY0LALE+6\L6URNW# M<*!B-]H>V<]B 8INFS[?-P,P*?P^Y%:@W9-AR5PKJ]$BWHZ68+? @TJ&=7@& MA);K6V^#]>J[2^& E9F1(Z@H%B-$9[E7N%SU$XJ+M*A]/WN,.=ELU]$>XTJ7 M=K-$Q'9 T,I>A&+M)).-13PNRT>[6.15!ZDJ+HY6>#5&QSGK*14H)=LGDR9[ M"B)KO::7=G\X"7+<-)<9==#_!Z6Z^.C&R?\Q7-$DAP M3+WS2I-.9WR01F$4.AQ-DF@Q!+6*XI1&X"_Q8SHGJYD<1)N!0'L5;:C5K!4= M]Y8U(Z4C1XB.=;&_V! (@5MC(0,J66(1]P$*DMZQL6TZ6'2U%1U%;G.IH]=0 MR,"%;<7,)HZ_"CG-GL!"U8T_I3IQFCL6B MS873(&9M+)E='L/M-ALOWL^6E?>0X\4BVI$=AD]WT3I8D)W-\6NZ\]9F;^&, M5H!]"F=(E)ISRN'0-V_5YZ8E*)3#0ADP%^N0]TR,2$P,0HLW&;!O>R>!'RU8 M.PPF5]!42*HOD$LJ;'.62#FP=\[X8]T5AL([OP[:XF0\N?&&XF/)C MQC>*4YMP]X"=6*D0W6". !!VQ$2)Y+ %\,&7K,>L1D.YTVW?B_%).BVCV61]W:/";%+Q$U^\(H=&5T#MP*"5N\B%&M< MZ%4YT-5;4]DW4[LYE7PPBSQ8KD]3+6?+>>R%"3F+$4](\R)5#@E,&ZH@*6%' MYVXBE3^<6!^J?C5[+'G'R@#AN[6W8)7QS"XH6Z! *\16Y([9+QN(BI$NWE%J M8[.58@.NX<7LIZ3>A;P'H&R&2QFN M79#:$N8.DB2*]RAD^#F5!=L%L[L2LULA9F"F6$G.A%981<@LZ@UZ),J< E&R M@CC9HQ$(M/EM0ZW&@.SP6WI_P#?=!I362JL1?*L.=](7WC9(O34#*[]Y/A M MZ7S;ADXCC&/MO- M1=$;CQ54UC\$B8!!*V,9JO5#1#:>L^ (E5,0F^/4R4@/-RY4E5:(CW3@"/DX M6<0!>^7FG.%18E7% Y.<3RW&Q.@FIJRK[>6.%C._X\VYZ5U@T M-!_C[,/EZ+9A"1?>A**\59Q!! (BTRI&I\EHU'; )-U#\Z+,('6XQ1VC*4LKXQ#[P"PP7Y M:X[?,$I1EF+?'<'Y*D@07N,LYXT,IC6F*9+;''6"]!&>(%GTNB(C#3BI2-Q0 M*H%[?JJNE3(\T(<^:@AK*XWL'.N$P]$!SWE$P[;;0WW2ID@&.]2:O]DQQ+I9 MO331PA$UTTT 55P336GN\AY1<.SD?[Z*8L*#S_2EV'&^A)+7TFT%$*^F*U&T M0W"C_$<"%^6 42VU"# X-PA=V@Y720;"B<"=-9R]*M=TK[4.C]F\RV'G9Q&0(WKYV6@GV27M'(AD$%6%,B'FSUYXIU*12 M/:(^:;^G9];OJ6I:''*;^R8$;VY%WZD=69=U@'S>PM(#:-$S2F'W<2@8R+?6;K**U3_Y&RPS0 M5_/SV/.) KOT]MJ7LL;K0-_3=B!0K;<9K3%8PLHSUQBT$2K@H0I E$%$%*03 MWM4 =*GBFV;X^@WX@M\.=A46I0O#CI("I3JX5Q,L[KQ]IM7"1;#U:GS5ENRB M" TJ04X96:G0YW-1-GF$BNE.I) 98SI^>HKQ$[/@^2CD-9;C N,W#,S,3*@+HAA45HZSG/5<>@3 (#F2:=T&V@LYV$'2Z>P;=$.+IG.7[7A\_ M$IB[(:[CME$24%_Y5P=0)FBZZ@TI*" -ATBN?3K$-,?$T62Q$]I'(;DL'T=I MW?^T0P&]VQ$A5W>YL[&(#4:7[>_$AE6 _:##"XKCU\6*_!4C+Y\J? '>+=B M]JEH>Y/$L;L0J43)[SEDXF3Y50D-E!".G?RY"]+]/:8:B#<+?-BN ^5JO2J@ M0-_L2=%LO.K-9OT%\7DCE,W,$Q[I7 <\*#,,L7I :B6[U(# 5$Z1H]9+#2C;M_<&>/WG+L2(?/R/" 9#_2HQ MEKX=4.$81:$35(]1D[@.BF$6!T]!Z*U9TM!ED+ V&F+%T.[P2X&!GH$54#UF MMGP*3U1$^21@.>H7Q>FE \+3@:>4SY**W-G=RGIU<9V_1/J&5@@'TM9*$&Q1 MV5ZCRB83W3-(F@B>XQ O@T5 %$6ES-(2>S3V[*914N%1J5U28- .TO2%):3$ MV#\N82D2IG9%H@ .U#PIH7O,><6D X_/@F09!FX[(EF]W!'7HH4U6NJL*S=; MRGP[C.$B\Q3+.FM 1YZ5634X<*&NK305Z0 'STW)Q6F6.,687@ MA)7K$^FCY]MY_O-HT#15\VS.+EC?XRW9+.U=S$I75I+.4(S7S)U)H^J-0PMM M'$L+U19]>8Q45^[MVOY+O/1VZ_0Z"I_2[(1?V=-L24X@K%Q>-D['*= %#>DM MZ)-!ZD9DZHZ-/] E/4Y//JO;(0S?D9/E*BX_%3,R?]K1!/4_3#D?:E?8L;X M-GLM10N,_>2*D"BO-L_5D>X!7@ )^L N1+)>B84/1I1K4+4"_V7#^R70T[@6 M7F/?#RC/>>OLMB3(9CAC==5Y4K&CDH0AH4[65]X"C]GS8[-S=66^&Z?J X2D MQI".1N/&Y]?#7O?W@$GV3!-YRN4>' @2")$J"U?$F/8ZI_5G!L*DO[>HBA@= M?YO&%ZC=#UUX2G'<&H:SIZJSB.RX]"G>YJ\ M;G&8:-]FM$"!=H1:D6LODQ'Z_/22C77*_U%&YQXOHJ'1'J71#KP@*Y'I>&4W5-/Q96+N]AK^7[XXE*W^+_!Q+ M%M@[S,ARH!"G#30=JPS6Q-_"R7BQB'?8-Z_L M)0,(;:]54*Z?4M@<5)DT0MDT5VMYZ6.9(Q2T( 1NQI6Y53%K0(U5H4(:XC(T M"L<%RQ5H%,X@XHHFQ44Z-0#$ETQQZ&-_V-N]KL$-,49'MQ+^8>0>W,(I\YW& M,=.L3HLT4V"V),));69RY^UIUC81TNCH581ANH 2:$=R!A3)(+A#GRU1#@)E M,*@%BVJ/B)PP9[VC3Z30R]'?9N@'%'VO]L#(R4R" 2EPC+^SJ0,ZND G?T!# M$73IGU$D(Y+U"&CV#_;HY#IZ(5['Q9IX)>$32V90._?K083IKZ&)=.T"L9C/ M%!B'0/_)WV!Q("B#PI.C' @'](@UE=H,:_+/-<=WD>&['09?@PX='1$^RGK: MMN&?LJ_>2 5'X@9&4B[H\6$@XAUTU.V./G^;+6D;@+L8/P?1+IE'I:;4\K2D MP$!]*P54C[F43V$IEV02RF>A>52I&NS*JVMS_.B!A>)WD&?HCE?8";%J5Q#: MI)=_P&$Q-7?_#% ]TJ3AX2>M8DQ_+K%VS.E3541R-T]1"]D+]E3]SDJ/9-[! M3;E$NP0*5-A'BISX@/+ 6X;S25FG2 ="/UVPXMUPRUK$1/*>HLAWH65P'^AE M)\BRIR6X&Z8G9\((EY*0V:P20%9GKI[N[4QE)O0US $2S76[ ?HN=-WRT$T3 MNUP)J6X?)IG+?.N35W(X"I*6W8-?6M6E5;$HQ)&HPM0H)ILX]Q):@&A#$UZ8 M[SJ.8VK"J"^;G._+,5G_F_&+%_MM!8V;"S[WMB!8Z?0>2=9:&GFVY![16S85 M5>&CZ@+H?'\P,%L$L57:JBF#>!Q6R!;E9'N4D.UQ?S!0B6QP1=+[%E)Q*?6> M)=2>,N-+DU7&KX%V):7#R= NTS$JM?P-QJAT /J=#G&C.&UONP>WY(VLI&3, MF_C(\GG!2&3+?8?^'?E:M]X&7T;T28.R:1]B;3 K/PPA:PXMZU61VQT^S!%[ M;8< 5570@CZ#A)%P;5X,L?.*T':_%Z(U'O@E+K'$([YN M+\L('^@X+7J!^S;]":9Z=*,/J3P!U37CY4=FNS1)O9!>._*[J-Y<*.V%G?6? M#$C8NYR.4+8:^4>YW@CQ%4_##>N#CJQQ7\0GH*B3=W'=#+7XZ!O S&9@F MT_".LE?R*JNW=0.3M,&]<:7 M\[[R:4R'3A):LU3F@"79;M031--=\,;0DF M*T(>1(C"#=2;7>CM_(#HH&_1FR!/P:NU-H YPO5"E"K^K*2"CY91?$"C@AKT MAP6A(GHS%!VZU*+JA1X-!KD8WG]64Y#0ER>[&.N6J!KLV^^VY"_"CS]JR3>% M[?5N9$CDK=]-K,CI'*>NHGB) U8Z;QSZD]=M$#,(A6=@^W EW]"I'[542-YL MW\496\*$K8I]KZS/BHA5=H"F,!;?.7HWV( ,#/;?,Q!?V?&L)R(M"R+AOHGT M$R=2R I(MD8Q3X%(4DXZ^<.MLE6Q9O.'A:$7K;,(=>A]0U#X]VWIOO0\WL._2TY>^+NE>PF M-]SBQ[?"W"/;SL, 1_5!R2_5U4 Y2PZ2ZK"2!+59224+FN40^-%Z[<5)6>*C M_VMT\]Y'L-3C,([8ZW1.^_V;GH&>\YG:G1,R\T4BDZ&E[^;P];L[Y^,%?7\, MD["!N&9)8XK;%,X%^,/3GD/H#K2E3[A_5!M$K_9S8AE J#FGTKA>Y5HYR M@V[2V69>-43,]1XE>S+& :GCA*&-4#CF,9/*=*3>QI3H= MQT 8XF0_7GHIOO*"^%=OO;-V3M3=UJF>#/7)/Z2#D-W\B8Y]; BBFT)T5XAM MZZLX_77_%#4]OJ04>J:C&Q[M(Y^]FA,8Q),]_1DJE4'/>V8:Q9XBSZM&FM10 M/I@+?58Z0J36<(_\%Z*_NUA N>/>P3VO)B92;UWS"5K)Z4/"2A:*V'4OE^ M/%2^G\0D@&G3W:=0M7?O[E&BH(.W[*_)>)>NHCCX%_:_A#Z.*P65Z(:3\_U! MW/F>1D%,0@=#; $Z C$,65LSV?G30#;4Q9B&<]0 CY(,*'8=[J+ZD+F34%UU M#/KH=]5M:;?NC[J24?6.J&C_72Z%V%JH6I:$.165O/!#$75D.C%L9@O$A& !VF.FS] MAW<_?(_>HK/O?GSWX8.#X3DI M^_^T@1^/CQW8_?#[=_\RB:(O-$(78LSM4L MO/(H5:/D=E4BY!BJ$2TZF@(2]ZEMN_F[T\",*Q$8Z9;_2F7L+?KAC,H_?IS%670KQSPG+? RJ*'I@F76$G'8H&V55T*>J"VU6/ M7)$/I^M55.; N14'&V_^_G2(6XZ%<-/$0/_DG&%6(/.2#'')--=96F*;:_Q\ MHA'1ZWY[<7?>Q0E?Z8B):S-4>GU2S;P'(^XPD5,!<4_YPDE!-0Q]YR37"Z>J M9*,7'&<(;8(4Y/[I> ]?Q454G;#V-,$(L=4SM<#6__KNIN0$KC]='F4DN0G" M8+/;@'MY-D7:WEU3LSR?J(+\LMU*%*0]LW>\EZ_*(ZT3VJ;"9*M#*DR7""U0 MG-XKE.*$$S,P'[-9WKN\V.ES=TH1MGY7!(G/]4VT1K6&&EZOJY^V&Y4:=(AP M:+I9J$RC'V6TPRS07;^JJ\7R'Y;3K"E49KY5;R\BA?KU.L1_^#AH6" M+DA?EU\L5Q'V762I?CAQ=5QQ>\*J;C:.J6/>8OIL@/U]$81I[BW3GK>O21PH$ZLR@@>"R#; H]#V234!0C-FTT:/MEDY.! 7;96/!6TGWA4Q[?!.,$WIL *$CCVHDM%U/?HJ'-D)&ZB%/TH!1$-H2(TVU M4)*XOI5"T5RPNY=4@G+/3ZJBJ:$DBFF.>Q8B])J4Q7!X]>Q1B! S4AK+'. I M>!4UX33T*XXELV\E4CG*=6D?W'T!=[P2=9)HJ*-JT,#E5KO_'Y%%-W(V!&FD MG0%/(;[F &&&[SW9DRMM3I$YP>U%3!4E,QJ5.W#9^]8T3)J^N9Y5&BBZV4>C MYFZ+N.?MJY%&V<+DX477;*X5JDAUZ%"QUV%BDT#Z\O1"F9U[ZO:A5 8+@0YS M3%$#[\XA194<)F%5UY3EP"11[75^ O%9(!5Y6N'< =Q)'>TQ6!AX6'=2;1GW M'$I5\IB$EEU3E)9((U68IQ>C!E*BMV>QDA7&*?'J?2J%Z MZ_5A38P@9,,7.P)HPU@^9JQ,3=2!T4H<<> MZV=+-32DRMDUBU9Y$)D+M]9! MPMJF8-N;VR,]@)&KOM3.=^+.N0:0]H6Y$[S5!CSO %*F-[N'*[QW8 ,3L1%4 MMW=L-R^K@)S3Z(R-%_]!@-!NRV1GY+<- _V,DY3NA]@Q/V"BLR+K/]*6U)2L MR3)P[@1GVQXH=(.W:PPZV-(IH7F8!L_X:!\:O30%K,^FG)HH+Z>"K(Z8C1H#TYCK\H$2\(8 M'YV5JB[\IFS@5%EW %G3:S>DQ1(WY1/*U;#]'7NW6F),"8M\CR9_[H)T;R1L@$?\KI^V M5CV9G(%CY]HP:DBLN8WNM5GC^(D HY]T_!I(*UHVS "QOL>;KC_9RGY'O],1 MCAB=1E*W&Y@F.O?QH2\C6F5(RW .V1#=UY<;J?DPTEWH+5ASO?5W]IL=#" MHGL:D*'KD6H1H<[2; AB8P"M?E\?0\4D&']C&,9N]3L:"X(US(2J%=B(A(0! M ?T.57**-*7T*U@L1;D*,+TZ6^SH46BV7 8+W-Y97BA_(E#0VD^,9BWAFXY& MQ7"4C0?R2WI$;/Z.)JX_)6BR^ .OR9AX[UXP7H,UE12XG"\[N/B3S78=[3%. M--SYXSD@KGM]X[6^8_D(Q_S4%I*W^Z3-].[CHYM=;#9,!SWR-Z+3S@UN7E3V MB 1L^**=N>01C%;.ZO+2C/BZNW5*\VDT=%Q]%LR#V8;-UZQ].<:9R$-?^P9Z M=-G&,H*WE"W\8L\3YC< T]#'K]B?1],DV9%OQJ^#YF1QD_B $DQHWU@1\6/V MRV[$LGDT9Y//_$N2W:&-$)WM:K1 YW,KN9D:W]H=IM:+&BA"@XHD*"-KS,JN MQ1WT/J\P%J'U;3NX$UEOCG'HYUFZ<_Q*6W&,'Q/6E4/+E99# _6L59!M9L8$ MD4G%*PN432/*-)OH0@RB,XI>%<4WV;S^FQ:9IU5T1:YXHY#R:8[E4RC+HOSD MH2J(T&U*QS%[_T'9X7Q?#KGS]BP7@'PP/W]0
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
&UL4$L! A0#% @ M;8.O2K_+0;VJ7P [<4% !4 ( !

Options and Warrants (Details 2) - Warrants [Member]	3 Months Ended
Options and Warrants (Details 2) - Warrants [Member]	Mar. 31, 2017 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding - beginning of the period \| shares	506,026
Number of Warrants, Granted \| shares
Number of Warrants, Exercised \| shares
Number of Warrants, Forfeited \| shares
Number of Warrants, Outstanding - end of the period \| shares	506,026
Weighted average exercise price, Outstanding - beginning of the period \| $ / shares	$ 5.25
Weighted average exercise price, Granted \| $ / shares
Weighted average exercise price, Exercised \| $ / shares
Weighted average exercise price, Forfeited \| $ / shares
Weighted average exercise price, Outstanding - end of the period \| $ / shares	$ 5.25